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Abstract 
The rapid development of DNA sequencing technologies has opened up new 
avenues of research, including the investigation of population structure within infectious 
diseases (both within patient and between populations). In order to take advantage of these 
advances in technologies and the generation of new types of data, novel bioinformatics tools 
are needed that won’t succumb to artifacts introduced by the data generation, and thus 
provide accurate and precise results. To achieve this goal I have create several tools. 
First, SeekDeep, a pipeline for analyzing targeted amplicon sequencing datasets 
from various technologies, is able to achieve 1-base resolution even at low frequencies and 
read depths allowing for accurate comparison between samples and the detection of 
important SNPs. Next, PathWeaver, a local haplotype assembler designed for complex 
infections and highly variable genomic regions with poor reference mapping. PathWeaver is 
able to create highly accurate haplotypes without generating chimeric assemblies. 
PathWeaver was used on the key protein in pregnancy associated malaria ​Plasmodium 
falciparum​ VAR2CSA which revealed population sub-structuring within the key binding 
domain of the protein observed to be present globally along with confirming copy number 
variation. Finally, the program Carmen is able to utilize PathWeaver to augment the results 
from targeted amplicon approaches by reporting where and when local haplotypes have 
been found previously.  
These rigorously tested tools allow the analysis of local haplotype data from various 
technologies and approaches to provide accurate, precise and easily accessible results.  
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Chapter 1: Introduction 
The development of high-throughput sequencing has helped to advance the field of 
molecular genetics, with the ability to generate data rapidly outstripping our ability to analyze 
it. With these advances in technologies constantly increasing the amount that can be 
sequenced and advances making sequencing cheaper, more and more research fields are 
performing sequencing analyses. This has necessitated the need for novel bioinformatics 
tools that are able to analyze a large amount of data at once and that can be used by 
researchers of many different skill levels. This means the output of results needs to be in a 
form that is most readily consumable by other analysis pipelines and researchers in order to 
ensure the most efficient workflows.  
The availability of high-throughput sequencing has been a great asset to the study of 
microbial populations, like the analysis of bacterial communities ​(Taft et al. 2015)​, viral 
quasispecies analysis ​(Beerenwinkel et al. 2012)​, and malaria infections ​(Lin et al. 2015; 
Mideo et al. 2016)​, among other infectious diseases. The analysis of microbial populations 
differs from sequencing approaches carried out on a human because rather than 
sequencing a single genome from one individual, there exists a population of individuals 
(microbes) with several genomes present. These populations are clonal populations which 
means that many of the individuals have the same exact genome and the population can 
either be monoclonal, meaning all individuals have the same exact genome, or polyclonal, a 
mix of genomes with varying degrees of differences with some individuals sharing the same 
exact genome. These polyclonal populations are often referred to as “complex” mixtures.  
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The study of the ​Plasmodium ​species, the causative agent of malaria, has benefited 
greatly from the advances in high-throughput sequencing. ​Plasmodium​ is a protozoan 
parasite transmitted by female ​Anopheles​ mosquitoes and there are five known species to 
infect humans; ​P. falciparum​, ​P. vivax​, ​P. ovale​, ​P. malariae​, and ​P. knowlesi, ​with ​P. 
falciparum​ being credited with the majority of the fatalities. Plasmodium was estimated to 
infect 216 million people and caused 445,000 deaths in 2016 ​(WHO 2017)​. Immunity to 
Plasmodium​ is not sterilizing allowing for repeated infections and people living in endemic 
areas eventually stop experiencing symptomatic infections by various processes but mostly 
thought to be achieved by building up a repertoire of antibodies to keep parasitemia low ​(A. 
Barry and Hansen 2016)​. The life cycle of ​Plasmodium​ is complex; it is diploid within its 
mosquito vector and haploid while it infects its human host. It undergoes several stages 
within the human host including a liver stage and a blood stage where it spends the majority 
of its time inside of infected erythrocytes and the species ​P. vivax​ and ​P. ovale​ can lay 
dormant in the liver.  
Plasmodium​ is a long time enemy of humans and has been credited with being one 
of the most powerful recent forces for causing genetic changes within the human genome 
(Evans and Wellems 2002; McManus et al. 2017)​. This genetics arms race between humans 
and ​Plasmodium​ has lead to the creation of extreme diversity within ​Plasmodium​, driven in 
part by balancing selection and directional selection ​(Weedall and Conway 2010)​.  
Balancing selection is a phenomenon that selects for diversity, especially in immune 
epitopes; the more diverse an epitope, the more likely the parasite is able to survive and 
reinfect a host with a previous infection especially if cross-strain reactive antibodies are not 
able to be formed. This is especially true for infectious agents that don’t induce lasting 
immunity and lead to individuals being infected multiple times which leads to a strain’s 
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frequency being inversely correlated with its survivability ​(Lipsitch and O’Hagan 2007)​. The 
presence of balancing selection is important for vaccine candidate consideration as epitopes 
that exhibit balancing selection will likely not make good vaccine candidates because the 
parasite will have the necessary diversity to avoid the antibodies induced by the vaccine. For 
this reason many vaccines for ​Plasmodium​ have failed to induce completely protective 
antibodies ​(Offeddu et al. 2012; Ouattara et al. 2013)​ with the most effective vaccine being 
only 35% protective ​(Neafsey et al. 2015)​. It has been shown that even a single base 
difference between strains can prevent cross reactivity of antibodies ​(Sedegah et al. 2016) 
and therefore it is essential to be able to achieve single base resolution for the study of 
vaccine candidate regions within ​Plasmodium​ for both informing the development of a 
potential vaccine and for the monitoring of current vaccines.  
While balancing selection maintains diversity and prevents allelic fixation, directional 
selection promotes allele fixation. Common examples of directional selection include 
mutations that help parasites to adapt to a new host and mutations that induce drug 
resistance. These pressures will cause a single mutation to fix rapidly within a population 
shortly after occuring. ​P. falciparum​ has a long history of developing drug resistance and 
often resistance can form with just a single base change like the K76T mutation in the 
chloroquine resistance transporter (CRT) ​(Lakshmanan et al. 2005)​ among several other 
examples ​(Basco et al. 1995; Nagesha et al. 2001; Nwakanma et al. 2014)​. As these 
mutations are not selected for until the pressure of a specific drugs is added, mutations can 
stay at low frequencies in populations and it is important for drug resistance monitoring 
purposes to be able to detect these single base differences even at these low frequencies to 
help predict the possibility of drug treatment failure ​(Ngondi et al. 2017)​.  
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One method for analyzing ​Plasmodium​ diversity is to focus analysis on specific 
genomic regions of interest by designing PCR primers to amplify and sequence only these 
regions, an approach called targeted amplicon analysis ​(Lerch et al. 2017; Hathaway et al. 
2017)​. Depending on the specific research goals, the targeted regions could be genes 
responsible for drug resistance ​(Ngondi et al. 2017)​, vaccine candidates ​(Bailey et al. 2012; 
Neafsey et al. 2015; Mideo et al. 2016)​, highly diverse surface antigens targeted by the 
immune system which make for good biomarkers to trace strains ​(R. H. Miller et al. 2017; 
Patel et al. 2017; Verity et al. 2018; Lin et al. 2015)​ or regions that are associated with 
disease mechanisms ​(Patel et al. 2017; Waltmann et al. 2018)​. Complex ​Plasmodium 
infections, being infected by more than one strain at a time, are a common occurrence in 
endemic areas ​(Juliano et al. 2010; Arez et al. 2003)​; as a result, in some research 
approaches, samples from multiple patients are pooled together, a common technique for 
studies on drug resistance mutations monitoring ​(Taylor et al. 2010; Ngondi et al. 2017)​. 
Therefore it is important that any analysis pipeline for targeted amplicon sequencing to be 
able to detect differences between strains within a mixture with single base resolution and at 
low abundances.  
In order to accomplish accurate targeted amplicon analysis from high-throughput 
sequencing, the various errors produced in the data generation need to be corrected without 
over-correcting by removing real biological variation or by under-correcting by reporting error 
as true biological variation. The major sources of error are in the PCR amplification step and 
the sequencing step. The errors produced by PCR include the creation of single base 
substitutions which can result at appreciable frequencies depending on the amount of input 
DNA and the PCR cycle within which the error occurred (e.g. errors in early cycles of PCR, 
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especially for low input DNA amounts, will prograte into the next cycles). The errors 
produced in the sequencing step will be dependent upon the specific technology used.  
There now exist many different sequencing technologies which all vary in 
sequencing methodologies and the number and length of sequences they can produce 
among many other aspects ​(Quail et al. 2012)​. While technologies share some similarities in 
the data they produce (e.g. most technologies will supply “per base quality scores,” a score 
representing how likely a base call is a sequencing error or not), each comes with its own 
set of specific biases that might have to be handled differently. For example, 454 and Ion 
Torrent create a large number of indels in homopolymers (long stretches of the same 
nucleotide base) due to the similarity in sequencing methodology they use; however, they 
also both compute their per base quality scores in very different ways, and thus special care 
is needed when utilizing the quality scores they report ​(Brazeau et al. 2016)​. Also, while 
Illumina, 454, and Ion Torrent tend to have decreasing quality scores and increased error as 
they move along a read, technologies like PacBio have high error rates that have no 
correlation with position in the read. For this reason, care must be taken when trying to apply 
one computational tool built for a specific technology to another technology; certain 
assumptions based on one technology's characteristics could be invalid on another 
technology and lead to artifacts.  
The majority of analyses with targeted amplicon approaches have been conducted 
determining various microbiomes by sequencing various variable regions of the 16S 
ribosomal subunit ​(NIH HMP Working Group et al. 2009)​ and this has greatly influenced the 
tools that are available ​(Caporaso et al. 2010; Edgar 2013)​. The 16S subunit is analyzed 
because it is shared by all bacterial species but, because of its extreme biological 
importance, it is slowly evolving and doesn’t differentiate bacteria at the species level ​(Woo 
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et al. 2008; Janda and Abbott 2007)​. In fact, the most closely related 16S sequence are 
often different 16S copies within one bacterial species genome ​(Kembel et al. 2012)​. For this 
reason the majority of 16S targeted amplicon sequencing is conducted by clustering 
sequences at an operational taxonomic unit (OTU) which involves clustering sequences that 
are similar up to a certain percent identity, commonly 97%. Clustering at 97% identity would 
serve to correct for any errors that arise in data generation but would also collapse many 
real biological differences which could be up to 9 differences for a region of 300 bases in 
length. Clustering at this level is not adequate for studying ​Plasmodium​ and a greater 
resolution is needed that would still correct for any errors. While some recent developments 
have greatly increased the resolution capable, these approaches either are unable to detect 
single base differences, like Swarm ​(Mahé et al. 2014)​, or fail to detect single base 
differences at low read depths or low frequencies like the programs UNOISE2 ​(Edgar 2016) 
and DADA2 ​(Callahan et al. 2016)​.  
Shotgun whole genome sequencing is another popular technique for analyzing 
Plasmodium​ infections. This process involves generating reads from the entire genome of 
interest, rather than just a targeted locus like in targeted amplicon sequencing. While this 
generates a large amount of data across the whole genome, reads all start and end in 
random locations and often require mapping to a reference genome to be analyzed. These 
mapped reads are normally run through a traditional variant-calling pipeline for calling single 
polymorphisms (SNPs) and short insertions and deletions (INDELs). While this process 
works for stable regions of the genome, it might fail to call variants in regions so diverse that 
mapping to a reference is not possible. For this reason, highly diverse regions of the 
Plasmodium​ genome are often masked from this type of analysis even though these regions 
encode key virulence factors for ​Plasmodium​. There is a growing large collection of publicly 
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available field samples that have been shotgun whole genome sequenced has been 
generated but remain unanalyzed for these key virulence factors.  
One of the major contributing factors to ​P. falciparum​ causing more fatal clinical 
outcomes is due to its multigene family called ​var​ genes that encode for the protein 
erythrocyte membrane protein 1 (PfEMP1) ​(Smith et al. 2000; Gardner et al. 2002)​. This 
highly diverse family encodes a protein that contains several domains capable of binding to 
various endothelial cell surfaces. The protein gets transported to the surface of ​P. falciparum 
infected erythrocytes and causes the erythrocytes to adhere to the walls of blood vessels. 
This helps the parasite survive by avoiding traveling through the spleen which is a major 
mechanism for clearing infected erythrocytes ​(Rowe et al. 2009)​. The adhesion of infected 
erythrocytes to blood vessel walls can lead to the destruction of microvasculature and 
depending on the location of the microvascular can lead to various clinical outcomes (e.g. 
destruction of microvasculature in the brain can lead to stroke) ​(Rowe et al. 2009)​. There are 
approximately 60 ​var ​genes each capable of binding to various targets and many of the 
genes undergoing recombinations between different ​var​ genes ​(Rask et al. 2010; Gardner et 
al. 2002)​. The ​var​ genes have a complex transcription regulation and only one ​var​ gene is 
expressed at a time ​(Duffy et al. 2017; Dimonte et al. 2016)​.  
One ​var​ gene of interest that appears to have become isolated from the other ​var 
genes and only undergoes recombination with itself is VAR2CSA which binds to chondroitin 
sulfate (CSA), a protein only found on placental tissue ​(Salanti et al. 2003a)​. Therefore, 
VAR2CSA​ ​expressing ​P. falciparum​ parasites that infect a pregnant woman can cause the 
destruction of placental tissue and poor birth outcomes ​(Salanti et al. 2003a)​. 
Naturally-acquired antibodies to VAR2CSA have been shown to be protective during 
pregnancy ​(Rogerson et al. 2007; Ataíde, Mayor, and Rogerson 2014)​. Efforts to develop a 
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VAR2CSA vaccine are underway ​(Fried and Duffy 2015; Tuikue-Ndam and Deloron 2015)​. 
However, their efficacy may be hampered by the genetic and geographical variation in the 
protein. Previous studies on VAR2CSA diversity have been limited to less than 30 full length 
genes and the full global diversity has yet to be fully revealed.  
The ​var2csa​ gene is approximately 8 kilobases (kb) long and key binding domains 
with the protein are 1.8kb. There are few conserved regions, due to its high diversity, to 
target for PCR and the gene’s long length make a targeted approach unfeasible. This high 
diversity also prevents traditional variant calling with reference based mapping approaches 
as the sequence differences prevent approximately 20% of the reads from mapping to the 
reference. Due to this poor mapping which is common to all ​var​ genes, previous attempts 
have been made to use assembly programs, like SPAdes ​(Bankevich et al. 2012)​, to 
construct ​var​ gene sequences ​(Jespersen et al. 2016; Lennartz et al. 2017)​. However, these 
previous attempts have not been extensively validated and it has been observed that 
assemblies done on polyclonal mixtures can lead to erroneous chimeric assemblies where 
sequences from different genomes are combined into one sequence. The assembly 
programs being used were designed to do assembly of only one genome and therefore do 
not handle the presence of multiple genomes well.  
In this thesis, I present several novel computational tools I have created to analyze 
the high diversity found within microbial mixtures with a focus on ​Plasmodium​. Chapter II 
describes the program SeekDeep for analyzing targeted amplicon sequencing to achieve 
single base resolution even at low frequencies. Chapter III extends the use of SeekDeep to 
be used on longer amplicon targets created by the PacBio technology. Chapter IV presents 
PathWeaver, a program designed to recruit ​var2csa ​sequences from shotgun whole genome 
sequencing datasets to assemble highly diverse regions of the genome, which I apply to the 
21 
var2csa​ gene to fully elucidate the global diversity to help further vaccine development. 
Chapter V further leverages the PathWeaver program to utilize the wealth of publicly 
available data to augment targeted amplicon analysis by reporting on where and when 
haplotypes have been found previously.  
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Chapter II: SeekDeep: single-base resolution de 
novo clustering for amplicon deep sequencing 
Preface 
The following research chapter was adapted from “SeekDeep: Single-Base Resolution de 
Novo Clustering for Amplicon Deep Sequencing.” Hathaway, Nicholas J., Christian M. 
Parobek, Jonathan J. Juliano, and Jeffrey A. Bailey. 2017 ​Nucleic Acids Research​, 
November. ​https://doi.org/10.1093/nar/gkx1201​. ​(Hathaway et al. 2017)​.  
ABSTRACT 
PCR amplicon deep sequencing continues to transform the investigation of genetic diversity 
in viral, bacterial, and eukaryotic populations. In eukaryotic populations such as ​Plasmodium 
falciparum ​infections, it is important to discriminate sequences differing by a single 
nucleotide polymorphism. In bacterial populations, single-base resolution can provide 
improved resolution towards species and strains. Here we introduce the SeekDeep suite 
built around the qluster algorithm, which is capable of accurately building ​de novo​ clusters 
representing true, biological local haplotypes differing by just a single base. It outperforms 
current software, particularly at low frequencies and at low input read depths, whether 
resolving single-base differences or traditional OTUs. SeekDeep is open source and works 
with all major sequencing technologies, making it broadly useful in a wide variety of 
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applications of amplicon deep sequencing to extract accurate and maximal biologic 
information.  
INTRODUCTION 
The development of targeted next-generation sequencing technologies has 
dramatically expanded research into population-level genetic diversity, from the study of 
bacterial communities ​(Taft et al. 2015)​, intrahost variation in infections, such as HIV and 
malaria ​(Beerenwinkel et al. 2012; Lin et al. 2015; Mideo et al. 2016)​, to heterogeneity in 
cancer tumors ​(Dawson et al. 2013)​. In general, targeted amplicon deep sequencing utilizes 
areas of conserved sequence for amplification primer placement, surrounding a region of 
interest containing known mutations or high sequence variability. Thousands to millions of 
product molecules from the amplification are then individually sequenced using current 
massively parallel techniques. To date, experimental and computational techniques for deep 
sequencing have been driven largely by microbiome 16S and targeted viral sequencing 
where single-base resolution is not a necessity ​(Quince et al. 2011; Beerenwinkel et al. 
2012; Prabhakaran et al. 2010)​. While initial microbiome work has focused on genus-level 
resolution of 97% sequence identity, there is greater interest in maximizing species and 
strain information in bacterial and viral populations ​(Benítez-Páez, Portune, and Sanz 2016; 
Beerenwinkel and Zagordi 2011)​. In eukaryotic populations, such as malaria strains, and for 
mutation detection, differentiation at the single-nucleotide level resolution is a necessity ​(Lin 
et al. 2015; Mideo et al. 2016)​. 
The central bioinformatic challenge of all targeted deep sequencing is to accurately 
resolve the true biologic differences that are obscured by the numerous errors introduced 
during PCR amplification and sequencing. PCR errors include substitutions, insertions and 
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deletions, as well as chimeras formed by incomplete extension and subsequent re-priming 
on a highly-similar (but non-identical) template (​Figure 2.1​). Sequencing error types and 
frequencies tend to be platform specific, and are related to either the sequencing 
polymerase or detection technology. For instance, pyrosequencing-based technologies 
generate numerous insertion-deletion (indel) errors, particularly in homopolymers, since 
these technologies estimate the number of a particular nucleotide in succession based on 
the cumulative fluorescent (454) or ion (Ion Torrent) signal. On the other hand, Illumina 
technology mainly misidentifies individual nucleotides, thus producing base-substitution 
errors ​(Lysholm, Andersson, and Persson 2011; Huang et al. 2012)​. 
Numerous computational solutions have been developed to correct for these errors 
(Zhbannikov and Foster 2015)​, including minimum entropy decomposition (MED ​(Murat 
Eren et al. 2014)​), homopolymer runs correction (Acacia ​(Bragg et al. 2012)​), clustering 
based on consistency of inferred error models (DADA2 ​(Callahan et al. 2016)​), operational 
taxonomic unit (OTU) clustering (UPARSE ​(Edgar 2013)​), k-mer correcting (KEC ​(Skums et 
al. 2012)​), and many others ​(Zagordi et al. 2011; Yang, Chockalingam, and Aluru 2013)​. All 
of these methods have advantages and disadvantages vis-a-vis speed, sensitivity, 
specificity, flexibility, range of sequencing technologies, and types of errors corrected. In 
general, the latest methods aim for greater resolution to allow better definition of microbial 
populations. The ultimate goal is discriminating sequences differing by a single base, which 
is the quantum level of evolutionary change. Such resolution will allow more detailed 
assessment of bacterial, viral, and eukaryotic microbial populations particularly with longer 
amplicons. Consistent single-base resolution is a particular necessity for studies of 
eukaryotic intra-species populations and for mutation detection. ​For example, in malaria 
research, the sequence of a single amplicon is frequently used to define strains within an 
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infected individual, and these sequences often differ by only a single base, representative of 
a SNP within the larger parasite population. In microbiome studies, single-base resolution of 
16S amplicon clustering extracts maximal information for downstream analyses. ​Thus, we 
sought to develop new algorithms that could consistently differentiate single-base 
differences in a wide variety of conditions and applications including improved accuracy and 
sensitivity of traditional operational taxonomic units (OTUs).  
Here we present SeekDeep, an open-source software suite for ​de novo​ (i.e 
reference free) analysis of amplicons that is fast, sensitive, customizable, and is able to 
resolve sequences differing by only a single base, even at low frequencies. At the center of 
SeekDeep is the algorithm qluster (for quality clustering) that improves the correction of 
PCR and sequencing errors in multiple key ways including base quality values and k-mer 
frequencies. SeekDeep also provides a growing set of pre- and post-processing tools, 
including an embedded web server to dynamically view results and ancillary data - 
particularly useful when working with large datasets and numerous samples, a scenario 
which has become common with targeted amplicon studies ​(Lin et al. 2015; Mideo et al. 
2016)​.  
We compared SeekDeep to other recent best-in-class programs, DADA2 ​(Callahan 
et al. 2016)​, MED ​(Murat Eren et al. 2014)​ and UNOISE in USEARCH (preprint 
https://doi.org/10.1101/081257), which also aim for single-base resolution. All programs aim 
to determine the local PCR amplicon haplotypes, herein referred to simply as haplotypes for 
brevity, that represent the specific sequences (linked variation from the same chromosome) 
found in the biologic material prior to amplification. We also compared OTU based clustering 
to commonly used programs USEARCH (aka UCLUST/UPARSE) ​(Edgar 2013)​ and to 
Swarm ​(Mahé et al. 2014)​ which cannot resolve at the single-base level. We focused our 
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comparisons on programs that could work with both Illumina and 454/Ion Torrent sequence 
and did not compare to programs that only correct 454 and Ion Torrent pyrosequencing 
errors like AmpliconNoise ​(Quince et al. 2011)​, Acacia ​(Bragg et al. 2012)​, and HECTOR 
(Wirawan et al. 2014)​ as we are interested in tools that are broadly applicable in the field.  
To ascertain the performance of these programs, we compared results of ​in silico 
simulated datasets and ​in vitro ​mixtures of isolated DNA representing mock infections of 
both ​Plasmodium falciparum​ and bacterial communities. The simulations focused on the 
quantitative accuracy of discerning minor (low-abundance) haplotypes in terms of how much 
they differ (1 to 13 bp equating to 99.6% to 95.6% similarity) from a major (high-abundance) 
haplotype and how much they differ from another minor haplotype unrelated to all other 
haplotypes. 
RESULTS 
Simulation Studies 
First we compared the performance of SeekDeep to the other programs on the two 
types of simulated mixtures: mixtures where minor haplotypes are closely related to a major 
haplotype which was at a much greater abundance (​Figure 2.2a-b​), and mixtures where a 
minor haplotype was closely related to another minor haplotype at the same abundance 
(​Figure 2.2c-d​). For all simulations, SeekDeep matched or outperformed MED, DADA2, and 
UNOISE in recovery of all haplotypes, especially one-off haplotypes (​Figure 2.3​). SeekDeep 
showed improved haplotype recovery compared to other methods, which was accentuated 
as read depth, divergence and abundance of haplotypes decreased (​Figures 2.3, 2.4-2.6​). 
Together these factors combined to show marked differences in haplotype recovery for 
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low-abundance haplotypes differing by a single-base (i.e. one off from the closest sequence) 
assessed with low numbers of reads (​Figure 2.3​). SeekDeep was also better able to 
estimate the expected abundance of haplotypes, demonstrated by a lower root mean 
squared error (RMSE) (​Figures S12-13​) compared to all programs. The MED algorithm 
appears to have trouble as a haplotype's abundance increases, which could be due to the 
fact that it was developed specifically for microbiome data where the abundance of each 
haplotype usually does not exceed more than 10%. Though SeekDeep creates more false 
haplotypes than DADA2 and UNOISE, the abundance of the false haplotypes is generally 
much lower than 0.1% while DADA2, MED, and UNOISE were shown, especially for 454, to 
create false haplotypes greater than 1%, with most falling between 0.1% and 1% (​Figure 
2.9​). While DADA2 minimizes the number of false haplotypes (​Figure 2.9​), it also loses 
sensitivity particularly with lower read depth input (​Figures 2.3, 2.5​). Overall, SeekDeep 
shows greater consistency at lower thresholds providing unbiased detection in the face of 
variable haplotype abundance and input read depths. 
In vitro​ Control Mixtures 
Plasmodium 454 and Ion Torrent pyrosequencing 
Next we evaluated the performance of haplotype detection for ​P. falciparum ​lab 
strains for ​TRAP​, ​AMA1​, and ​CSP​ genes on both 454 and Ion Torrent by creating mock 
mixtures in the lab that were PCR amplified and then sequenced. This provides important 
insight into factors that may not be captured in the simulated sequence. For these ​in vitro 
mixtures, both SeekDeep and MED were able to achieve 100% haplotype recovery across 
all samples while UNOISE had 92% and DADA2 had 83% haplotype recovery (​Figure 
2.10a​). Missed haplotypes usually represented the collapse of low-abundance highly similar 
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haplotypes. In part, it also appeared that haplotype recovery for UNOISE and DADA2 were 
hampered by indel errors especially in homopolymers which are difficult to overcome in Ion 
Torrent and 454 data. This is a known issue as UNOISE’s website states that UNOISE does 
not work well on Ion Torrent and 454 data 
(http://www.drive5.com/usearch/manual/faq_unoise_not_illumina.html). All programs had 
appreciable false haplotypes (​Figure 2.10c​), and, while DADA2 had the lowest number of 
false haplotypes, when they did occur they often had appreciable frequencies even 
exceeding 10%. Only SeekDeep limited the occurrence of false haplotypes to low 
abundances (<=0.5%). Replicates again aided all programs but dramatically reduced the 
number of false haplotypes for SeekDeep. SeekDeep again showed the most accurate 
abundance estimates (​Figure 2.10b​). Notably MED, while demonstrating 100% haplotype 
recovery, consistently underestimated abundances due to the numerous false haplotypes at 
appreciable frequencies (​Figure 2.10c​).  
Plasmodium Illumina MiSeq 
We also evaluated a mock mixture of ​P. falciparum​ across 23 loci that represent 
important markers of drug resistant or regions of diverse variation. These amplicons were 
PCR amplified and sequenced on Illumina MiSeq 2x250 paired end. SeekDeep and MED 
were able to achieve 100% haplotype recovery of all 23 targets while DADA2 and UNOISE 
both failed to detect nine out of the 88 total haplotypes. Five haplotypes were missed in 
common by both programs (​Figures 2.11 and 2.12​). The haplotypes that UNOISE and 
DADA2 failed to detect where either related to another haplotype by a single nucleotide or 1 
large indel (~10 nucleotides) and ranged in abundance from 4 - 20%. SeekDeep 
demonstrated a minimal number of false haplotypes on par with UNOISE (​Figure 2.11c​). 
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Unlike UNOISE and the other programs which report false haplotypes at abundances that 
can exceed 10%, SeekDeep’s false haplotypes were all less than 0.8% abundance. Again 
SeekDeep showed the highest accuracy in terms of predicting the abundance (​Figure 
2.11b​).  
Mock Microbiome 
We also tested SeekDeep on a mock microbiome dataset previously described in 
Salipante ​et al​. 2014 ​(Salipante et al. 2014)​, which had been amplified and sequenced in 
triplicate on the Illumina platform. It contained 47 distinct 16S copies (​Table 2.1)​. MED and 
SeekDeep were able to recover 100% of all expected haplotypes in all datasets, while 
DADA2 missed one haplotype. For all three replicates of this dataset, DADA2 missed the ​L. 
monocytogenes​.2 haplotype, which had an expected abundance of 0.8% and is one 
nucleotide different from the ​L. monocytogenes​.5 haplotype which had an expected 
abundance of 1.5%. UNOISE also missed ​L. monocytogenes​.2 in one replicate and in all 
three replicates missed ​B. vulgatus.3 ​(0.035%), ​B. cereus.4 ​(0.33%), and ​B. cereus.1 
(0.36%), haplotypes, which all differ by one nucleotide from another haplotype.  
Downsampled Mock Microbiome  
Because the mock microbiome dataset previously described in Salipante ​et al​. 2014 
(Salipante et al. 2014)​ was sequenced to a great depth (>600,000 reads), we randomly 
downsampled the dataset to lower read depths (2,000-20,000) to test detection at levels of 
sequencing more commonly employed in experiments. For the downsampled mock 
microbiome dataset from Salipante ​et al​. 2014 ​(Salipante et al. 2014)​, SeekDeep 
outperformed DADA2, MED, and UNOISE in haplotype recovery of the twenty-three one-off 
haplotypes (out of forty-seven total haplotypes in the dataset). The highest relative 
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abundance of missed one-off haplotypes was approximately 3% for DADA2 and MED, 2% 
for UNOISE, but only 0.25% for SeekDeep (​Figure 2.13​). Again, SeekDeep does well using 
fewer input reads in estimating the expected abundance of the known haplotypes with a 
lower RMSE (​Figure 2.14​). 
Viral strain mixtures 
To further ensure that SeekDeep works across a breadth of experiments and 
organisms, we examined control mixtures of viral strains. All programs performed well with 
respect to recall for both the EBV (​Figure 2.15)​ and HIV (​Figure 2.16) ​mixtures, which was 
not unexpected as these mixed strain haplotypes all differed by more than a single base. 
Importantly, SeekDeep’s specificity compared well. All other programs other than SeekDeep 
created false haplotypes above 1% in the EBV dataset with the highest for each program 
being 2% for UNOISE, 17% for MED, 22% for DADA2, 19% for ShoRAH and 0.65% for 
SeekDeep which was mitigate but not completely removed with replicates (1% for UNOISE, 
16% for MED,14% for DADA2, 16% for ShoRAH and 0.46% for SeekDeep). Programs 
performed better on the HIV dataset and though SeekDeep had a large number of false 
haplotypes all of them fell below the recommended cut off of 0.5% with the highest being at 
0.35%. This high amount of apparent false haplotypes at low frequency was probably 
representative of both increased biologic variation due to HIV replication by error-prone 
reverse transcriptase as well as the elevated 65 rounds of PCR amplification prior to 
sequencing. 
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Chimera detection 
For these ​in vitro​ control mixtures, chimera formation and abundance was highly 
variable depending upon the experiment. The Illumina ​P. falciparum​ dataset only 
demonstrated 3 chimeras across all 28 amplicions. The IonTorrent controls demonstrated 
significant numbers of low abundance chimeras. Across the 7 samples there were a total of 
186 false haplotypes of which 83% (155) were chimeras. These IonTorrent false haplotypes 
generally showed higher abundances relative to other false haplotypes and were 
highly-reproducible abundances across replicates (R​2​=0.81-0.99; ​Figure 2.17​). The 
differences in chimera formation between datasets most likely originates from differences in 
the amount of input template and PCR conditions as well as potentially the library 
preparation which involves PCR. The mock microbiome showed minimal chimera formation 
likely due to the decreased sequence relatedness and greater amounts of starting template. 
Overall, the variability in chimera occurrence rates along with their high-degree of 
reproducibility within replicates emphasizes the need to carefully consider the experimental 
conditions and the utilization of experimental controls to determine the need and optimal 
settings for chimera detection.  
Traditional Microbiome OTU Analysis 
In addition to providing single-base resolution between sequences, SeekDeep was 
designed to also allow users to define the needed level of resolution by setting either the 
number of bases or percent identity to create operational taxonomic units (OTUs). We 
therefore compared SeekDeep to older commonly used programs offering OTU level 
resolution that can operate on multiple platforms. In comparison to USEARCH (i.e. 
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UCLUST), Seekdeep showed both better accuracy and precision clustering at 97% OTUs 
(​Figure 2.18​). Also, USEARCH at times misconstructs the OTUs, returning a consensus 
sequence that is not one of the actual input haplotypes (​Figure 2.18b​). SeekDeep routinely 
returns the major haplotype within an OTU. We also compared to SWARM collapsing on 
1-base differences - the most sensitive setting for SWARM (​Figure 2.19​). Again SeekDeep 
demonstrated better haplotype recovery and fewer false haplotypes. Thus, SeekDeep 
provides more optimized OTU definition, which again is more robust to varying read depth.  
Performance 
Algorithm speed can be an important factor in terms of practicality, and SeekDeep 
compares favorably with other programs. While UNOISE is the fastest algorithm (​Figure 
2.20​), this speed comes at a cost (​Figure 2.3​). The proprietary algorithm in UNOISE works 
by collapsing one-off errors if the ratio of abundance between two sequences is at a certain 
threshold, which precludes UNOISE from detecting new haplotypes that differ by only one 
nucleotide from the major haplotype in the population. This aspect can be problematic when 
screening for cancer mutations or pathogen drug resistance. Also UNOISE recommends not 
using singlet sequences, decreasing haplotype recovery at lower read depths. This, in part, 
contributes to its speed (​Figure 2.20​) but decreases haplotype recovery. Apart from 
UNOISE, SeekDeep is comparable in speed to DADA2 and MED (​Figure 2.20​). In fact, for 
the mock microbiome data set ​(Salipante et al. 2014)​, which had approximately 800,000 for 
each of three replicates, the run times for the programs were 2hrs and 41 minutes for 
SeekDeep, 2hrs and 40 minutes for DADA2, and 1hr and 58 minutes for MED on standard 
hardware as found in a personal computer. Given runtimes are comparable, the built-in 
general pipelines for sample processing make SeekDeep a potentially less-time consuming 
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option for the general user looking to process numerous samples and multiple amplicons per 
sample. 
DISCUSSION 
With newer sequencing technologies increasing our ability to probe a wide variety of 
biologic samples, the ability to bioinformatically discern the full extent of sequence diversity, 
even if only a single-base difference, is key to answering many important questions. Though 
all programs tested are able to detect one-off haplotypes, SeekDeep is the only one 
consistently able detect these haplotypes at lower frequencies and at lower input read 
depths for all technologies (​Figures 2.3​, ​2.4-2.6​, ​2.13​). SeekDeep performs well across a 
diverse set of simulations and ​in vitro​ control data sets and provides a more favorable 
balance between haplotype recovery and false haplotypes such that missed haplotypes and 
false calls are limited to the lowest frequencies, usually below 0.25%. In fact, when applying 
0.25% as a lower threshold, SeekDeep has near perfect haplotype recovery and precision 
(​Figure 2.21​). We apply a slightly higher cutoff of 0.5% as the default in processClusters, 
the final processing step, ensuring high confidence in the called haplotypes. Essentially, 
SeekDeep provides the ability to confidently detect haplotypes across variable read depths 
regardless of haplotype abundance, similarity or platform, a feature which is crucial for 
maximizing experimental information and minimizing biases. Minimizing bias is important for 
downstream analyses such as time series that generally presume random deviations ​(Bucci 
et al. 2016; Friedman and Alm 2012)​. 
SeekDeep showed important differences in terms of haplotype recovery and false 
haplotype creation compared to other programs. While DADA2 creates a smaller number of 
false haplotypes than SeekDeep, this comes at the cost of missing low-abundance one-off 
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haplotypes. Also, when DADA2 does create a false haplotype it is generally at a higher 
abundance than SeekDeep (​Figures 2.10-2.11, 2.9​). DADA2 did not compare well at lower 
read depths where haplotype recovery suffered remarkably. Thus, for users of DADA2 it 
may be important to ensure that all samples have deep read depth to minimize biases. MED 
has good haplotype recovery but also creates numerous false haplotypes, particularly 
high-abundance haplotypes in samples with low diversity (​Figures 2.10-2.11, 2.17​). 
SeekDeep’s balance between haplotype recovery and false haplotypes at very 
low-abundances was by design. For subsequent aggregate or longitudinal analyses across 
samples, low-level noise in individual samples can often be better controlled across the 
entire sample set. However, missing haplotypes or false calls at appreciable levels are more 
difficult to compensate for and can be a source of significant bias. 
Importantly SeekDeep is extremely robust to sequence quality or types of sequence 
variation. SeekDeep directly utilizes the actual base quality of each sequencing read. Thus, 
it is robust to sequences that are outliers with extremely poor quality. Unlike both MED and 
DADA2 that require that input sequences be the same exact length, SeekDeep can handle 
variable length input given it performs optimal global alignments, and thus is adept at 
analyzing sequences with insertions or deletions. Variable length inputs are very common 
among Ion Torrent and 454 sequencing data. 
Users can further optimize SeekDeep for more advanced applications. It can flexibly 
cluster based on insert size, allowing for the detection of biologically relevant insertions such 
as nucleotide triplets consistent with an amino acid change while filtering out homopolymer 
or smaller indels that are particularly common in some sequencing platforms such as 
IonTorrent. With SeekDeep, users can set the specific number of each type of alignment 
differences (indels and/or SNPs) upon which to collapse clusters, enabling concrete tuning 
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for the specific biologic questions. For instance, this allows a user to collapse haplotypes 
that differ by one base, two bases, or traditional analyses collapsing to 97% or 99% OTUs 
and detect more divergent lower abundance variants that may be only represented by a few 
sequences in a sample.  
SeekDeep offers robust and flexible pre- and post-clustering tools and workflows for 
rapidly preprocessing numerous samples by demultiplexing barcodes, identifying and 
removing primers, trimming, and cleaning sequence to user specifications. After clustering, 
the tool set helps evaluate the sequence and perform initial data evaluation with key sample 
and population statistics. SeekDeep has built-in support for a number of steps including (1) 
scanning for contamination, which is especially helpful, for example, in ​Plasmodium​ datasets 
which can often be contaminated with human DNA due to low relative amount of parasite 
DNA, (2) built-in support for incorporating replicate comparison, and (3) support for analysis 
of multiple amplicon targets at once. It also supports chimera detection and removal akin to 
other programs which should be carefully considered and tuned based on experimental 
conditions, controls and the biologic question of interest. SeekDeep also provides a 
dynamically interactive HTML viewer, which makes it easy to explore differences between 
strains and has support for viewing results on subgroups in large sample sets when given 
group metadata. 
Overall, SeekDeep expands the potential for ​de novo​ amplicon clustering - 
particularly given its improved haplotype recovery at lower read depths for haplotypes 
differing by one base. This is crucial for projects that seek to detect and quantify minority 
haplotypes that may be represented by a single SNP. Such projects are becoming 
increasingly common in the oncology and infectious disease fields. For example, when using 
marker regions to differentiate bacterial strains, or when monitoring for pathogen 
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drug-resistance mutations, these sequences often only differ from the wild type by a single 
base ​(Miotto et al. 2015)​. Accurately quantifying these low-abundance and genetically 
similar strains in these cases is key.  
In summary, SeekDeep can be widely applied to all forms of amplicon deep 
sequencing to improve the haplotype recovery of highly-similar sequences while minimizing 
false haplotypes across a broad range of relative frequencies, read depths and platforms. 
This should allow users to maximize information extraction while minimizing biases in their 
downstream analyses and conclusions. In addition, the full SeekDeep suite of tools for pre- 
and post-processing will speed clustering optimization and provide high-quality and 
interpretable haplotype data for further analysis.  
Code availability​.  
Source code for the current stable release of SeekDeep can be found at 
https://github.com/bailey-lab/SeekDeep​ and full usage and tutorials can be found at the 
S​eekDeep website. For full install information see 
http://baileylab.umassmed.edu/SeekDeep/installingSeekDeep  
Availability of Data and materials.  
The ​in vitro​ data can be found via their original publications. The simulation raw data and the 
P. falciparum​ Illumina MiSeq data can be found at 
http://baileylab.umassmed.edu/data/SeekDeepPaperData​. 
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MATERIALS AND METHODS 
Overview of the SeekDeep Suite​.  
SeekDeep is a software suite written in C++ centered around ​de novo ​clustering providing 
rapid sample and input sequence preprocessing, and postprocessing sample and population 
summaries for further downstream analysis. SeekDeep can be utilized with most major 
sequencing technologies, including Ion Torrent, 454, and Illumina, to swiftly analyze 
numerous samples and amplicons (​Figure 2.22​). SeekDeep provides start-to-finish workflow 
from raw sequence files to population-level clustering and tabular and graphical summaries. 
SeekDeep is freely available under the GNU Lesser General Public License v3.0 and is 
actively developed on github​ ​(​https://github.com/bailey-lab/SeekDeep​)​ ​while usage and 
details on the program can be found at the SeekDeep website 
(​http://baileylab.umassmed.edu/SeekDeep/​). SeekDeep has three main components, 
extractor, qluster, and processClusters, that are central to generating clustering results, and 
an additional component, popClusteringViewer, to aid in viewing and sharing the results. 
extractor: de-multiplexing and read filtering 
The subprogram​ ​extractor is generalized to process 454 and Ion Torrent standard 
flowgram format (SFF) files and standard FASTQ files from any source. Extractor also 
demultiplexes samples and amplicons using a wide variety of barcode and primer schemes 
but can also operate on already demultiplexed data (e.g. data that has been demultiplexed 
by standard Illumina pipelines). Like most extraction programs, SeekDeep includes typical 
tools for initial filtering based on read length, presence of primers, quality score metrics, 
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and/or presence of ambiguous bases (i.e. Ns). Extractor first separates reads based on 
sample barcodes handling a wide range of barcoding schemes that are commonly 
employed. Next, multiple or a single pair of forward and reverse primers are detected, 
demultiplexed and removed. Filtering is then done on per base quality scores, and on 
expected read lengths which can be set per primer set. Also, optional contamination filtering 
can be performed by supplying the sequences of target regions whereby sequences that 
differ drastically from these are removed. 
See ​http://​baileylab.umassmed.edu/SeekDeep/extractor_usage​ for full details on 
the options offered by extractor. 
qluster: rapid and accurate clustering based on quality 
At the core of the SeekDeep package is the qluster algorithm, which iteratively 
collapses amplicon reads based on pairwise global alignments (​Figures 2.23-2.24​). It 
leverages sequencer-generated quality values to discern likely true differences from 
sequencing errors as well as k-mer frequencies to filter out likely low abundance PCR 
errors. Although SeekDeep can process multiple amplicons at once, they are processed 
independently and haplotypes are not built or phased across different amplicons. The 
clustering process is summarized below. 
First, reads lacking differences are collapsed into identical sequence clusters, which 
are then indexed for k-mers (default size 9). These initial identical clusters are then sorted 
based on the associated number of reads. An iterative comparison process is then 
undertaken with successive rounds of clustering allowing for an increasing number of 
differences to trigger the merger of two clusters. Majority-rule consensus of the smallest 
clusters are pairwise aligned and compared sequentially to the consensus of the largest 
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clusters to determine if they should be merged into one cluster or remain as two separate 
clusters (​Figures 2.23-2.24​). Once the clusters have all been initially compared and 
collapsed, if meeting threshold, the threshold for collapse is stepwise-raised to allow for 
more divergence in a subsequent iteration. At the end of each iteration majority-rule 
consensus are generated to represent each of the clusters. If consensus have changed due 
to the addition of new sequences, the clusters are again compared at the same error 
thresholds before advancing to the next iteration. The algorithm allows for flexibility not only 
in the number of iterations, but also in the threshold number and type of differences to 
collapse. Differences are classified as one-base indels, two-base indels, greater than 
two-base indels, low-quality mismatches, high-quality mismatches, and low k-mer frequency 
mismatches. In this way, the clustering is similar to operational taxonomic unit (OTU) 
percent identity clustering, but instead of counting all differences equally we are able to 
weigh the type and the quality of the difference before determining whether to merge 
clusters - an important feature for sequencing technology-aware clustering.  
For clustering iterations, there are default collapse threshold profiles for 454, Ion 
Torrent, and Illumina, or a custom file can be supplied. The custom input parameter file 
allows the expert user to balance sensitivity, specificity, and speed for specific applications. 
The default profiles were used for all analyses in this paper. For a 454/Ion Torrent dataset, 
our standard error profile limits initial collapsing to sequences differing by single-base indels, 
given that the predominant errors in these datasets are small indels caused by 
homopolymer misestimation. On an Illumina dataset, which is unlikely to have erroneous 
single-base indels but more likely to have base miscalls, the default profile does not collapse 
on indels but allows more low quality mismatches. This framework makes the qluster 
algorithm highly extensible and adaptable to changing error profiles in updated or novel 
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sequencing platforms. In terms of applications, the ability to collapse to an exact number of 
differences allows for biologic questions to be concretely addressed. For example, settings 
could allow 2-3 mismatches when sequencing viruses like HIV to collapse the viral clouds, 
or settings could be used to not allow a single high quality difference when searching for 
point mutations in the domain of a gene associated with drug resistance. 
Differentiating mismatches with quality 
The quality of any mismatch is determined by assessing the quality scores of the two 
mismatching bases in the pairwise alignment between clusters and the quality of the 
neighboring bases in the region ​(Altshuler et al. 2000)​. A primary quality and a neighboring 
quality is calculated. For a mismatch to be considered high-quality it must exceed the set 
thresholds for both of these quality values. The number of neighboring bases included can 
be changed; the default value is 2, which includes 2 bases upstream and downstream for a 
total of 4 neighboring bases examined. If a mismatch is determined to be a high quality 
error, its k-mer frequency is also checked to determine if the mismatch is in a low frequency 
k-mer. To calculate this, the mismatched base is centered in odd number length k-mer 
(defaulting to 9). Next, the previously indexed k-mers are checked to determine if 
mismatched centered k-mer has a low frequency – either as user defined or as a percentage 
of total reads. The k-mer cutoff defaults to 1 read, so if the k-mer occurs only once in the 
sample read set it is counted as a low frequency error. The k-mer position within the 
sequence can also be taken into account and helps to improve the filtering when repeats are 
present. 
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Homopolymer indel weighting for 454 and Ion Torrent 
In the Ion Torrent and 454 technologies, the most common errors are indels in 
homopolymers. Thus, for homopolymers, indels are weighted to count less than other indels 
rather than separately categorizing them. Weighting incorporates the length by taking the 
size of the indel and dividing by the average size of both homopolymer runs. For example, a 
single-base indel found in a homopolymer of 4 bases (meaning one read has 4 bases and 
the other has 3 bases), the indel weight will be counted as 1/3.5 instead of 1. 
Chimera Detection 
After clustering, the resultant haplotypes can be examined for likely chimeras that 
may have resulted from PCR (​Figure 2.22b​). If replicates are available, then potential 
chimeras not appearing in all replicates will be removed. However, chimeras are often 
reproducible ​(Haas et al. 2011)​ ​which requires additional checks.​ This is accomplished by 
pairwise comparison of all the putative haplotypes from qluster checking to see if any cluster 
could be the result of a composite of two other clusters, which is similar to other approaches 
(Quince et al. 2011; Callahan et al. 2016)​. Since, by definition, parental haplotypes 
contributing to a cluster must preexist for a chimera to form from them, we normally require 
that the parents are of equal or greater abundance relative to the potential chimera. By 
default, chimeras are called when both parents are at least 2-fold greater in abundance 
(user definable). This is a conservative approach to minimize false discovery that prioritizes 
removal of artifactual chimeras at the cost of potentially excluding low abundance biologic 
recombinants, but for most applications chimeras tend to be more numerous. To minimize 
the loss of true biologic haplotypes in population analyses, we have implemented an option 
in our population clustering to check if a cluster marked as possibly chimeric appears in 
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another sample as one of the dominant haplotypes. If such a sample is found, the haplotype 
in question is, in that sample, unlikely to be chimeric since ideally a chimera would have two 
parents greater in abundance than itself. In this case, the putative chimera can be recovered 
in the original sample where it was at low-abundance. It is important to note that this step 
may not recover all true haplotypes as they might never appear at a high abundance in 
another sample. Also, a low-level chimera could be reinstated as a true haplotype. As there 
is no optimal solution for defining chimeras, we recommend every effort should be made 
during the PCR step to decrease likelihood of chimera formation. Also, chimera removal 
should be carefully considered and tuned, preferably with adequate controls, for the specific 
biology and experiment conditions. Again, these are options and during the sample and 
population clustering step it is possible to keep all putative chimeras for further analysis or to 
apply other chimera detection methods. 
OTU Clustering 
SeekDeep also offers classical OTU clustering, which is slightly modified to be 
calculated by taking into account only errors not characterized as low k-mer frequency or 
low quality mismatches and optionally weighing indels in homopolymers less when 
analyzing 454 and Ion Torrent data. In this way, the percent identity calculated takes into 
account only likely biological differences between sequences.  
See ​http://​baileylab.umassmed.edu/SeekDeep/qluster_usage​ for full qluster 
usage information. 
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processClusters: Replicate and Population Comparisons​. 
The qluster algorithm removes sequencing error and low level PCR error, but rare 
high-abundance errors due to polymerase errors in early rounds of PCR amplification are 
not easily discriminated. Therefore, when available, the SeekDeep pipeline uses PCR 
replicates (independent parallel amplifications of biologic sample aliquots) to identify and 
remove such errors – as early PCR errors should occur only in a single replicate, while 
biologic differences should occur faithfully in all samples. To compare replicates, the 
clustering results from each PCR are pooled and clustered again using the qluster algorithm. 
After this cross-replicate clustering a replicate number cutoff is applied, which defaults to the 
number of replicates used; for example, if three replicates were analyzed, the default would 
require all 3 replicates contain a given haplotype. Though PCR replicates are recommended 
they are not required for SeekDeep to run.  
Additionally, a cutoff for the fraction of total reads within the cluster can also be given 
for comparison; if the average fraction of a new cluster is not above the cutoff, the new 
cluster is removed. This cutoff defaults to 0.005 (0.5%), a generally conservative cutoff to 
minimize false haplotypes for the vast majority of experimental conditions, but can be set to 
more appropriate levels. For chimera filtering, if the majority of a cluster is made up of reads 
marked as possibly chimeric, it is also marked as chimeric and is removed by default. Final 
relative abundances for haplotypes are re-calculated after cutoffs have been applied and 
when replicates are available the final abundances of a haplotype is calculated by averaging 
the abundances across the replicates.  
In addition to replicate processing and applying final cutoffs,​ ​processClusters can 
also assess the haplotypes across samples to provide population-level statistics. Once each 
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sample has been processed, information is then collated across biologic samples within the 
defined population for each haplotype. 
popClusteringViewer: viewing and manipulating final results 
A web server has been added to the SeekDeep suite to aid in the visualization and 
exploration of final results; this can be very helpful with large sample sets. The viewer is 
interactive and allows rapid exploration of final consensus sequences and the population 
haplotypes. It can also be used to extract subsets of the data. The viewer can easily be run 
on an individual’s computer and can also be broadcast over the internet to provide persistent 
access to additional individuals.  
See​ http://​baileylab.umassmed.edu/SeekDeep/popClusteringViewer_usage  
for full usage information.  
Performance Studies 
To validate performance of the SeekDeep pipeline, we used two types of data. The 
first was simulated 454 and Illumina datasets. The second was actual PCR-amplified and 
sequenced (by Ion Torrent, 454, and Illumina) control mixtures of DNA from strains of 
several different pathogens to create mock mixed infections, which were collected from 
several previous studies and work in our own lab. We also used available mock bacterial 
communities. See below for a detailed description of these datasets. 
Simulated Datasets 
The 454 and Illumina simulated datasets were created to test theoretical limits of 
detection for SeekDeep and other popular programs. The 454 datasets were simulated with 
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454sim ​(Lysholm, Andersson, and Persson 2011)​ and Illumina datasets were created with 
ART ​(Huang et al. 2012)​. While a specific Ion Torrent simulator could not be found, the 454 
simulator should provide results representative of Ion Torrent pyrosequencing given their 
similarities. An in-house program was used to generate the PCR error by simulating the 
rounds of PCR where a PCR error that occurred in an earlier round would appear at higher 
abundance than latter round errors, a feature not available in other PCR simulators. The 
program takes a starting DNA template amount, PCR error rate, a fasta file with relative 
abundances for reference haplotypes to simulate, and the number of rounds to simulate. For 
these simulations we used 2,000 copies of starting DNA template, a PCR error rate of 
3.5e-6 (representative of high-fidelity polymerases), and 30 rounds of PCR. Given the 
complexity of their formation, chimeras were not simulated. 
Two mock haplotype mixtures were simulated to generate multiple test conditions: 
• Mock haplotype mixture 1 (Minor vs Major):​ This mixture tests the ability of programs 
to discriminate minor haplotypes at various levels of divergence and abundance from a 
major abundant haplotype (​Figure 2.2a​); thereby assessing the likelihood of minor 
haplotypes being collapsed into the major as probable error. Specifically, we simulated 
seven different haplotypes with increasing base mismatches (decreasing % identity) of 
1 (99.7%), 2 (99.4%), 3 (99.1%), 4 (98.8%), 6 (98.2%), 8 (97.6%), and 13 (96.1%) from 
the major haplotype, with no shared mismatches between minor haplotypes to create 
distances always greater to other minor haplotypes than to the major haplotype, e.g. the 
minor haplotype with 1 mismatch and the minor haplotype with 2 mismatches from the 
major haplotype are 3 mismatches away from each other. The relative abundance of 
the minor haplotypes were simulated at 10%, 5%, 2%, 1%, 0.5%, 0.25%, 0.1%, and 
0.05% (​Figure 2.2b​).  
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• Mock haplotype mixture 2 (Minor vs Minor Pairs with Varying Differences)​: This 
mixture examined the effect of divergence between minor haplotype pairs unrelated to 
the major haplotype (​Figure 2.2c​). For this, we simulated 15 different haplotypes, 
making one major abundant haplotype and 14 minor haplotypes. Each minor haplotype 
was paired with another closely related minor haplotype, and each haplotype in the pair 
differed by at least 15 mismatches from the other pairs or to the major haplotype. Pairs 
had a range of base mismatches (% identity) consisting of 1 (99.7%), 2 (99.4%), 3 
(99.1%), 4 (98.8%), 6 (98.2%), 8 (97.6%), and 13 (96.1%) nucleotides. The relative 
abundances of the minor haplotypes were simulated at 5%, 2%, 1%, 0.5%, 0.25%, 
0.1%, and 0.05% with the rest composed of the major haplotype. (​Figure S4d​). 
For each mixture and minor haplotype abundance above, we generated simulated 
datasets with two replicate PCRs with 2,000-10,000 reads incrementing by 2,000 and at 
50,000 reads (to test the extremes of coverage) for a total of 6 different read depths 
(equivalent throughout to nonredundant read or stitched-read coverage across the 
amplicon--or equivalently per base). Each of these conditions was simulated 10 times and 
the results were averaged to get the best estimate of program performance. 
Known Control Mixture Datasets 
Five different experimental ​in vitro​ control mixtures were analyzed spanning the 
common sequencing technologies; 454, Ion Torrent, and Illumina (​Table 2.2)​. This included 
data from a eukaryotic parasite (​Plasmodium falciparum​) and a mock microbiome. 
Specifically these were:  
• Plasmodium falciparum ​control mixtures, 454 and Ion Torrent​:​ Plasmodium 
falciparum​ control mixtures from our labs were sequenced on Ion Torrent and 454 
47 
(​Table 2.2​). These pools contained three different amplicons: thrombospondin-related 
anonymous protein (​TRAP​) (​Figure 2.25​), apical membrane antigen 1 (​AMA1​) (​Figure 
2.26​), and circumsporozoite protein (​CSP​) (​Figure 2.27​). The ​AMA1​ and ​TRAP 
samples had the same mixture of five strains: 40% K1, 30% 7G8, 15% Dd2, 10% 
RO33, and 5% V1/S and the ​CSP​ region had a mixture of 40% K1, 30% 7G8, 20% 
DD2, and 10% RO33 (​Figures 2.25-2.27​). 
• Plasmodium falciparum​ control mixtures, Illumina MiSeq​: Additionally, twenty-eight 
different regions, including vaccine candidates and drug resistance genes, were PCR 
amplified and sequenced with 2x250 paired-end Illumina MiSeq from a control mixture 
of ​Plasmodium falciparum ​(​Table 2.2)​. The mixture consisted of the following strains 
and relative abundances; 3D7 (~79%), HB3 (~7%), 7G8 (~7%), and DD2 (~7%). These 
targets included multiple probes in important vaccine candidate regions in ​AMA1​, ​CSP​, 
and merozoite surface protein 1 (​MSP1​). Also known drug resistance or associated loci 
were targeted including apicoplast ribosomal protein S10 (​ARPS10​), multidrug 
resistance protein 1 (​MDR1​), multidrug resistance protein 2 (​MDR2​), ​kelch13 (​K13​), 
protein phosphatase (​PPH​), Cytochrome b (​CYTB​), dihydrofolate reductase thymidylate 
synthase (​DHFR-TS​), and dihydropteroate synthase (​DHPS​) (​Figure 2.28)​.  
• Mock Microbiome:​ Previous mock microbiome datasets by Salipante et al. 2014 were 
analyzed consisting of Illumina paired-end sequencing of the V1 region of the 16S 
coding region with 3 PCR replicates ​(Salipante et al. 2014)​. This mock microbiome 
mixture contains 20 species, but due to highly similar copies within each species the 
number of expected haplotypes at one-base resolution for the V1 region is 47. Twenty 
of these haplotypes are only one base pair different from another haplotype. The 3 PCR 
replicates were deeply sequenced with approximately 800,000 reads each. To analyze 
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data at more commonly assessed read depths ​(MacIntyre et al. 2015; Mideo et al. 
2016; Lin et al. 2015)​ the replicates were downsampled to depths between 
2,000-20,000 increasing by intervals of 2,000. Each read depth was sampled 10 times 
each for all 3 PCR replicates which generated a total of 300 different randomly sampled 
datasets.  
• Epstein-Barr Virus (EBV) and Human immunodeficiency virus type 1 (HIV) 
controls​: To provide a broader set of biologic examples, we also examined available 
viral controls of amplicon sequencing consisting of a previous mock HIV mixture ​(Seifert 
et al. 2016)​ and a mock EBV mixture from our lab. The HIV dataset had 5 strains mixed 
together; 89.6 (10%), HXB2 (14%), YU2 (16%) , NL4-3 (24%) and JR-CSF (36%). The 
mixture was sequenced 5 different times, two of the replicates were chosen and due to 
the great depth (>600,000) were each downsampled to 10,000 reads 10 times each for 
a total of 20 randomly sampled datasets. The EBV dataset was mixtures of an EBV 
type 1 strain and an EBV type 2 strain with frequencies ranging from 1% to 90% and a 
monoclonal sample of the type 1 strain. See ​Table 2.2​ for more details. 
MED (version 2.1), DADA2 (version 1.0.3), UNOISE (USEARCH version 9.2), and 
SeekDeep (version 2.4.0) were each run on the datasets with default or recommended 
parameters. The program ShoRAH ​(Zagordi et al. 2011)​ (version 1.1.0) was used on the 
viral datasets to represent a standard program for viral analysis. DADA2 and UNOISE have 
their own chimera detection program; MED and ShoRAH do not have a chimera-detection 
utility, so our own chimera detection was applied to the final results produced by MED and 
ShoRAH to make the results comparable. Each program has a different output format from 
which the consensus sequences and relative abundances of final clusters were extracted. 
The expected abundance of pooled species for each dataset was determined by aligning 
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raw reads to reference sequences for that dataset. This calculation was performed because 
mock mixtures are manually produced in the lab, making the targeted mixture frequencies 
approximate. Common sources of experimental error arise by pipetting inaccuracy and 
imperfect amplification of the initial low abundance template leading to the introduction of 
random noise during the early rounds of PCR. Final clustering results were compared to the 
expected reference sequences and to determine which references were identified. For the 
paired-end Illumina data, sequences were stitched together with the program FLASH 
v1.2.11 ​(Magoc and Salzberg 2011)​.  
To evaluate performance of each program we determined the number of expected 
haplotypes recovered - especially one-off haplotypes - and how well their abundances were 
predicted. We also determined the number and abundances of false haplotypes created. 
Recovery was calculated as the number of haplotypes exactly matching expected 
haplotypes divided by the total number of haplotypes expected. The haplotype recovery for 
MED, DADA2, and UNOISE was calculated based on each replicate separately, while 
SeekDeep’s haplotype recovery was calculated if it found the expected haplotype in both 
replicates for a sample, as this is its default. Thus, SeekDeep’s haplotype recovery is 
conservative relative to the other programs given that a haplotype must be present in both 
replicates to be counted as recovered. 
All ​analyses and program comparisons were run on an Ubuntu 14.04 server with 64 
2.4-GHz AMD processor cores and 512 gigabytes (GB) of RAM to allow parallelization of all 
simulations and ​in vitro​ datasets. For SeekDeep, all analyses presented could also be run 
individually on a laptop, a Macbook Pro with 16GB of RAM and a 4-core 2.4 GHz Intel i7 
processor.  
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Tables  
Table 2.1: Full Mock Microbiome Results 
Program Replicate 
True Haplotypes 
Predicted 
True Haplotypes 
Expected Recall 
UNOISE 1 44 47 93.62 
UNOISE 2 44 47 93.62 
UNOISE 3 43 47 91.49 
MED 1 47 47 100 
MED 2 47 47 100 
MED 3 47 47 100 
DADA2 1 46 47 97.87 
DADA2 2 46 47 97.87 
DADA2 3 46 47 97.87 
SeekDeep 1 47 47 100 
SeekDeep 2 47 47 100 
SeekDeep 3 47 47 100 
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Table 2.2: ​In vitro​ control datasets 
Dataset Amplicon Technology 
Read 
Depth* 
Sample 
Number Replicate** 
Read 
Length 
Region 
Length 
Unique 
Haploty
pe 
Number 
Range of 
Haplotype base 
differences (% 
identity) *** 
PfTRAP 454 812 - 987 1 2x 345 345 5 
1 (99.7%) - 7 
(97.9%) 
PfAMA1 Ion Torrent 
1,323 - 
1,712 2 2x 494 494 5 
2 (99.1%) - 12 
(94.9%) 
PfCSP Ion Torrent 
1,054 - 
6,403 4 2x 319 319 4 
2 (99.3%) - 9 
(97.2%) 
Various ​P. falciparum 
targets**** 
Illumina 
MiSeq 
614 - 
4,497 28 none 2x250 
330-40
3 2-4 
1 (99.7%) - 17 
(95.3%) 
Microbiome 16S-V1 
Illumina 
MiSeq 
584,575 - 
899,804 1 3x 2x250 280 47 
1 (99.6%) – 101 
(63.9%) 
EBV 
Illumina 
MiSeq 
342 - 
1,350 6 2x 2x250 372 2 20 (92.6%) 
HIV 
Illumina 
MiSeq 10,000 20 2x 2x250 206 5 2 (99%) - 5 (97.5%) 
* Read depth equals number of stitched read pairs with minimum and maximum observed 
depths in the case of multiple samples and replicates. 
** 2x = two independent PCRs; 3x = three independent PCRs, or none = no replicate (single 
PCR) done 
*** Number of differences are enumerated and followed by the corresponding percent 
identity, the range is shown when there are more than 2 unique haplotypes 
**** Summary of the 28 targets here, see ​Table 2.3​ for details for each target 
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Table 2.3: ​In vitro P. falciparum ​Illumina control datasets 
Dataset 
Amplicon Technology 
Read 
Depth* 
Sample 
Number 
Replicate*
* 
Read 
Length 
Region 
Length 
Unique 
Haplotype 
Number 
Range of Haplotype 
base differences (% 
identity) *** 
PfAMA1_0 
Illumina 
MiSeq 1,362 1 none 2x250 389 4 1 (99.7%) - 4 (99%) 
PfAMA1_1 
Illumina 
MiSeq 1,016 1 none 2x250 389 4 
9 (97.7%) - 14 
(96.4%) 
PfAMA1_2 
Illumina 
MiSeq 3,220 1 none 2x250 395 4 
9 (97.7%) - 14 
(96.5%) 
PfAMA1_3 
Illumina 
MiSeq 2,171 1 none 2x250 392 4 2 (99.5%) - 9 (97.7%) 
PfAMA1_4 
Illumina 
MiSeq 1,221 1 none 2x250 359 4 2 (99.4%) - 6 (98.3%) 
PfAMA1_5 
Illumina 
MiSeq 936 1 none 2x250 403 4 1 (99.8%) - 8 (98%) 
PfAMA1_6 
Illumina 
MiSeq 1,642 1 none 2x250 387 4 1 (99.7%) - 7 (98.2%) 
PfARPS10_
2 
Illumina 
MiSeq 2,159 1 none 2x250 330 2 1 (99.7%) 
PfCSP_1 
Illumina 
MiSeq 926 1 none 2x250 354 4 2 (99.4%) - 9 (97.5%) 
PfCYTB_2 
Illumina 
MiSeq 4,303 1 none 2x250 361 2 1 (99.7%) 
PfDHFR-TS
_0 
Illumina 
MiSeq 4,497 1 none 2x250 371 4 1 (99.7%) - 3 (99.2%) 
PfDHFR-TS
_2 
Illumina 
MiSeq 3,165 1 none 2x250 360 4 1 (99.7%) - 3 (99.2%) 
PfDHFR-TS
_3 
Illumina 
MiSeq 1,365 1 none 2x250 349 2 1 (99.7%) 
PfDHPS_5 
Illumina 
MiSeq 2,946 1 none 2x250 346 3 1 (99.7%) - 2 (99.4%) 
PfDHPS_6 
Illumina 
MiSeq 1,433 1 none 2x250 388 2 1 (99.7%) 
PfK13_8 
Illumina 
MiSeq 614 1 none 2x250 351 2 2 (99.4%) - 3 (99.1%) 
PfMDR1_0 
Illumina 
MiSeq 2,347 1 none 2x250 358 3 2 (99.4%) 
PfMDR1_1 
Illumina 
MiSeq 2,059 1 none 2x250 391 4 1 (99.7%) - 3 (99.2%) 
PfMDR1_11 
Illumina 
MiSeq 3,075 1 none 2x250 360 3 1 (99.7%) - 2 (99.4%) 
PfMDR1_12 
Illumina 
MiSeq 3,846 1 none 2x250 373 3 1 (99.7%) - 2 (99.5%) 
PfMDR1_13 
Illumina 
MiSeq 2,067 1 none 2x250 347 2 1 (99.7%) 
PfMDR1_2 
Illumina 
MiSeq 1,960 1 none 2x250 402 2 1 (99.8%) 
PfMDR2_3 
Illumina 
MiSeq 3,159 1 none 2x250 359 2 1 (99.7%) 
PfMDR2_5 
Illumina 
MiSeq 2,292 1 none 2x250 354 4 2 (99.4%) - 2 (99.4%) 
PfMSP1_2 Illumina 1,051 1 none 2x250 364 4 1 (99.7%) - 17 
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MiSeq (95.3%) 
PfPPH_1 
Illumina 
MiSeq 2,770 1 none 2x250 403 2 1 (99.8%) 
PfPPH_10 
Illumina 
MiSeq 2,384 1 none 2x250 358 2 1 (99.7%) 
PfPPH_11 
Illumina 
MiSeq 1,171 1 none 2x250 384 4 1 (99.7%) - 3 (99.2%) 
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Figures 
 
Figure 2.1: PCR and Sequencing Errors 
Clustering of amplicon sequencing must contend with errors that occur during PCR and 
sequencing. ​a) ​Early round PCR errors can be difficult to identify because these propagate 
in subsequent rounds and can reach a relatively-high abundance. While usually uncommon, 
the degree of such high-abundance errors is highly dependent on the number of initial target 
DNA copies in the PCR. Thus, experiments that utilize nested PCR to amplify low DNA 
concentration samples are particularly prone to high-abundance errors. Low-abundance 
errors that occur in later rounds of amplification may be numerous but are more easily 
identified and removed. ​b) ​Another common problem in PCR, particularly when 
co-amplifying highly-similar sequences, is the creation of chimeras, which are formed when 
a partial PCR product re-anneals to a similar template creating a hybrid product. 
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Figure 2.2: Simulated Mixtures 
Two types of haplotype mixtures were simulated to assess performance. ​a) ​The first mixture 
tests discrimination of related low-abundant minor haplotype and highly-abundant major 
haplotype and is comprised of 7 minor haplotypes differing from the major haplotype by 1 to 
13 differences. ​c) ​The second simulated mixture tests the ability to discriminate highly 
similar low-abundance haplotypes from each other. There are seven minor haplotype pairs 
differing by 1, 2, 3, 4, 6, 8, or 13 nucleotides. Between pairs and between the major 
haplotypes there are at least 15 nucleotides (all red dots not shown). ​b) ​The 8 different 
abundances at which haplotypes in panel ​a) ​were simulated. ​d) ​The 7 different abundances 
at which haplotypes in panel ​c) ​were simulated. Each was simulated 10 times at a variety of 
read depths. The number of red nodes between haplotypes is the number of base pair 
mismatches (bpm) differentiating them. 
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Figure 2.3: Haplotype Recovery of Simulated Minor Haplotypes Differing 
by a Single Base 
a) ​Recovery of the haplotype differing by a single-base from a major haplotype in the 
mixture described by ​Figure 2.2a-b​.​ b) ​Recovery of the two minor haplotypes that are 
one-off from each other described in the mixture described by ​Figure 2.2c-d​.​ ​For both 
panels​, ​the y-axis represents the percent of simulations in which the haplotype differing by a 
single-base was detected and the x-axis represents the simulated expected abundance of 
the minor haplotype. Data is broken down by read depth (rows) and sequencing technology 
(columns), and bars are colored by program. Grey boxes at low-abundances represent 
combinations where the depth is not sufficient for reads to be observed for the minor 
haplotypes. For each minor haplotype abundance, there are 20 simulations from which 
DADA2, MED and UNOISE haplotype recovery was calculated as a percent of simulations 
in which the minor haplotype was detected. To best emulate real world situations in which a 
user would use SeekDeep to analyze replicates, we used paired simulations with the 
requirement that SeekDeep detect haplotypes in both simulations. 
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Figure 2.4: Haplotype Recovery of Simulation Data - Platform 
The average haplotype recovery of the simulation datasets binned on technology and minor 
haplotype divergence for each program. The top row shows the average haplotype recovery 
of the minor haplotypes closely related to the major haplotype (​Figure 2.2a​), and the bottom 
is the average haplotype recovery of minor haplotypes close to another minor haplotype 
(​Figure 2.2c​). Error bars represent one standard error. 
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Figure 2.5: Haplotype Recovery of Simulation Data - Read Depth 
The average haplotype recovery of the simulation datasets binned on simulated read depth 
and haplotype divergence for each program. The top row shows the average haplotype 
recovery of the minor haplotypes closely related to the major haplotype (​Figure 2.2a​) and 
the bottom is the average haplotype recovery of minor haplotypes close to another minor 
haplotype (​Figure 2.2c​). Error bars represent standard error. 
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Figure 2.6: Haplotype Recovery of Simulation Data - Minor Haplotype 
Abundance 
The average haplotype recovery of the simulation datasets binned on minor haplotype 
abundance and divergence for each program. The top row shows the average haplotype 
recovery of the minor haplotypes close to a major haplotype (​Figure 2.2a​), and the bottom is 
the average haplotype recovery of minor haplotypes close to another minor haplotype 
(​Figure 2.2c​). Error bars represent standard error. 
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Figure 2.7: Predicted vs Expected Haplotype Abundances for 
Simulations 
Panel ​a) ​is the plot of every simulated minor haplotype comparing each program’s predicted 
abundance to the expected abundance based on direct read counts (​Figure 2.2 ​mixtures). 
Panel ​b) ​is the complementary plot of the major haplotypes for all simulations. ​c) ​A violin 
plot of the root mean squared error (RMSE) on the y-axis on a log scale for each program 
for all simulated datasets. For panels ​a) ​and ​b), ​the black line of identity for expected and 
predicted is shown. If points are above the line of identity the program is overestimating the 
abundance of the haplotype and if points are below the line the program is underestimating 
the abundance of the haplotype. The Spearman’s correlation (R​2​) is in the upper left corner 
of each plot. 
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Figure 2.8: Predicted vs Expected Haplotype Abundances for 
Simulations of Closely Related Haplotypes 
The predicted vs expected abundances for known haplotypes differing by only one (​Panels 
a-b​), two (​Panels c-d​), or three (​Panels e-f​) bases is plotted to illustrate the effects of 
different read depths and technology for each program. Data points are colored by program. 
A diagonal black line is drawn to indicate perfect predicted for the expected abundance. 
Points above this line are overestimating haplotype abundance and points below this line 
are underestimating haplotype abundance. The Spearman’s correlation has been placed in 
the upper left corner of each plot. Panels are ​a) ​haplotypes one mismatch off a major 
haplotype, ​b) ​haplotypes one mismatch off of another minor haplotype, ​c) ​haplotypes two 
mismatches off a major haplotype, ​d) ​haplotypes two mismatches off of another minor 
haplotype, ​e) ​haplotypes three mismatches off a major haplotype, and ​f) ​haplotypes three 
mismatches off of another minor haplotype. 
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Figure 2.9: False Haplotype Abundances from Simulations 
The relative abundances of predicted false haplotypes are binned by read depth (x-axis), 
technology (columns), and the use of replicates (rows). The y-axis is log scaled and is the 
relative abundance at which the false haplotypes were predicted.  
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Figure 2.10: ​In Vitro ​Ion Torrent and 454 Mixtures Performance 
 ​a) ​The mean haplotype recovery for ​in vitro​ pyrosequencing samples with bars showing 
standard error. ​b) ​Predicted abundance (y-axis) estimated by the various programs is 
plotted against the expected abundance (x-axis). Deviation from the line of identity 
represents the error and is summarized by the correlation coefficient. ​c)​ False haplotypes 
are shown on a jitterplot to demonstrate their relative abundances and numbers. ​Results are 
shown per program and also by the effect of utilizing or not utilizing replicates (haplotypes 
are only accepted if they appear in both replicates)​.  
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Figure 2.11: ​In Vitro ​Illumina ​P. falciparum​ Performance 
a) ​The mean haplotype recovery for ​P. falciparum​ ​in vitro​ Illumina datasets with bars 
showing standard error. ​b) ​Predicted abundance (y-axis) estimated by the various programs 
plotted against the expected abundance (x-axis). Deviation from the line of identity 
represents the error and is summarized by the correlation coefficient. ​c)​ False haplotypes 
are shown on a jitterplot to demonstrate their relative abundances and numbers. No 
replicates were available for this dataset. 
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Figure 2.12: ​In vitro ​P. falciparum Illumina Mixtures Performance 
The expected vs predicted abundances for all the target regions for when any of the 
programs failed to recover one of the expected reference haplotypes. The leftmost bar is the 
expected abundance based on direct mapping to the known reference and subsequent bars 
represent predicted abundances by program. 
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Figure 2.13: Down-sampled Mock Microbiome Haplotype Recovery of 
Haplotypes Differing by One Base 
a) ​Shows the haplotype recovery of the 23 haplotypes that are one-off from another 
haplotype in an overall mixture of 47 bacterial haplotypes which were down-sampled from 
the Salipante ​et al​. 2014 data. Each of the three original replicates was down sampled 
randomly 10 times for each of 10 different read depths, which means each read depth has 
30 randomly down sampled samples. ​b) ​A bar graph of the greatest observed abundance of 
missed one-off haplotype is shown for each program at each read depth. 
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Figure 2.14: Down-sampled Mock Microbiome Predicted vs Expected 
Haplotype Abundances 
a) ​A plot of predicted vs expected haplotype abundances is shown for each program for all 
down sampled datasets from Salipante ​et al​. 2014. If the program predicted an abundance 
that equalled the expected abundance, points would fall on the depicted black line of 
identity. If a program overestimated the haplotype abundance, points would fall above the 
line. If a program underestimated the haplotype abundance, points would fall below the line. 
b) ​The log-scaled RMSE is shown as a violin plot for all down sampled data. 
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Figure 2.15: In Vitro EBV Illumina Performance 
a) ​The mean haplotype recovery for the EBV datasets. ​b) ​Predicted abundance (y-axis) 
estimated by the various programs is plotted against the expected abundance (x-axis). 
Deviation from the line of identity represents the error and is summarized by the correlation 
coefficient. ​c) ​False haplotypes are shown on a jitterplot to demonstrate their relative 
abundances and numbers. Results are shown per program and also by the effect of utilizing 
or not utilizing replicates (haplotypes are only accepted if they appear in both replicates). 
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Figure 2.16: In Vitro HIV Illumina Performance 
a) ​The mean haplotype recovery for the HIV datasets. ​b) ​Predicted abundance (y-axis) 
estimated by the various programs is plotted against the expected abundance (x-axis). 
Deviation from the line of identity represents the error and is summarized by the correlation 
coefficient. ​c) ​False haplotypes are shown on a jitterplot to demonstrate their relative 
abundances and numbers. Results are shown per program and also by the effect of utilizing 
or not utilizing replicates (haplotypes are only accepted if they appear in both replicates). 
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Figure 2.17: Chimera Detection 
a) ​A jitter scatter plot of the SeekDeep results for the haplotypes for samples that had 
appreciable chimeras with the x-axis being sample and y-axis being predicted relative 
abundance (truncated at 10%, all haplotype above 10% are true haplotypes). The 
haplotypes are to appear in both replicates to be plotted. The haplotypes that were marked 
chimeric are orange diamonds, true haplotypes less than 10% are green circles, and false 
haplotypes that didn’t get marked chimeric are grey circles. ​b) ​A plot comparing the the 
predicted relative abundances of the replicates for the false haplotypes which demonstrates 
the reproducibility of chimera formation across PCR reactions. Deviation from the line of 
identity represents the difference in the replicates and is summarized by the correlation 
coefficient.  
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Figure 2.18: OTU Clustering Performance on Simulation Data 
SeekDeep offers OTU clustering that is based on only high quality differences rather than 
any difference. This helps to improve both haplotype recovery and false haplotype creation 
compared to the OTU clustering offered by USEARCH. Performance of OTU clustering for 
SeekDeep is shown for both 99% and 97% OTU clustering while only 97% OTU clustering is 
shown from USEARCH due to a reported bug in the program that only allows 97% 
clustering. ​a) ​Haplotype recovery is shown for the two different simulation mixtures depicted 
in ​Figure 2.2​. Haplotype recovery is binned by the degree of difference (and corresponding 
percent identity) between the haplotypes, and is further stratified by read depth. ​b) ​A jitter 
scatter plot is shown of the relative abundance of false haplotypes, stratified by read-depth 
(x-axis) and sequencing technology. Bars and points are colored by program and OTU level 
of clustering. 
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Figure 2.19: Collapsing on Single-base Differences Performance on 
Simulation Data 
SeekDeep, like swarm, can be tuned to account for the number of differences upon which to 
collapse; however, unlike swarm, SeekDeep can account for type and quality of errors 
during clustering. Here, we demonstrate the performance of swarm collapsing on 1 
difference compared against SeekDeep collapsing on 1 high quality difference and allowing 
for low abundance and low quality differences as well is shown. ​a) ​Haplotype recovery is 
shown for the two different simulation mixtures depicted in ​Figure 2.2​. It is binned by the 
degree of difference (and corresponding percent identity) between the haplotypes, and is 
further stratified by read depth. ​b) ​A jitter scatter plot of the relative abundance of false 
haplotypes, stratified by read-depth (x-axis) and sequencing technology. Bars and points are 
colored by program. 
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Figure 2.20: Program Run Times 
The distribution of program run times in seconds is shown ​a) ​for simulation datasets across 
read depths, ​b) ​for all the randomly down sampled samples from Salipante ​et al​. 2014, ​c) ​for 
the ​in vitro P. falciparum ​control datasets. These times should approximate what a user 
would expect using a personal computer. 
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Figure 2.21: Haplotype Recovery of Expected Haplotypes and Creation 
of False Haplotype above ≥0.25% on Simulated Datasets 
Performance on the simulations dataset is shown, using a minimum haplotype abundance 
threshold of 0.25%. ​a) ​SeekDeep is able to haplotype recovery all expected haplotypes 
across all read depths simulated. ​b) ​By making a cut at 0.25% SeekDeep calls practically no 
false haplotypes. Detection of haplotypes at ​≥ ​0.25% likely approaches what can be 
detected by sampling and PCR. At this level of resolution SeekDeep has excellent 
performance characteristics with better haplotype recovery than other programs with 
minimal false haplotypes rates that occur only at low abundances.  
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Figure 2.22: SeekDeep Overview 
The depicted SeekDeep pipeline was designed to handle diverse experimental and 
computational workflows. In general, input sequence data is organized as one or more 
groups of samples that can represent natural populations, different experimental conditions, 
or any other defined classification. The pipeline is modular, allowing for substitute or 
additional processing at any step as well as access to the underlying data. The goal of 
SeekDeep is to perform initial processing and clustering along with exploration of the results 
and quality control. Extraction is done by ​extractor ​to demultiplex on sample barcodes 
(depicted here as colored squares at the beginning of sequences) and/or multiple primers if 
either are still present in input data. Next, sequences are clustered at the sample level by 
qluster​ based on either presets for specific sequencing technologies or user defined 
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parameters to provide the requisite level of resolution (see ​Figure​ ​2.23 ​for how these errors 
are characterized). Finally the haplotypes generated by ​qluster ​are analyzed by 
processClusters ​to take into account replicate comparisons (if available) and then compare 
sample haplotypes to generate population-level haplotypes and statistics. Final results can 
be viewed with ​popClusteringViewer​ in an interactive HTML viewer. For more specific 
downstream analyses, data can be outputted in multiple formats.  
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Figure 2.23:Overview of the qluster Algorithm 
 
Qluster starts by operating on the initial reads that have already been demultiplexed 
by sample and primers. Qluster first ​(1) ​creates initial clusters of identical sequences 
and then sorts these clusters by read count in descending order. Pairwise global 
alignments are then used to compare the representative sequences and ​(2) ​collapse 
initially on a minimal amount of allowable errors (see ​Figure 2.24 ​for depiction on 
how errors are characterized). Qluster thus collapses only the most similar 
sequences and creating larger aggregate clusters for further comparisons. After 
each collapse, a consensus sequence is created. On the next iteration comparing all 
clusters, the amount of ​(3) ​allowable error is increased to further collapse clusters. 
Further iterations ​(4) ​increase amount of error allowed, again creating a consensus 
after each collapse. Final clusters are created after the final iteration. After 
clustering, ​(5) ​mark any sequences that could be a possible chimera. 
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Figure 2.24: Characterizing Errors in Pairwise Comparisons within 
qluster  
Clustering incorporates both base quality and abundance of k-mers as well as parameters 
relevant to the error profile of the sequencing platform. Depicted is a detailed example of 
how qluster scores and then determines whether to collapse two clusters. ​a) ​After pairwise 
global alignment of the cluster consensus, potential errors are categorized into indels and 
mismatches. ​b) ​Mismatches between sequences are first checked for base quality, which 
includes comparing the base quality scores of mismatching bases and the surrounding 
bases to a quality thresholds (default is 20 for mismatching bases and 15 for surrounding 
bases). Both the mismatch site and regional qualities must be higher than this threshold to 
be considered a high quality mismatch. ​c) ​High quality mismatches are then further 
classified by their occurrence in the input data based on the abundance of k-mers in each 
sequence centered on the mismatch. By default, if the k-mer only occurs once in the input 
data it is marked as a low abundance mismatch signifying likely error. ​d) ​Indels are 
classified by size and are classified into 1-base indels, 2-base indels, and > 2-base indels. 
Optional weighting for indels that occur in homopolymers can be turned on for 
pyrosequencing platforms (i.e. 454 and Ion Torrent). ​e) ​Errors are tabulated and then 
compared to the current thresholds to determine if the two given clusters should be merged 
or maintained. In the depicted example, the clusters are not merged as the number of high 
quality mismatches observed exceeds the threshold for collapse. 
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Figure 2.25: ​In vitro P. falciparum TRAP ​Strain Mixture 
The ​TRAP ​mixture consisted of 5 different ​P. falciparum ​strains. The mixture was amplified 
and sequenced twice. Panel ​a) ​gives the expected relative abundances for the mixture and 
b) ​is a distance matrix describing the number of base mismatches and percent identity 
between the strains. 
  
87 
 
Figure 2.26: ​In vitro P. falciparum AMA1 ​Strain Mixture 
The ​AMA1 ​mixture consisted of 5 different ​P. falciparum ​strains. The mixture was amplified 
and sequenced 4 times. Panel ​a) ​gives the expected relative abundances for the mixture 
and ​b) ​is a distance matrix describing the number of base mismatches between the strains 
and the corresponding percent identity. 
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Figure 2.27: ​In vitro P. falciparum CSP ​Strain Mixture 
The ​CSP ​mixture consisted of 4 ​P. falciparum ​strains. The mixture was amplified and 
sequenced 8 times. Panel ​a) ​gives the expected relative abundances for the mixture and 
panel ​b) ​is a distance matrix describing the number of base mismatches between the strains 
and the corresponding percent identity. 
  
89 
 
Figure 2.28: ​In vitro P. falciparum ​Illumina Strain Mixtures 
The expected abundances for all amplicons in the control mixture of the strains 3D7, 7G8, 
HB3, and DD2. While the mixture of the individual strains was constant (3D7 = 79%, 7G8 = 
HB3 = DD2 = 7%) for all amplicons the strains often shared the same haplotype leading to 
variation in the number and abundance of haplotypes (2-4) across the amplicons. 
Differences between strains range from 1-2 SNPs and sometimes large indels (10-15 bp). 
 
 
 
 
 
 
 
 
 
 
 
 
  
90 
Chapter III: kluster: Long Amplicon Clustering 
using k-mer Similarity Scores 
Preface 
The following chapter is currently being drafted into a manuscript for submission.  
Abstract 
Longer amplicon analysis than what is possible with Illumina or Ion Torrent can greatly aid a 
targeted approach when analyzing highly diverse regions, where shorter target primers 
cannot be designed, or if the region of interest is longer than the length possible with 
Illumina and Ion Torrent which could occur when sequencing several SNPs associated with 
drug resistance that are more than 1kb apart from each other. To that end, PacBio, which 
has sequence reads at lengths of several kb in length, is the ideal tool; unfortunately, PacBio 
also suffers from a much higher error rate that hinders analysis. Here, I introduce a novel 
cluster algorithm that clusters PacBio reads to 1-base resolution, and I test its performance 
on both ​in silico​ datasets and known lab strain control mixtures.  
Introduction 
SeekDeep, which was introduced in the previous chapter, performs well for targeted 
amplicon analysis when dealing with sequencing from sequencing platforms 454, Ion 
Torrent, and Illumina; unfortunately, SeekDeep ran into challenges when its pipeline was 
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tried on PacBio data. Challenges encountered included much higher error rate and the much 
longer sequencing length which can be several kilobases (kb) for PacBio but only ~400 bp 
for Ion Torrent, 454, and Illumina. This presents challenges for SeekDeep’s pipeline, since 
the pipeline relies on building solid initial clusters by collapsing on unique sequences and 
then comparing with global alignments to other sequences. PacBio’s high error rate and long 
sequence length means that the majority of the time no sequences are identical enough to 
be used to create solid initial clusters; thus the amount of time required to create pairwise 
global alignments goes up exponentially due to the need to create a matrix of sequence 
length by sequence length to dynamically determine the best alignment--which means that 
costly all-by-all pairwise comparison would have to be conducted. Previous attempts have 
either simply clustered the sequences at an 97% OTU ​(Schloss et al. 2016)​ or have 
attempted to determine local haplotypes by mapping to a reference sequence and 
correlating SNP variants ​(Alexander Artyomenko et al. 2016)​. However, these methods are 
not adequate if studying regions that can’t be mapped to a reference, or if looking for 
causative single nucleotide differences in drug resistance genes. For these reasons, I 
developed a novel method for clustering PacBio sequences based off of a similarity score 
using shared k-mers between sequences which can be used instead of the qluster algorithm 
described in Chapter II.  
The method proves to be much faster than alignment-based comparisons and is 
sensitive to 1 base pair difference for variants down to 1% abudances. Here, I provide 
results to validate the method by analyzing mixtures of ​P. falciparum​ lab strains artificially 
created in the lab by mixture DNA of known lab strains at specific concentrations. The 
regions analyzed were a 5kb region of VAR2CSA (a gene that goes under a high level of 
recombination which prevents mapping to a reference genome), a 1.8kb region of dhfr-ts (a 
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known drug resistant gene). Previously published control mixtures were also analyzed which 
included an influenza mixture ​(Alexander Artyomenko et al. 2016)​. Also, to determine 
theoretical limits of detection, a PacBio simulator was created based off monoclonal lab 
strains and was used to simulated PacBio samples of read depths of 500 to 3,000 reads 
with sequences of 1.8 kb in length differing by 1, 2, 3, 4, 8,10, and 20 nucleotides.  
Results 
in silico ​ simulations 
All simulated haplotypes differing by 8, 10, and 20 nucleotides showed perfect 
recovery for all frequencies and read depths. Haplotype recovery for haplotypes that differed 
by 2, 3, and 4 were 100% recovered at abundances down to 5% but only got up to 80% for 
lower abundances even at read depths of 3,000 (​Figure 3.1a​). Recovery is dramatically 
improved (​Figure 3.1b​) when utilizing the method of removing internal clusters based off of 
SNPs falling 2 standard deviations above the mean error rate (​Figure 3.2​). False haplotypes 
were rare and never appear above 0.89% abundance and utilizing replicates removed all 
false haplotypes.  
Known Lab Strain Mixtures 
An influenza dataset from a previous study ​(A. Artyomenko et al. 2015)​ which 
contained 10 clones with strains and differences ranged from 2 (99.0% identity) to 21 
(89.5% identity). All 10 clones were recovered at close to expected frequencies and no false 
haplotypes were created (​Figure 3.4​).  
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The ​P. falciparum dhfr-ts ​dataset consisted of 3 different mixtures of the four lab 
strains Pf3D7 (major), Pf7G8 (minor), PfDd2 (minor), PfHB3 (minor), with minor strains at 
5% (mixture 1), 1% (mixture 2), and 0.2% (mixture 3) abundances (​Figure 3.3​). All strains 
were recovered for mixtures 1 and 2, but all three minors were missing in mixture 3 (​Figure 
3.4​). Recovered strains were close to expected frequencies and no false haplotypes were 
created.  
The ​P. falciparum var2csa ​dataset consisted of 6 mixtures with 7 different known lab 
strains at various abundances ​(Figure 3.4) ​done in duplicate​. ​All expected strains were 
detected in all mixtures very close to expected abundances. One false haplotype was 
created and this was removed by utilizing duplicates.  
Discussion 
Longer amplicon analysis can improve the amount of information gained from a 
targeted amplicon analysis; in some cases, a longer amplicon is needed to encompass the 
entire region of interest or is needed due to lack of regions with sufficient sequence 
conservation to design shorter target primers. PacBio can generate sequences of several kb 
in length, but also suffers from a high error among other issues. In order to take advantage 
of the longer read lengths offered by PacBio but still have single base resolution, the kluster 
algorithm was added to the SeekDeep pipeline described in Chapter II. The kluster algorithm 
works by creating connections between sequences based on similarity scores created by 
counting the number of k-mer shared between sequences at various k-mer lengths. In this 
way, a connected graph of reads is created and clusters determined with a density-based 
spatial clustering of applications with noise (DBSCAN) approach to avoid over-clustering.  
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Kluster is able to detect single base differences in sequences down to 10% 
abundance at read depths of 500-3,000, but starts to over-collapse the closely related 
strains below that (​Figure 3.1​). To further help detect closely related strains at low 
frequencies that may have been over-collapsed, reads within a cluster that all contain a 
variant detected at a frequency higher than expected based on the error rate calculated 
across all clusters are removed to form their own cluster; this dramatically increases 
haplotype recovery without creating more false haplotypes (​Figure 3.1​).  
Using kluster, we have shown that it has perfect recall of a mixture of 4 ​P. falciparum 
strains all related to another strain by one difference on a region of Pfdhfr-ts, an important 
gene involved in drug resistance in ​P. falciparum​. In ​P. falciparum ​even a single difference in 
a gene can lead to drug resistance, and 1-base resolution is paramount when sequencing 
such genes. Here, we have demonstrated that the novel algorithm, kluster, is able to cluster 
sequences with single base resolution even at low read depths. 
 
Methods 
Datasets  
in silico simulations 
PacBio Simulator 
At the time of writing, there are no available simulators for PacBio that will do 
targeted amplicon sequencing, so an in-house simulator was created. This was done by 
utilizing 10 monoclonal FCR3 ​var2csa​ PacBio samples and 20 monoclonal 3D7 ​var2csa 
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PacBio samples and first aligning the samples to their expected sequences. The PacBio 
technology currently reports quality values up to a max of 42, and the per base error rate 
was calculated for bases with quality of 42 and assumed to be the PCR error rate. This 
theoretical PCR error rate was subtracted from overall error rate to get a PacBio error rate 
per base. Quality score distributions were then created for both mismatches and matches 
after subtracting the theoretical PCR error rate for each quality score. Insertions and 
deletions of up to 5 bases were observed, and the per base indel rate was calculated; a size 
distribution for both insertions and deletions was created based off of the counts observed. 
No correlation between position and error rate was observed (unlike Illumina and Ion Torrent 
that show positional effects). This is not unexpected due to the circular nature of PacBio 
sequencing and the fact each position gets several sequencing passes rather than just 
being sequenced once in a linear fashion; the same was true for rate of insertions and 
deletions.  
Using the calculated rates and distributions, a simulator was written to take a 
sequence and simulate per base whether there was no error, a mismatch, a deletion, or 
insertions. If a match, the quality score is determined by pulling from the match quality score 
distribution. For mismatches, the mutated base was based off the observed substitutions 
rates per base, above which favored transitions over transversion and the quality score was 
pulled from the mismatch quality score distribution. The size of a simulated deletion or 
insertion was determined from the appropriate size distribution; if an insertion was 
simulated, the bases inserted was randomly generated using the base composition of the 
input sequence. In this way, a simulator was created that could take an input sequence and 
emulate reads that would result from PacBio sequencing. This was combined with the 
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simulator described in Chapter II, which simulates PCR by taking PCR cules into account, 
with errors occuring in earlier cycles appearing at higher abundances.  
Simulated Datasets 
Datasets representing several different abundances, read depths, and sequence 
identities were simulated using the above simulator to test the theoretical bounds of kluster. 
Each dataset consisted of 7 minor strains and 1 major strain for a total of 8 strains per 
mixture. The minor strains differed from the major strain by 1, 2, 3, 4, 8, 10, and 20 SNPs, 
and did not share SNPs. A template haplotype of ​P. falciparum​ 3D7 ​ama1​ was used as the 
major strain and SNPs were randomly generated off this template to generate the minor 
strains. Mixtures were simulated with all the minor strains at the same abundance, with the 
major strain taking up the rest of the mixture. The minor strains abundances were 10%, 5%, 
2%, 1%, and 0.5%. Each of these abundance datasets were simulated twice to emulate 
duplicates and were simulated at read depths of 500, 1,000, 1,500, 2,000, 2,500, and 3,000. 
This was done 10 times, with new SNPs generated each time. This resulted in 600 
simulated datasets; kluster was evaluated for its ability to recover all expected sequences, 
and this was averaged across the ten different sets of randomly generated SNPs. 
Influenza  
An influenza dataset from a previous study was also analyzed ​(A. Artyomenko et al. 
2015) ​. The amplicon was 2kb and was a mixture of 10 clones at relative frequencies of 50%, 
25%, 12.5%, 6.25%, 3.125%, 1.56%, 0.78%, 0.39%, 0.19%. The clones were closely related 
and differences ranged from 2 (99.0% identity) to 21 (89.5% identity) and sequenced at a 
depth of 18,134. 
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Plasmodium falciparum 
dhfr-ts 
A 2kb region of the ​dhfr-ts​ gene of ​P. falciparum​ was amplified in three different 
mixtures of the lab strains 3D7, HB3, 7G8, Dd2 in duplicate. The three mixture were HB3, 
7G8, and Dd2 all at 5% (mixture 1), 1% (mixture 2), and 0.2% (mixture 3) with the rest of the 
mixture being 3D7 for each mixture. For the ​dhfr-ts ​region each strain differed from at least 
one other strain by 1 mismatch while the differences between strains for the ama1 region 
ranged from 16 (99.2 identity shared) to 28 (98.5% identity). Read depth for samples ranged 
from 557 to 2800.  
var2csa 
Six different mixtures of known lab strains of​ P. falciparum​ that were amplified in 
duplicate for a 3kb region of the ​var2csa​ gene were analyzed. Strains were very distantly 
related to each other (90.6% to 92.2%) and sample read depths ranged from 119 to 319.  
 
Algorithm Overview 
K-mer Similarity Score 
First, I define a k-mer similarity score for a given k-mer length of k as the total 
number of shared k-mers between the two sequences divided by the total number of 
possible k-mers shared (which is the length of the shorter sequence minus k plus 1). A score 
of 0 would mean that there are no k-mers shared between the sequences, and a score of 1 
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would mean that all the k-mers of the shorter sequence can be found within the longer 
sequence.  
Graph Based Clustering 
The algorithm starts with calculating all pairwise comparisons with k-mer similarity 
scores which has the option to be parallelized if multiple CPUs are available. A graph is 
created, with nodes as sequences and the edges connecting the nodes are undirected with 
weights as the similarity scores.  
The goal of the first round of clustering is not to cluster all sequences that belong to 
one haplotype into 1 cluster: rather, the goal is to gather together enough sequences into 
each cluster to ensure that when a consensus sequence is created from this cluster, it 
creates the correct consensus for the local haplotype it belongs to--thus, clusters that end up 
creating the same consensus can then be further clustered together (​Figure 3.5​). This 
allows the initial clustering to be strict enough to minimize clustering together similar 
haplotypes. Several attempts at optimizing k-mer length and a k-mer similarity score cut off 
for making connections in the graph were attempted but it was found that each dataset with 
different read lengths had different optimal k-mer lengths and k-mer similarities that were 
able to recover all expected sequences. Therefore, a new score was calculated to make 
connections: first, calculate the k-mer similarity scores between sequences for k-mer lengths 
of 2, 3, 4 and 5 and take the slope in k-mer similarity between lengths to calculate a distance 
score to be used in edge connections. This approach was settled upon from out of the 
several approaches and different scores attempted because it proved to be able to recover 
all expected sequences for different read lengths and different species datasets; the 
approach could also be calculated quickly, as the time it takes to calculate scores for these 
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k-mer lengths is small compared to longer k-mers. Clusters are then created by using a 
density-based spatial clustering of applications with noise (DBSCAN) approach ​(Ester et al. 
1996)​. In short the DBSCAN algorithm works by taking a node connecting all nodes that are 
connected under a certain distance, called epsilon, and if the number of nodes connected is 
greater than or equal to a set number, called minimum number of neighbors, then the nodes 
are clustered into one group. Once neighbors from a single node are connected, one of 
these neighbors is chosen and its neighbors are connected under the epsilon. Nodes that do 
not meet the minimum number of neighbors requirement do not spread to their neighbors 
and are considered edge points while nodes that do have the minimum neighbors and do 
spread are considered center points. Nodes that are not center or edge points are 
considered noise points and do not fall into any clusters. Nodes are chosen at random and 
classified until all nodes are classified as either center, edge, or noise points and 
interconnected points are considered a cluster. The clustering for sequences are carried out 
with a default epsilon of 1, chosen based off simulations where only sequences originating 
from the same original haplotypes had a slope of decreasing k-mer similarity below 1, and a 
minimum number of neighbors of a default of 4.  
Once final clusters have been created the original raw PacBio sequences are then 
mapped to the final consensus sequences to determine final read count for each cluster. 
Sequences that differ by more than a certain percent identity (default 90%) are placed in a 
separate file which can be investigated for possible missed haplotypes. To avoid clustering 
together very similar sequences, a per base error rate is calculated from the remapped 
sequences to the final consensus and then on a per consensus sequence basis, sequences 
are removed from a cluster to form their own cluster if they all share the same differences to 
the consensus sequence and if that difference is at least 2 standard deviations (SD) from 
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the mean per base error rate (​Figure 3.2​). Final consensus sequences are given in a fastq 
file with quality scores being the average quality score for that base along with the number 
of reads for each given cluster (​Figure 3.6​). These final results can then be given to 
SeekDeep’s processClusters function to determine shared haplotypes between samples.  
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Figures 
 
Figure 3.1: ​in silico​ Haplotype Recovery Results 
Haplotype recovery for the ​in silico​ datasets. This was calculated as the number of times the 
haplotype was recovered divided by the total number expected which was 10. The x-axis is 
the abundance for the minor haplotypes, the lines are colored by read depth, and the plots 
are paneled where each panel is one minor haplotype and the title indicates the number of 
differences from the major haplotype it is. ​a) ​is haplotype recovery without removing sub 
clusterings that contain the same SNPs that fall two SD above the mean error rate observed 
and ​b) ​is haplotype recovery when this feature is utilized which greatly improves the recall 
for all haplotypes down to 1%.  
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Figure 3.2: Removing Internal Clusters on Shared SNPs 
A feature is offered to attempt to recover closely related haplotypes that were improperly 
clustered with another haplotype where the per base error rate is calculated across all 
clusters. The PacBio error rate is randomly distributed across the reads and so it’s 
unexpected for the same error to occur in the same base positions multiple times. Therefore, 
any SNPs that occur at a rate greater than 2 standard deviations above the global error rate 
are determined and reads containing that SNP are removed to form their own cluster. 
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Figure 3.3: ​P. falciparum​ ​dhfr-ts​ Mixture Setup 
a) ​The relative frequencies of the lab strains in the three mixtures. ​b)​ Each strain is one 
base different from at least one other strain, the number of red dots on the lines connecting 
strains is the number of difference between them.  
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Figure 3.4: kluster Results on Known Lab Strain Control Mixtures 
a)​ kluster recovers all ten of the influenza clones and created no false haplotypes, x-axis is 
expected abundance and y-axis is kluster’s abundance for the clone, black line is line of 
identity. ​b) ​kluster recovers all 3 minor strains at 5% and 1% mixtures but fails to recover all 
at the 0.1%, no false haplotypes were created, x-axis is expected abundance and y-axis is 
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kluster’s abundance for the clone, black line is line of identity. ​c) ​kluster recovers all strains 
in all mixtures for ​P. falciparum var2csa​ datasets, the first bar represents the expected the 
frequencies and the second bar is the frequencies obtained from kluster which matches very 
close to expected.  
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Figure 3.5: Example Initial Clustering Step 
This is an example of the first round of cluster described in the methods section. The nodes 
are colored by the strain they belong to. Multiple small clusters of the same color can be 
seen and that is because the goal of the first step of clustering is not to gather every single 
read that belongs to the same strain but rather to gather enough reads to gather that when a 
consensus sequence is created for each cluster and it will match the consensus sequence 
of clusters coming from the strain they belong to.  
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Figure 3.6: Workflow Overview 
1)​ Initial reads are taken and clustered based on k-mer similarity scores to create initial 
clusters. ​2)​ Consensus are created for these clusters and each consensus is compared to 
collapse clusters with the same consensus to create clusters again. ​3)​ final clusters are 
used to map the raw reads to better determine read abundance. 4) optionally clusters are 
checked internally to remove any reads that all contain SNPs that appear at a higher 
abundance than expected when comparing to a base error rate calculated across all clusters 
by taking internal reads and comparing to consensus sequence.  
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Chapter IV: Global antigenic diversity and copy 
number polymorphism of ​var2csa​ the leading 
vaccine candidate for placenta malaria 
Preface 
The following is adapted from a manuscript being prepared for submission.  
Abstract 
Pregnant woman can be infected with the ​Plasmodium falciparum​ species expressing 
VAR2CSA protein which primarily binds to placental chondroitin sulfate (CSA), leading to 
sequestration of parasites in the placenta and poor birth outcomes. Antibodies against 
VAR2CSA has been found to be protective in multigravid women and for this reason the 
minimum CSA binding ID1-DBL2x-ID2a has been used in two vaccine trials; however, the 
trials might be hampered by the high degree of diversity of VAR2CSA. For this reason, we 
have developed a novel program PathWeaver to extract VAR2CSA sequence from publicly 
available shotgun whole genome sequenced field samples to better characterize this 
diversity globally and across time. We have found 4 major and 2 minor groups within the 
ID1-DBL2x-ID2a region that are stable across time and space; this stability is suggestive of 
balancing selection as well as evidence confirming previous reports of possible VAR2CSA 
copy number variation.  
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Introduction 
The protozoan disease malaria is still endemic in much of the developing world, 
infecting an estimated 216 million people per year and causing 445,000 deaths in 2016 
(WHO 2017)​. Pregnant women are particularly susceptible to malaria; ​Plasmodium 
falciparum-​infected erythrocytes sequester in the placenta and can cause poor birth 
outcomes ​(Rogerson et al. 2007; Salanti et al. 2003b; Tuikue Ndam et al. 2005)​. Placental 
sequestration is mediated by a highly variable protein called VAR2CSA, that primarily binds 
to placental chondroitin sulfate (CSA) ​(Rogerson et al. 2007; Duffy et al. 2006; Salanti et al. 
2004)​. Naturally-acquired antibodies to VAR2CSA have been shown to be protective during 
pregnancy ​(Rogerson et al. 2007; Ataíde, Mayor, and Rogerson 2014)​. Efforts to develop a 
VAR2CSA vaccine are underway ​(Fried and Duffy 2015; Tuikue-Ndam and Deloron 2015)​. 
However, their efficacy may be hampered by the genetic and geographical variation in the 
protein. 
The gene ​var2csa​, like most ​P. falciparum​ ​var​ genes, has two exons and is 
composed of multiple Duffy binding-like (DBL) domains along with a transmembrane 
domain. The first exon contains 3 DBLX domains and three DBLε, with the 6th and last 
domain traversing into exon 2. Most ​var​ genes can be classified by their 5’ upstream (ups) 
region and fall primarily into UpsA, UpsB, UpsB/C or UpsC groups, but VAR2CSA is the only 
var​ with that has UpsE. UpsE also contains an ups open reading frame (uORF) that 
encodes 119 amino acids that ends 274 base pairs before the VAR2CSA start codon. This 
uORF was confirmed to be part of the mRNA transcript of the VAR2CSA transcript although 
it’s not clear if it’s translated or not ​(Lavstsen et al. 2003)​.  
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One particular region of VAR2CSA, ID1-DBL2x-ID2a, appears to be most 
responsible for placental cytoadherence and will hereafter be referred to as the minimum 
CSA binding domain (MCBD) ​(Srivastava et al. 2011; Clausen et al. 2012)​. Antibodies 
directed to this minimal binding region have shown to occur naturally in woman protected 
from malaria and have been shown to block binding​(Bigey et al. 2011; Salanti et al. 2010)​. 
This region is the target of two current vaccines undergoing clinical trial and vaccine efforts 
of several groups has recently been summarized ​(Chêne et al. 2016)​.  
In a study of pregnant women in Benin and Malawi, we found that the gene is highly 
variable with 152 variants in 101 clinical malaria isolates. Previous studies have found two 
regions within the MCBD to be dimorphic, one region in the beginning of the DBL2 region 
(VAR2CSA3D7 amino acids 589-617) ​(Sander et al. 2009)​ and the other region takes up the 
majority of ID1 region (VAR2CSA 3D7 amino acids 397-568) ​(Doritchamou et al. 2015)​. The 
combinations of these two regions creates 4 subtypes with one of the types being found 
exclusively in multigravid women ​(Doritchamou et al. 2015)​. The global distribution of these 
types has yet to be adequately described and it is not known if all types are found globally. 
Beyond polymorphisms, copy number variation of var2csa has also been recognized 
(Sander et al. 2011)​. The lab strain HB3 has two copies of VAR2CSA although it is unclear if 
this was a culture adaptation or was naturally present in the strain before culturing. Unlike 
other PfEMP1 vars where only one copy at a time is expressed, these copies showed 
coexpression in two field isolated and HB3 with confirmed two copies of ​var2csa ​(Sander et 
al. 2009)​. ​The genomic positions of these copies were estimated using using pulsed field gel 
separation of chromosomes and placed HB3’s on chromosome 1, confirmed with assembly, 
and the position of the two field isolates’ copies on chromosome 8 and somewhere on 5-8 
(Sander et al. 2009)​. Further investigation of 111 natural isolates from Sudan and Tanzania 
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showed that 20% of isolates had multiple copies ​var2csa​ ​(Sander et al. 2009)​. Follow up 
study of isolates from the Cameroon found frequent multicopy isolates as well and 
determined that multiple copies were associated with pregnancy and increasing gravida. 
Infections with multicopy strains had longer persistence further suggesting a survival 
advantage for placental parasites carrying multiple copies ​(Sander et al. 2011)​. While such 
studies suggest var2csa copy number polymorphism may be common occurrence, a full 
survey of the extent of copy number across the world is lacking. 
Recently, thousands of ​Plasmodium​ ​falciparum​ genomes have been shotgun whole 
genome sequenced with primarily 100-base paired end Illumina 
sequencing(​https://www.malariagen.net/projects/pf3k​, ​Plasmodium 100 Genomes initiative, 
Broad Institute (​https://www.​broadinstitute.org​)​). However, because of the high variability of 
va2csa​ and its proximity to the telomere, it has been difficult to assess the gene using 
standard read mapping to reference genome or assembly approaches. Previous studies 
have tried to use standard de novo assembly programs to analyze complex ​P. falciparum 
genes ​(Crosnier et al. 2016; Jespersen et al. 2016; Dara, Drábek, et al. 2017)​ but these 
were meant for monoclonal sample assembly and were not built to handle mixtures of 
multiple genomes (polyclonal samples) or samples with increased gene copy number. This 
can lead to chimeric assembled sequences where sequence from one strain or copy are 
falsely combined with sequences from another copy of the gene to create false sequence.  
Here we present PathWeaver, a new method which leverages initial read recruitment 
to a region of interest in a reference genome followed by iterative de novo local assembly 
and recruitment of unmapped reads in order to assemble highly variable genes that are not 
amenable to analysis using standard short-read reference mapping methods. Using publicly 
available whole genome sequencing data, we use this method to interrogate ​var2csa 
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diversity and copy number variation in order to comprehensively describe genetic variation, 
genomic signatures of selection and global population structure. These data provide critical 
information about the potential impacts var2csa diversity may play on the successful 
development of PAM vaccines. 
Results 
Assembly on VAR2CSA Upstream Region and Exon 1 (UpsE-ID5)  
The PathWeaver algorithm, described in the methods section, was run on all 
datasets. Subsequent analysis was then performed on full length contigs and then 
subsequently on contigs that spanned smaller subregions of interest. These subregions 
were the five DBL regions, their inter domains, the minimal CSA binding domain ​(Bordbar et 
al. 2012)​, and the previously found dimorphic regions in ID1 ​(Doritchamou et al. 2015)​ and 
in DBL2 ​(Sander et al. 2009)​.  
Mapping Characteristics of in silico Simulated Sequences  
The 30 unique ​var2csa ​UpsE-ID5 sequences collected from the Pf3k Pacbio genome 
assemblies and from previous studies ​(Rask et al. 2010)​ were used to ​in silico ​simulate 
shotgun 2x100 Illumina sequencing runs with approximately 40 per base read coverage 
using a custom shotgun simulator and an Illumina simulator ​(Huang et al. 2012)​. On average 
90.81% of the simulated sequences aligned to 3D7 (range 81.66%-97.48%), with on 
average 95.41% of the paired sequences both mapped together (range 92.48%-98.08%) 
and the rest of the pairs only had one mate mapped. Sequences mapped to ​var2csa​ 98.93% 
(range 96.24%-99.95%) of the time, while an average of 1.2% sequence reads mapped to 
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other ​var​ genes (range 0.07%-3.38%) and an average of 0.28% mapped to other genomic 
locations (range 0.07%-0.65%). Mapped sequences were then examined for the extent of 
soft clipping, with on average 31.57 bases being soft clipped (range 28.08-35.73). This 
suggests that like most ​var​ genes, ​var2csa​ cannot be assembled using reference based 
variant calling pipelines and thus necessitate novel assembly approaches. 
Performance on in silico Simulations and Monoclonal Lab Strains 
In order to show that PathWeaver accurately recruits reads and reconstructs the 
UpsE-ID5 region, the ​in silico ​simulation datasets were analyzed. In all cases, PathWeaver 
assembled a single contig which perfectly matched the expected sequence. Shotgun short 
reads of monoclonal samples from publicly available laboratory strains, for which the 
var2csa​ sequence is known, DD2, GB4, IT/FCR3, W2, 7G8, and 3D7 were also analyzed by 
PathWeaver. Each produced a single contig, perfectly matching the expected ​var2csa 
sequence. This suggests that other ​var​ genes aren’t being erroneously recruited and 
assembled.  
Performance on laboratory strain mixtures (Pf3k Controls) 
Twenty eight lab control mixtures generated by MalariaGen were then also analyzed 
by PathWeather and compared against a gold standard de novo assembler and the 
assembler used most often previously for ​var​ genes ​(Jespersen et al. 2016)​, SPAdes 
(v3.11.0) ​(Bankevich et al. 2012)​. SPAdes can be run with a standard or “careful” mode, 
which maps sequences back to the assembled contigs to try to error correct them. Results 
from both the default mode and the careful mode along with PathWeaver are shown in 
Table 4.1. ​In samples with more than 1 copy of ​var2csa​, the default SPAdes program 
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created inaccurate contigs in almost all but two of the samples. While SPAdes careful mode 
improves its results it still fails on the majority of the samples with copies of ​var2csa​ >=3, 
while PathWeather accurately reconstructed contigs in all samples with three or less copies 
and created only one false contig in the samples with 4 ​var2csa​ copies.  
Field Samples  
We then sought to better determine the global diversity of ​var2csa​ using available 
whole genome sequence data from global isolates. Approximately 2,900 field samples were 
processed yielding a total of 743 UpsE-ID5 sequences and an average of 1,800 sequences 
on sub-regions, see ​Table 4.2 ​and​ Table 4.3 ​for a breakdown of total sequences found per 
geographical region and ​var2csa​ sub-regions. Rarefaction curves were created for each 
defined region broken down for each geographical region, see ​Figure 4.1. ​The rarefaction 
curves only reached saturation in Southeast Asia suggesting a significant level of diversity in 
the African regions yet to be described. 
Given the high number of variants described, we assessed for population structure 
using Principal Components Analysis (PCA).​ ​When evaluating the complete amino acid 
sequence of NTS-ID5 contigs (3D7 codons 1-2481), we identified two major population 
clusters (​Figure 4.2​). ​Figure 4.3​ shows that most of the structured amino acid variation 
(positions with the highest loading values for PC1 and PC2) is mostly contained in two 
regions within the MCBD (the ID1 hypervariable region and DBL2 hypervariable region). Of 
note, while these regions showed an excess of variation, there remained a high level of 
diversity along the entire region of the gene analyzed. We then evaluated how individual 
sub-domains of the protein impacted the population structure by generating PCAs based 
upon their amino acid sequence (​Figure 4.4​ and ​Figure 4.5​ of all domains). The MCBD 
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(3D7 codons 373-999) (​Figure 4.4a​), combined hypervariable region of ID1 and DBL2 (3D7 
codons 392-624) (​Figure 4.4b​), ID1 hypervariable region (3D7 codons 392-568) (​Figure 
4.4c​) and DBL2 hypervariable region (3D7 codons 585-624) (​Figure 4.4d​) broke into 4, 6, 4 
and 3 groups respectively and PCA of MCBD outside of the polymorphic region shows no 
structure (​Figure 4.6​). PCA of the regions outside of these shows little to no structure 
(​Figure 4.5​) with the exception of DBL1. Interestingly, all major groups were found across all 
geographic regions and were also found across years of collection consistent with a 
semi-stable population for these most polymorphic regions (​Figure 4.7​). 
The number of sequences that make up each group and the amount of amino acid 
conservation is summarized in ​Table 4.4​. Though the PCA plot shows fairly tight clustering 
in this region, amino acid conservation for within groups averages at 55% ranging from 40% 
to 62% though that is much higher than the 18% conservation when all sequences within 
this region are considered. 
UpsE Open Reading Frame 
Among var genes, var2csa is distinct in terms of its upstream sequence, UpsE. All 
1559 sequences collected for the UspE open reading frame had the start codon and stop 
codon conserved and 79% of its 119 codons are perfectly conserved. The translated protein 
doesn’t match any other proteins when protein blasted on the NCBI website. Though it has 
been found that this region is present in the VAR2CSA mRNA transcript ​(Lavstsen et al. 
2003)​ it’s not clear what function it serves or if it is also translated. This open reading frame 
is also conserved in the UpsE region of the ​P. reichenowi​ ortholog of ​var2csa​.  
116 
Copy number variation in var2csa 
To examine the extent of copy number variation, we limited our analysis to field 
samples representing monoclonal infections. Monoclonal infections were determined by 
running PathWeaver on 300 non-overlapping additional hypervariable 200 bp window in 230 
single copy genes. A sample was then classified as monoclonal if data was recovered for 
200 or more of these loci and if PathWeaver constructed only a single haplotype. This 
identified 1514 monoclonal samples. Since samples were observed to have non-uniform 
coverage which biased copy number conformation, we then eliminated samples using a 
t-SNE analysis to cluster samples with uniform coverage away from the non-uniform sample 
(Supplemental Figure ​Figure 4.8​) and additionally eliminated samples with a coverage 
standard deviation of greater than 20 and mean coverage of less than 50. This left 525 high 
quality coverage monoclonal samples for copy number variation analysis. Of these samples, 
373 (71%) had a singular contig constructed and the coverage for each matched mean base 
coverage in areas with similar GC content across the genome. Due to read sizes not always 
being long enough to span areas of conservation, full NTS-ID5 contigs were not always 
possible to generate, leading to several different contigs (see ​Figure 4.9​). Mean base 
coverage was again normalized to the mean base coverage of genomic regions with similar 
GC content. For each sample with increased copy number, each copy var2csa had a unique 
haplotype. Copy calls were then summed by geographic regions and collection year and 
shown in ​Figure 4.10​. Samples from South America were only found to have a single copy 
of var2csa across all years sampled there (2009-2012), while samples from South East Asia 
had samples with up to 3 copies and African samples had evidence of up to 5 copies. This 
distribution is similar to other studies of copy number variation in the ​Plasmodium falciparum 
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genome ​(Cheeseman et al. 2016)​. Also, another lab strain other HB3, UGT5.1, was also 
found to have two copies of ​var2csa​.  
The samples with 2 var2csa copies (n=107) were typed for their ID1 and DBL2 
polymorphic hypervariable regions to determine if they contained different types, typing was 
done with what PCA group on the ID1 and DBL2 polymorphic regions PCA analyses ​Figure 
4.11​, ​Figure 4.12​. These samples almost all have the at least 1 copy of ID1 type 2 with the 
majority of samples (62.2%) having a different ID1 type in the other copy of var2csa. Given 
the high prevalence of type 2 ID1 hypervariable regions in the single var2csa copy 
monoclonal infections (87% of 383 infections), this type of ID1 region appears to be 
underrepresented in parasites with more than one var2csa copies (66% of copies) 
(Chi-squared test X-squared = ​53.7​, df = 3, p-value = 2.64e-11). There did not appear to be 
a significant different in the number of DBL2 types (​X-squared = 6.68, df = 2, p-value = 
0.0708) 
We used Pf3k’s PacBio assembled genomes to then confirm the locations of multiple 
copies of var2csa on these genomes. The genomic location of the HB3 duplicate was 
confirmed on chromosome 1 when extracting from the Pf3k assembled genomes. Two of the 
clinical isolates were also found to have multiple VAR2CSA genes. One isolated, PfSN01 
from Senegal, had two copies on chromosome 12 and the other isolate, PfTG01 from Togo, 
had 2 copies on chromosome 12 and 2 on chromosome 8 in close proximity, all of which 
had an intact UpsE region, see ​Figure 4.13​. The relatedness of the four copies in PfTG01 
ranged from 90.5% to 93.8% and the relatedness of the two copies in PfSN01 was 92.0%. 
Previous studies have suggested that the possible location of additional VAR2CSA copies 
could be on chromosome 8 which would consist with what is seen here ​(Sander et al. 2011)​.  
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Discussion 
Var2csa​, which mediates the binding of malaria parasites to the placenta, is an 
important potential vaccine candidate to prevent malaria in pregnancy. Antibodies to var2csa 
have been found to be protective against malaria-associated poor birth outcomes​(Rogerson 
et al. 2007; Ataíde, Mayor, and Rogerson 2014)​. The study of ​var2csa​ is obstructed by its 
high diversity which prevents it from being studied with traditional reference based variant 
calling as it does not map well to a single reference. Another hurdle to studying ​var2csa 
using short read sequencing libraries is the fact that it has multiple copies and that many ​P. 
falciparum​ infections are polyclonal which means special care has to be taken when 
attempting to apply genome assembly approaches that unique copies are not improperly 
stitched together to form false sequence.  
Here we introduced a novel algorithm, PathWeaver, for extracting local haplotype 
sequence from even highly diverse regions of a genome and within polyclonal infections. 
The need for this algorithm arose from current assembly tools not being specifically 
designed for this purpose. While SPAdes does well on monocopy samples, which is what it 
was designed for, it does create false haplotypes even on careful mode when dealing with 
polyclonal samples. Other assembly type programs were tested as well, Trinity, Velvet, 
SSAKE, megahit among others and all suffered when it came to polyclonal samples (data 
not shown) for various reasons ranging from over collapsing variation to creating false 
haplotypes to not allowing output contigs to both contain regions of conserved sequence. 
While some of these problems had the potential to be circumvented with writing programs to 
wrap the assemblers in various ways a greater benefit was seen in creating a custom 
assembler specifically designed to handle cases of polyconality and that could be more 
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easily adapted for various scenarios it was needed for. While there do exists programs that 
were created to handle local haplotype assembly of polyconal infections (ShoRaH ​(Zagordi 
et al. 2011)​, ViQuaS ​(Jayasundara et al. 2015)​, etc) these all work directly with only the 
mapped portions of sequences rather than the full query sequence which, as shown above 
with 30% of ​var2csa​ sequences being clipped off, wouldn’t work for regions like ​var2csa​ and 
the concept of PathWeather was conceived with special interest in regions like var2csa, 
other var genes, and other ​Plasmodium​ regions that contain DBL domains or other binding 
domains that often show polymorphic allelic types​(Crosnier et al. 2016; Ware et al. 1993; 
McColl and Anders 1997; Pearce et al. 2004)​.  
By utilizing ​in silico​ simulation of 30 different ​var2csa​ variants we have proved that 
our iterative recruitment method of using 3D7 ​var2csa​ and subsequent recruitment of 
unmapped reads is adequate to gather enough UpsE-ID5 ​var2csa​ reads to be assembled 
into the expected sequence. Followed by tests on lab strains which had been whole genome 
shotgun sequence showed that this recruitment method only assembled the expected 
var2csa ​and does not recruit other ​var​ sequences. What aids in this endeavor to recruit only 
var2csa​ sequence is the utilization of mapping all reads to the 3D7 genome and pulling only 
the sequences that map to the 3D7 ​var2csa​ which due to the nature of mapping reads via 
local alignment and soft clipping if a portion of the read matches a region then it will be 
recruited unless it matches another region better. Though ​var2csa​ is fairly unique among the 
var​ genes it still shares some homology blocks with other ​vars​ as well as other DBL proteins 
like EBA-175 and so if only ​var2csa​ was used to recruit reads it could improperly recruit 
reads from other regions while using the whole 3D7 genome will help recruit these similar 
reads to their proper regions because they will more closely match those regions. However, 
it was observed that from the ​in silico​ simulations that approximately 1-3% of sequences 
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were recruited to other 3D7 regions including ​var​ genes and an algorithmic improvement 
could be to incorporate checking other regions once initial contigs have been assembled but 
based on our results here it was shown that this wasn’t necessary to assemble the expected 
sequence. It might also be tempting to utilize multiple ​var2csa​ sequences in the initial 
recruitment but this increases the potential danger of recruiting sequences other than 
var2csa and again we with our results here we have shown that such an approach is not 
necessary. In addition, by mapping to the 3D7 reference genome for the initial recruitment 
also allows the study of multiple regions from the same alignment file, which can be quite 
large and could potentially hamper the investigation of several regions at once if multiple 
alignments had to be created for each region. PathWeaver has allowed us to extract a large 
number of sequences for ​var2csa​.  
PCAs of the entire gene show little structure (​Figure 4.2​). However, a higher degree 
of structuring is observed when focusing on the MCBD and its polymorphic regions which 
demonstrates 4 major groups and 2 minor groups (​Figure 4.4​). Thus, much of the structured 
diversity in var2csa is found within the MCBD. This is consistent with evidence that the 
MCDB is the principal CSA ligand and that antibodies to the MCBD are particularly 
protective ​(Rogerson et al. 2007; Ataíde, Mayor, and Rogerson 2014)​. The MCBD regions 
also show the least amount of conserved amino acids and the highest mean expected 
heterozygosity for the gene (​Table 4.3​).  
Balancing selection is a phenomenon that selects for diversity, especially in immune 
epitopes; the more diverse an epitope, the more likely the parasite is able to survive and 
reinfect a host with a previous infection especially if cross-strain reactive antibodies are not 
able to be formed. This is especially true for infectious agents that don’t induce lasting 
immunity and leads to individuals being infected multiple times which leads to a strain’s 
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frequency being inversely correlated with its survivability ​(Lipsitch and O’Hagan 2007)​. 
There is substantial evidence for for balancing selection in malaria antigens especially for 
blood stage antigens ​(Weedall and Conway 2010)​. All 4 major groups and to a certain the 2 
minor groups are observed at a similar frequency across time and space (​Figure 4.10​) 
suggests that the same balancing selection forces are occurring independently on different 
continents.  
Gene duplication in var2csa has been previously reported ​(Sander et al. 2009, 
2011)​. Here, using the PathWeaver algorithm we were able to detect multiple copies of 
var2csa​ in monoclonal field samples found that each copy had approximately mean base 
coverage. When multiple copies do exist in a single genome, they were always found to be 
unique from each other which is consistent with previous findings ​(Sander et al. 2009)​. We 
were able to utilize chromosome level assemblies provided by MalariaGen’s Pf3k project 
( ​https://www.malariagen.net/projects/pf3k​) to confirm that ​var2csa​ has a conserved 
chromosome 12 loci and to show that the genomes of two field isolates had two tandem 
copies on chromosome 12 for one isolate and the other isolate had two tandem copies on 
12 and 8 which is also consistent with previous finding suspecting the possible location of 
additional var2csa copies being on 8 ​(Sander et al. 2009)​. As more chromosome level 
genome assemblies become available the possible locations of these copies can further 
characterized. It’s been postulated before that the multiple copies could explain the 
polymorphic types seen within ​var2csa ​(Sander et al. 2009)​, however we have observed 
here that all types for both ID1 and DBL2 appear in the monocopy samples so though the 
multiple copies are likely helping drive this diversity it doesn’t appear that the conserved 
chromosome 12 loci is associated with just one type.  
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We have only scratched the surface for analyses that could be done here. However, 
conventional tools and metric are not easily applied to a gene like ​var2csa​ with its complex 
evolutionary history, high rate of recombination, high diversity preventing the ability to use 
one sequence as a reference and its multiple copies. With having extremely divergent types 
there is no single good reference for sequences to be compared to which is the 
basis/requirement for many traditional measures of diversity and other population structure 
analyses. Also, a 3D structure could greatly inform the information gained from the 
sequence variation gathered here to see if variation is buried or forms pockets. There is 
currently no 3D structure available for ​var2csa​ but the amount of sequence gathered here 
could aid in the simulation of one.  
Methods 
PathWeaver 
PathWeaver represents a novel iterative multistep assembly method that allows 
accurate local assemblies of highly variable genes. Raw sequences are aligned to a 
reference genome using BWA-MEM (​http://bio-bwa.sourceforge.net/​) with default 
parameters. Extracted reads are then processed through a custom graph based method 
described below. Extracted reads are all oriented to the either the plus or negative strand, 
depending on input settings, so that final contigs are all oriented in the same direction. 
Recruited reads are then k-mer indexed at a certain k-mer size, default 40, to create nodes, 
nodes that fall below an occurrence cut off, default 5, are remove. Edges are then added to 
connect the nodes using a method called “threading” ​(J. R. Miller, Koren, and Sutton 2010) 
where nodes are connected if the k-mers occur adjacent in the input reads as opposed to a 
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classical approach of simply connecting k-mer nodes when their suffix and prefix match 
perfectly. Once de novo contigs have been constructed, the initially unmapped sequences 
are then aligned against the de novo assembled contigs using BWA-MEM 
(​http://bio-bwa.sourceforge.net/​) again. Graph assembly is repeated using the reads initially 
pulled down and these newly recruited reads to create new contigs. The still unmapped 
sequences are then aligned again to the new contigs to recruit more of the unmapped 
sequences. This is done iteratively until there are no newly recruited sequences or a max 
iteration number is hit (default of 20).  
Once the final iteration is done the final sequences are then trimmed to the region of 
interest. The number of final contigs and whether they span the whole region will be 
dependent on the size of the region, the depth, the amount of variation present if there are 
more than one unique copy of the region of interest, and the size of the read length of the 
input data. For example, if unique copies share a region of conserved sequence longer than 
read length than the variation flanking the conserved region cannot be stitched together or if 
a portion of the region of the interest fails to get sequenced than the output will be several 
contigs that covered the region. Another scenario where a full length contig might be 
possible is if there is a tandem repeat in the region which is longer than the read length and 
therefore the size of the repeat cannot be easily determined, several contigs will be reported 
even when there is only one unique copy. See ​Figure 4.14​ for a visual representation of the 
read recruitment strategy.  
var2csa Assembly 
The untranslated upstream region UpsE to the inter domain 5 (ID5) region of var2csa 
(UspE-ID5, genomic position Pf3D7_12_v3 49360-57446 in 3D7 (v3) 
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(​http://plasmodb.org/common/downloads/release-34/Pfalciparum3D7/fasta/data/PlasmoDB-
34_Pfalciparum3D7_Genome.fasta​)) was chosen for the ​var2csa ​assembly to ensure the 
highest recovery of data. Exon 2 of ​var2csa​, like most ​var​ genes, shows a high degree of 
similarity to other ​var​ exon 2 sequences and has a high potential to recruit other ​var 
sequences and so was avoided. DBL6 is split between exon 1 and exon 2 and was also 
avoided recruiting sequences that extend into the intron, which has hard to assembly 
sequences with long tandem repeats. For samples with multiple copies of ​var2csa​, full 
length UspE-ID5 reconstruction is not possible due to long conserved regions that reads are 
unable to span and the unique path cannot be determined. Partial sequences were used for 
subregion analyses if they covered the entire length of the analyzed region. 
In silico ​Simulations of ​var2csa​ UpsE-ID5 sequences 
In order to test the PathWeather algorithm, we simulated shotgun sequencing of 
UpsE-ID5 ​var2csa​ sequences. We collected UpsE-ID5 sequences by using MalariaGEN’s 
15 Pacbio chromosome level genome assemblies for 5 lab strains (GB4, 7G8, DD2, HB3 
and IT/FCR3) and for 10 clinical isolates (​https://www.malariagen.net/projects/pf3k​). 
UpsE-ID5 of 3D7 ​var2csa​ was extracted from these genomes by determining ​var2csa’s 
location using LASTZ ​(Harris 2007)​. Additionally, the ​var2csa​ sequences from a previous 
study on ​var​ genes which collected ​var​ sequence from NCBI’s BLAST and available lab 
genome assemblies ​(Rask et al. 2010)​. A total of 30 unique ​var2csa ​sequences were 
collected and each were used to simulate a shotgun 2x100 Illumina sequencing run with 
approximately 40 reads per base coverage.  
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Parasite Whole Genome Shotgun Sequencing Data  
Data was collected from several publicly available studies ​(Baniecki et al. 2015; 
Cerqueira et al. 2017; Parobek et al. 2017; Dara, Drábek, et al. 2017; Kumar et al. 2016)​ by 
parsing the SRA database and by using MalariaGEN’s Pf3K 
(​https://www.malariagen.net/projects/pf3k​) and Broad’s 100 genome project (​Plasmodium 
100 Genomes initiative, Broad Institute (​https://www.​broadinstitute.org​)​). The number of 
samples collected for each country was Bangladesh=50, Cambodia=663, DRC=113, French 
Guiana=58, Ghana=605, Guinea=100, Laos=85, Malawi=269, Mali=119, Myanmar=60, 
Nigeria=5, Senegal=137, Thailand=536, The Gambia=65, Uganda=11, Vietnam=97. In 
addition to the field samples, datasets contained the following lab strains, DD2, GB4, W2, 
IT/FCR3, 3D7, Tanzania (2000708), UGT5.1, 7G8, FCH/4, CAMP/Malaysia, 
MaliPS096_E11, NF135/5.C10, NF54, Santa Lucia, Palo Alto/Uganda and Vietnam 
Oak-Knoll (FVO). See below for a description of each study.  
Pf3k 
MalariaGEN’s Pf3K sequence reads (data release 5) of 2,512 whole genome sequencing 
samples were downloaded using their SRA accession numbers 
(​https://www.malariagen.net/projects/pf3k​). Data represents samples collected from 14 
different countries across Africa and Southeast Asia {Supplemental Table}. The majority of 
samples were 2x100 paired end Illumina sequencing. The Pf3k data also consists of 28 lab 
control various mixtures of 3D7, DD2, 7G8, and HB3 with the strains mixed with frequencies 
range from 1-99% (6 mixtures of 3D7/DD2, 3 mixtures of DD2/HB3/7G8, 16 mixtures of 
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HB3/7G8, 1 monoclonal of HB3, and 1 monoclonal of 7G8). Pf3K contains multiple 
instances of some samples and these were removed.  
Other Lab Strains 
Several more monoclonal lab strain sequencing samples were also found by querying the 
SRA database. The strains were DD2 (ERR663287), GB4 (ERR027100), IT/FCR3 
(ERR713965), and W2 (ERR663245) and 10 3D7 samples (ERR043381, ERR043382, 
ERR044266, ERR047177, ERR047178, ERR047179, ERR047184, ERR047185, 
ERR047186 and ERR047187).  
Broad 100 Genomes Project 
The data from The Broad Institute’s 100 Genome project for Plasmodium (​Plasmodium 100 
Genomes initiative, Broad Institute (broadinstitute.org)) has produced whole genome 
sequencing for the following lab strains ​Tanzania (2000708), UGT5.1, 7G8, FCH/4, 
CAMP/Malaysia, MaliPS096_E11, NF135/5.C10, NF54, Santa Lucia, Palo Alto/Uganda and 
Vietnam Oak-Knoll (FVO). The majority of lab strains were sequenced in triplicate with two 
libraries having a target insert size of 180 and 1 library with a target insert size of 5000. 
Whole genome sequencing was also produced for 44 samples from three different countries, 
22 from French Guiana, 11 from Mali and 11 from Uganda. The French Guiana samples 
were sequences similarly to the lab strains described above while the Mali and Uganda 
samples were sequenced only once with a target insert size of 180. All libraries were 
sequenced by Illumina 2x100 paired ends. 
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Baniecki et al. 2015 
An additional 34 samples from a longitudinal study in French Guiana from South America 
(Baniecki et al. 2015)​. 
Cerquerira et al 2017 
An additional 179 samples from a longitudinal study in Thailand were used though the 
majority of these samples were captured used hybrid capture which avoid the var gene 
regions so some samples lacked ​var2csa​ sequences ​(Cerqueira et al. 2017)​. 
Parobek et al 2017 
Data from a study on the effect of artemisinin partner drug usage had 93 clinical samples 
from 3 different regions in Cambodia, see paper for further details ​(Parobek et al. 2017)​.  
Dara et al 2017 
Data from a study on constructing var genes by utilizing Pacbio assemblies combined with 
Illumina paired end sequence had 12 samples from a village in Mali, see paper for further 
details ​(Dara, Travassos, et al. 2017)​.  
Kumar et al 2016 
Five samples from a study looking at Plasmodium falciparum diversity in India were also 
used ​(Kumar et al. 2016)​. 
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Determining Monoclonal Samples 
In order to investigate copy number we needed to determine which samples were 
monoclonal. We identified 300 hypervariable non-overlapping 200bp windows within 230 
single copy genes spread across all the chromosome of the Plasmodium genome. These 
were identified by interrogating the genomes of known laboratory strains to find small 
hypervariable regions that uniquely mapped back to the reference strain. We then 
determined that these windows had reliable coverage across the clinical datasets, then 
using PathWeather to conduct local reconstruction. A region was only considered if all 
contigs constructed spanned the whole region and not just a sub-portion of the region as 
these could represent failed constructions due to having more than one clone. Contigs also 
had to consist of at least 98% of the recruited reads to a region to ensure that all possible 
variants were being assembled. A sample was then classified as monoclonal if data was 
recovered for 200 or more of these 230 genes (some genes have more than 1 of the 300 
windows) and if PathWeaver constructed only a single haplotype. These windows had an 
expected heterozygosities ranging from .53 to .98 (mean 0.68). 
Analysis Programs Used  
Other analysis methods: Rarefaction curves generated by R package vegan 
(v​2.4-6​)​(Oksanen et al. 2018)​; PCAs on multiple protein alignments were generated by 
custom c++ scripts using the method described in ​(Wang and Kennedy 2014)​ and using R’s 
(R version 3.4.3) prcomp followed by group clustering by ​Hierarchical DBSCAN ​(Ricardo J 
G, Moulavi, and Sander 2013)​.  
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Tables 
Table 4.1: Pf3k Control Assembly Programs Results 
Program 
# of var2csa 
copies 
Error Free 
Samples 
Total 
Samples 
Average # of 
False Contigs 
PathWeaver 5 5 5 0 
PathWeaver 2 7 7 0 
PathWeaver 3 16 16 0 
PathWeaver 4 2 3 0.67 
Spades 5 5 5 0 
Spades 2 1 7 1.29 
Spades 3 1 16 5.81 
Spades 4 0 3 9 
Spades-careful 5 5 5 0 
Spades-careful 2 6 7 0.29 
Spades-careful 3 2 16 2.75 
Spades-careful 4 0 3 6.33 
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Table 4.2​: Reconstructed Sequences Count Per Region 
Region* 
UpsE-ID5 
NTS-ID5 
(Codon1-Codon24
81)** 
ID1-DBL2x-ID2a 
(MCBD) 
(Codon372-Codon999)
** 
Polymoprhic Region in 
MCBD 
(Codon391-Codon624)** 
South 
America 44 (7) 52 (8) 54 (7) 55 (7) 
West Africa 158 (142) 246 (205) 331 (240) 856 (506) 
Central Africa 23 (23) 34 (32) 40 (38) 111 (100) 
East Africa 54 (52) 68 (63) 82 (72) 274 (210) 
India 4 (2) 4 (2) 5 (2) 6 (2) 
South East 
Asia 456 (106) 518 (115) 644 (132) 1079 (172) 
Total 739 (332) 922 (420) 1156 (472) 2381 (906) 
Number of total sequences collected with number of unique sequences collected in 
parentheses  
* Countries per Region: Central Africa = Democratic Republic of the Congo; East Africa = 
Malawi,Mozambique,Uganda; India = India; South America = French Guiana; South East 
Asia = Bangladesh,Cambodia,Laos,Myanmar,Thailand,Vietnam; West Africa = 
Ghana,Guinea,Mali,Nigeria,Senegal,Gambia  
** Start amino acid (AA) codon to the beginning of DBL6  
*** Minimal binding domain spanning ID1-DBL2x-ID2a  
**** Polymorphic Region within minimal binding domain, includes regions from ID1 to DBL2
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Table 4.3: Counters Per Domain  
region 
3D7 
Codo
n 
Start 
3D7 
Codo
n 
Stop 
le
ng
th 
# of 
Seque
nces 
# of Unique 
Sequences 
# of 
Singl
ets 
Max 
Uniq
ue 
Coun
t*** 
# of 
Sampl
es**** 
# of 
Positions 
>=95% 
Conserved
***** 
% of 
Positions 
>=95% 
Conserved
***** 
Mean 
He(S
D) 
Upse-ID5* 
4936
1 
5744
6 
80
86 743 332 261 60 730 6076 75.14% 
0.241
(0.20
2) 
UpsE ORF** 1 119 
11
9 1553 197 81 223 1462 95 79.83% 
0.213
(0.17
7) 
NTS-ID5 1 2481 
24
81 904 405 309 63 904 1438 57.96% 
0.317
(0.22
1) 
NTS 1 65 65 2864 693 353 139 2109 40 61.54% 
0.296
(0.22
5) 
DBL1 66 356 
29
1 1694 612 397 73 1480 149 51.20% 
0.301
(0.22
7) 
ID1 357 568 
21
2 2558 936 591 110 1936 31 14.62% 
0.365
(0.19
6) 
Minimal CSA Binding 
Domain 372 999 
62
8 1145 465 331 72 1095 279 44.43% 
0.328
(0.22
4) 
Minimal CSA Binding 
Domain Polymorphic 
Region 391 624 
23
4 2366 885 569 108 1869 44 18.80% 
0.37(
0.197
) 
ID1-Polymorphic 391 572 
18
2 2648 914 554 112 1992 20 10.99% 
0.367
(0.19
1) 
DBL2 569 916 
34
8 1286 509 359 77 1196 213 61.21% 
0.252
(0.24
5) 
DBL2-Polymorphic 579 624 46 3313 306 107 210 2272 17 36.96% 
0.419
(0.20
8) 
ID2 917 1331 
41
5 1143 440 313 72 1118 229 55.18% 
0.34(
0.206
) 
DBL3 1332 1646 
31
5 1096 414 298 75 1095 230 73.02% 
0.29(
0.202
) 
ID3 1647 1715 69 1751 166 72 165 1594 54 78.26% 
0.337
(0.22
2) 
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DBL4 1716 2001 
28
6 1135 415 284 76 1130 209 73.08% 
0.156
(0.19
5) 
ID4 2002 2150 
14
9 1413 455 283 67 1294 115 77.18% 
0.199
(0.20
4) 
DBL5 2151 2430 
28
0 1564 573 384 81 1412 144 51.43% 
0.256
(0.22
9) 
ID5 2431 2481 51 3022 397 141 100 2158 23 45.10% 
0.308
(0.25
9) 
* 3D7 genomic location on chromosome 12 are given for the UpsE to ID5 region as it can't 
be fully translated 
** Codon positions are for the open reading frame and not the VAR2CSA codons 
*** The max number of times the same sequence was found 
**** The number of samples sequences were recovered from, some samples contribute 
more than one sequence for a region if it has more than 1 contig spanning the region 
***** 95% conserved meaning that for a given position 95% of the total sequences had the 
same amino acid/base 
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Table 4.4: Counts for MCBD PCA Groups  
 
group 
# of 
Sequen
ces 
# of 
Unique 
Sequen
ces 
# of 
Singlets 
Median 
Unique 
Count 
Max 
Unique 
Count 
# of 
Sample
s 
# of 
Position
s >=95% 
Conserv
ed 
% of 
Position
s >=95% 
Conserv
ed He 
1 947 325 212 3 108 872 127 54.27% 0.975 
2 52 27 15 2.5 6 50 95 40.60% 0.943 
3 926 348 226 3 104 862 127 54.27% 0.979 
4 96 11 5 10 38 96 147 62.82% 0.736 
5 128 71 42 3 6 124 138 58.97% 0.98 
6 230 105 65 3 18 227 145 61.97% 0.979 
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Figures  
 
Figure 4.1: Rarefaction Curves 
Rarefaction curves for the ​a) ​NTS-ID5 region, ​b)​ MCBD, and c) the polymorphic region in 
the MCBD. South East Asia shows signs of leveling out but the African regions are still very 
steep suggesting that there is still a high degree of diversity in Arica not yet documented.  
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Figure 4.2: PCA of NTS-ID5 
PCA of the protein multiple alignment of the NTS-ID5 region. The nodes are colored by the 
groups based on the PCA of the polymorphic region in the MCBD. Lab strains are labeled. 
PC1’s highest loading values fall mostly into the ID polymorphic region (​Figure 4.3a​)  
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Figure 4.3: PC1 and PC2 Loading Values for NTS-ID5, MCBD, 
MCBD-Polymorphic 
The PC1 and PC2 for the protein PCAs loading values normalized to the the max loading 
values for each, PC1 loading values are always the bar on top and PC2 loading values are 
always the bar on the bottom. ​a)​ shows the loading values for NTS-ID5, the highest values 
are PC1 fall within the ID1-Polymorphic ​b)​ shows loading values for the MCBD,the highest 
values for both PC1 and PC2 can be seen within the MCBD-Polymorphic region, and ​c) 
shows the loading values for the MCBD-Polymorphic region, showing that PC2 is being 
driven by the DBL2 polymorphic and PC1 is being driven by the ID1 polymorphic.  
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Figure 4.4: PCAs on the MCBD Domains 
PCAs on protein multiple alignments for several domains within the MCBD. ​a)​ The full 
minimum CSA binding domain itself, it is colored by the clusters determined for the 
polymorphic region in ​b)​, ​b) ​The polymorphic region of the MCBD made up of the ID1 
polymorphic ​c) ​and the DBL2 polymorphic ​d), ​shows 4 major groups and 2 minor groups, ​c) 
the ID1 polymorphic region colored by HDBSCAN on its own region,splits into 4 groups ​d) 
the DBL2 polymorphic region, breaks up into 3 groups  
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Figure 4.5: All Domains PCAs 
PCA plots for each DBL and ID domains and the NTS and the UpsE ORF. Coloring is done 
by HDBSCAN on the PCA.  
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Figure 4.6: PCA of the Region Beyond the DBL2 within the MCBD 
PCA of the region beyond the polymorphic region in the MCBD, cover most of the DBL2 
region and the ID2 region within MCBD. No structure is evident from the plot showing that 
the majority of the structure in the MCBD is in the polymorphic regions in ID1 and DBL2.  
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Figure 4.7: MCBD Polymorphic PCA Group Counts 
Counts across years and regions of the groups determined by the PCA on the polymorphic 
region in MCBD. The groups appear to stay stable across ​a)​ regions and ​b)​ years, 
suggestive of balancing selection keeping diversity.  
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Figure 4.8: t-SNE of the Chromosome 12 Coverage 
A TSNE off of the mean genome coverage of chromosome 12 of all monoclonal samples to 
select groups that were observed to have normal coverage.  
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Figure 4.9: Example of Assembly Output of 2 var2csa Copies Samples 
Example of 4 monoclonal samples with evidence for two copies of ​var2csa​. The relative 
positions of the domains are shown on the bottom. The length of the blocks indicate length 
and the height of the blocks indicate read depth. Blue rectangles have 1 tail and pink 
rectangles have 2 tails.  
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Figure 4.10: ​var2csa​ Copies Calls Across Time and Region 
The x axis is both year and region, y axis is the relative amount of the monoclonal samples 
for each copy count. Bars are colored by the number of copies. The total amount for a given 
year and region is on the top of the bars.  
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Figure 4.11: ID1 Types Monocopy var2csa Samples 
The y axis is the rounded var2csa coverage for this region divided by the mean base 
coverage and x axis is samples. The bars are colored by ID1 type determined in ​Figure 
4.4a.  
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Figure 4.12: ID1 Types Two Copies var2csa Samples 
The y axis is the rounded var2csa coverage for this region divided by the mean base 
coverage and x axis is samples. The bars are colored by ID1 type determined in ​Figure 
4.4a.  
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Figure 4.13: Locations of var2csa in Pf3k Assembled Genomes 
The locations of ​var2csa​ as determined by LASTZ​(Harris 2007)​ in the chromosome level 
assemblies of the Pf3k genomes. ​a) ​PfTG01 is from Togo and has 4 copies have var2csa, 
two in tandem on chromosome 12 and two in tandem on chromosome 8. How related the 
copies are shown to the right. ​b)​ PfSN01 is from Senegal and has two var2csa copies in 
tandem on chromosome 12. ​c)​ Lab PfHB3 strain is from Honduras and has a var2csa copy 
on chromosome 12 and one on chromosome 1.  
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Figure 4.14: PathWeaver Recruitment Algorithm Overview 
a)​ First what reads do map to a region are extracted and are used to construct initial contigs. 
b)​ These contigs are then used to recruit reads from the reads that are unmapped and 
assembly is ran again with all reads. ​c)​ This is done iteratively until there are either no more 
reads recruited or the max iterations (default 20) is hit.  
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Chapter V: Carmen: Where in the world is my 
haplotype?  
Abstract  
There have been many tools invented to view or summarize SNP/INDEL variant calls from 
shotgun whole genome sequencing; however, as targeted amplicon sequencing becomes 
more popular, tools that report haplotype information rather than the traditional variant calls 
will be more useful. For this reason, Carmen was invented to utilize the PathWeaver 
algorithm introduced in Chapter IV to both collect and visualize haplotype data from publicly 
available datasets to better inform targeted amplicon studies. Carmen was found to be 
accurate based off of results on various regions in the ​P. falciparum​ genome using known 
lab strain control mixture, and proved to be useful on a previous targeted amplicon dataset.  
Introduction 
As mentioned in previous chapters, the analysis of infectious disease by using 
haplotypes rather than just by calling SNP/INDEL variants is becoming more popular of late 
(Bailey et al. 2012; Mideo et al. 2016; R. H. Miller et al. 2017; Verity et al. 2018)​. However, 
there aren’t as many programs that report haplotype worldwide prevalence like MalariaGen 
does with its Panoptes application for SNP variants ​(Vauterin et al. 2017)​. Haplotypes can 
also be checked in NCBI’s BLAST to determine if a haplotype has been found before, but 
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this lacks the ability to report comprehensive summary reports on how many times, where, 
and when a haplotype has been found as appropriate metadata is often lacking or hard to 
collate. For that reason, I have invented the program dubbed Carmen to find where in the 
world certain haplotypes are found.  
Carmen takes a genomic location, a directory of bam alignment files, and a metadata 
file for the input samples with country and collection year to collect local haplotypes for the 
given region and report the years in which each haplotype was found. Carmen was 
designed to be broadly applicable to any species, but was tested here on ​P. falciparum​ with 
several highly variable genomic regions, including regions often studied in targeted 
sequencing approaches, such as thrombospondin-related anonymous protein (TRAP), 
circumsporozoite protein (CSP) ​(Mideo et al. 2016; Bailey et al. 2012)​, and apical membrane 
antigen 1 (AMA1) ​(R. H. Miller et al. 2017)​, among many others; see ​Table 5.1​ and ​Table 
5.2​ for a list of all genes. These regions were chosen because highly variable regions are 
the common target of targeted approaches and represent the most likely regions Carmen 
would be used on. Carmen was then tested for accuracy on known lab control mixtures 
provided by MalariaGen’s Pf3k project (​Table 5.3​) and then used on output of a previous 
study on the CSP gene ​(Mideo et al. 2016)​.  
Results 
Known Lab Strains  
The goal of Carmen is to collect as many high quality accurate local haplotype 
sequences from samples as possible, and not necessarily to call all expected sequences 
from a sample (especially since, depending on the length of the region of interest, this is not 
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always possible with a short read assembly method, as variation cannot always stitched 
together if read length is not adequate enough to bridge conserved sequence in between). 
For this reason, Carmen was evaluated for the number of haplotypes that matched the 
expected sequence, here coined “True haplotypes.” Results are summarized in Tables 5.4 
and 5.5. Carmen shows high accuracy on all samples for all MOIs. For the 200 bp window, 
20/31 (67%) of the samples showed perfect accuracy, with at most 5 windows out of the 
1862 windows containing errors for a sample, and 1819/1862 (97.7%) of the windows were 
always reconstructed correctly. For the 400 bp window, 27/31 (87.1%) of the samples 
showed perfect accuracy, with at most 2 windows out of the 128 windows containing errors 
for a sample, and 123/128 (96.1%) of the windows were always reconstructed correctly. 
With the exception of the IT sample, Carmen was able to accurately reconstruct the majority 
of windows for both 200 bp and 400 bp for the monoclonal samples, showing that Carmen is 
able to accurately reconstruct all windows. The failure on the polyclonal samples are due to 
read length not being able to span the variation present in the multiple clones.  
Example PfCSP Dataset 
To test Carmen on a real set of haplotypes from a targeted amplicon analysis, I 
selected a previous study on the region of ​P. falciparum ​CSP encoding the polymorphic 
C-terminal region the gene, which resulted in 45 unique population haplotypes ​(Mideo et al. 
2016)​. Carmen determined the genomic location of the 45 haplotypes to be Pf3D7_03_v3 
221423-221670(-) in the 3D7 reference genome (v3), which is the correct region targeted in 
the study (247 bp long). Carmen used this determined region to call haplotypes from the 
samples described in Chapter IV which, in short, contain samples from the following 
countries: Bangladesh=50, Cambodia=663, DRC=113, French Guiana=58, Ghana=605, 
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Guinea=100, Laos=85, Malawi=269, Mali=119, Myanmar=60, Nigeria=5, Senegal=137, 
Thailand=536, The Gambia=65, Uganda=11, Vietnam=97, as well as the control datasets 
described above. The sequences extracted from the control dataset all matched the 
expected sequences for all 31 samples. Carmen was able to collect 3,181 (219 unique) 
sequences from the field samples.  
Carmen was able to create a connected haplotype network by connecting all 
haplotypes that were 2 or fewer differences from each other (​Figure 5.1​ PfCSP Network). 
The network is made up of nodes of haplotypes colored by the region found in, and the area 
of the circle corresponds to number of times it was found. It can be observed that there is 
some distinct clustering by geography, where haplotypes are more likely to cluster with other 
haplotypes found in the same region--which has been observed for this region previously ​(A. 
E. Barry et al. 2009)​. Nodes were also created for all 45 input population sequences, and 
colored by the country they came from in the previous study. The top 5 that appeared in the 
most subjects in the previous are labeled. We can see that the most abundant haplotype 
from the Cambodia samples (which was the dominant infection across all Cambodian 
subjects), matches perfectly with the most abundant haplotype from South East Asia; 
similarly, the most abundant haplotypes from the Tanzania samples cluster closely with 
haplotypes from Africa.  
Discussion 
As the focus moves from SNP/INDEL variant calling to targeted amplicon 
approaches, we will need more tools specifically for analyzing haplotype data. For that 
reason, I have created Carmen, a tool that can take advantage of the wealth of publicly 
available data which has associated country and collection year metadata to report 
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important prevalence data for newly found haplotypes. Carmen should be an important aid 
for interrupting targeted haplotype approaches.  
I have evaluated Carmen’s accuracy by utilizing control mixtures of known ​P. 
falciparum ​lab strains for which there are whole chromosome level assemblies available to 
check expected sequences against. I have demonstrated that Carmen can accurately 
reconstruct regions of interest of 200 bp and 400 bp which includes genes like AMA1 and 
CSP, which are often targets of targeted amplicon approaches in ​P. falciparum​ studies ​(R. 
H. Miller et al. 2017; Bailey et al. 2012; Mideo et al. 2016)​. Carmen has demonstrated the 
ability to accurately collect local haplotypes from the majority of windows from monoclonal 
samples, as well as from polyclonal samples, which allows it to optimize the amount of 
haplotype data it can collect and is not limited to only monoclonal samples.  
Carmen was then used on a real dataset from a previous study ​(Mideo et al. 2016) 
using targeted amplicon sequencing of ​P. falciparum​ to create strain specific clearance 
curves for patients from Cambodia and Tanzania. Carmen was able to determine the 
appropriate region and extracted 3,181 (219 unique) from publically available field samples. 
Using the metadata associated with these field samples, we are able to see that the 
haplotypes from the Cambodian and Tanzanian samples matched haplotypes from the 
corresponding regions in the field samples. At the time of writing of the previous study 
(Mideo et al. 2016)​, there were some concerns whether to trust the data from the Cambodia 
dataset, since all of the samples were strongly dominated by a single haplotype; it was 
postulated that it could have been contamination. At that time, there wasn’t a comprehensive 
way of determining whether this haplotype had been found before in Cambodia, other than 
by looking at haplotypes reported by other studies; however, now with Carmen, we can 
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confirm that the haplotype found is in fact the most dominant haplotype in the South East 
Asia region.  
In conclusion, Carmen has proven to accurately extract haplotype sequence from 
publicly available shotgun whole genome field samples for ​P. falciparum​; used on a real 
dataset, Carmen has shown the utility of being able to compare to expected haplotype 
sequence for both the genomic and geographical regions being studied. Carmen is written to 
be able to work with a variety of species, and should prove to be a valuable resource for 
targeted amplicon studies moving forward.  
Methods 
Algorithm Overview  
Carmen can either be run by giving it a set of genomic location in a ​Browser 
Extensible Data (BED, ​https://genome.ucsc.edu/FAQ/FAQformat.html#format1​)​ file, or a 
set of haplotypes from which Carmen will determine the genomic location by mapping to a 
reference genome using LASTZ ​(Harris 2007)​ to create a BED file. Carmen then runs the 
PathWeaver algorithm, described in Chapter IV, on the region(s) from the BED file on a 
directory of alignment of files. In short, the PathWeaver algorithm is a graph assembly based 
algorithm designed specifically to construct local haplotypes from a region of interest in an 
alignment file, with special care taken to avoid creating false haplotypes for the cases of 
multiple copies, or multiple clones for a region that share large amounts of conserved 
sequence. Carmen then collates the haplotypes called for a region from each sample into 
one file, and reports countries and years found in supplied with a metadata file, which is a 
tab separated file with one column being sample names and each additional column being a 
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meta field for the given samples. The only requirements of Carmen are that all alignment 
files are aligned to the same reference genome file; for inputs, Carmen also needs the 
reference genome that the samples were aligned to, and a metadata file that contains at 
least country and collection year (NAs can be provided as placeholders). In addition, other 
genomes or assemblies of known/lab strains can be provided, and the sequences of these 
strains will be added to the output. Carmen was designed to be broadly applicable and, 
therefore, as long as the input data matches the above requirements, Carmen should be 
able to run on input from a variety of sources.  
Carmen’s output is a directory which contains all the result files. These files include 
1) a fasta file of collected sequences, given a unique identifier named with genomic location 
extracted from and appended with an ID number starting from 0 where 0 is the most 
commonly found haplotype, 1 is the second most commonly found haplotype, etc., 2) a 
report of the samples the haplotypes were found in and a summary of the years and 
countries these samples are from, and 3) if Carmen was run with input haplotypes rather 
than just a given BED file, a report of the newly constructed haplotypes that match or most 
closely match the input haplotypes. Carmen also comes with a lightweight HTML viewer that 
can be run on the output directory to interactively view where haplotypes are found on a 
map, an interactive sequence viewer, and a network of how all the haplotypes are related 
(​Figure 5.2​).  
P. falciparum​ Known Control Mixtures  
Though Carmen is designed to be broadly applicable, my lab primarily works with ​P. 
falciparum​, and therefore its capabilities and accuracy was tested on input from ​P. 
falciparum​. Carmen’s accuracy was tested on 27 known lab strain control mixtures provided 
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by MalariaGen’s Pf3k project (​https://www.malariagen.net/projects/pf3k​). The mixtures were 
of either 2 or 3 strains and consisted of the lab strains 3D7, Dd2, HB3, and 7G8; see Table 
5.3 for details. Also, four additional monoclonal lab strains shotgun whole genome samples 
were analyzed, GB4 (ERR027100), 3D7 (ERR043381), IT (ERR713965), and Dd2 
(ERR663287). These sample were chosen because Pf3k have assembled genomes for 
them and therefore expected sequences can be determined and checked for accuracy in 
reconstructions.  
P. falciparum ​Genomic Locations Analyzed 
Carmen was run on 1,843 windows of 200 base pairs (bp) in length, and 127 
windows of 400 bp in length from an analysis on highly variable regions in ​P. falciparum 
(unpublished). The 200 bp windows covered 390 genes and the 400 bp windows covered 27 
genes, see ​Tables 5.1​ and ​5.2​. Window sizes of 200 bp and 400 bp were chosen as these 
are common sizes for targeted approaches due to sequence technology read length 
limitations of Illumina. Carmen was run on the lab control mixtures and monoclonal samples 
to extract local haplotypes from these regions. Extracted sequences compared to the 
expected sequence. Expected sequences were determined by extracting sequences from 
the Pf3k PacBio assembled genomes using LASTZ ​(Harris 2007)​ to determine their location. 
Data is only reported for a location if a haplotype that spans the whole region of interest is 
reconstructed. This is not always possible for polyclonal samples or for polycopy regions 
when the read length is insufficient to properly stitch together variation on the ends of 
conserved regions when the conserved region is longer than read length. In this case, 
segments that are shorter than the region of interest are created, but since the interest here 
is the local haplotype that spans the whole region, only full length local haplotypes are 
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collected. For this reason, some samples will have no local haplotypes called for a region 
which can happen more often as the number of strains/copies increases. 
Example Dataset 
To test Carmen, a real dataset a previous study had done in collaboration with our 
lab was used. The study had amplified the region of ​P. falciparum ​CSP encoding the 
polymorphic C-terminal region the gene in order to create strain specific clearance curves 
from samples from patients in Tanzania and Cambodia to look for evidence of slow clearing 
parasites ​(Mideo et al. 2016)​. The study had 14 patients sampled over 72 hours up to 4 
times each. Analysis resulted in 45 final unique population haplotypes and these haplotypes 
were run through the Carmen pipeline.  
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Tables 
Table 5.1: Gene IDs for 200 bp Windows  
 
Gene ID Gene Description 
# of 
200bp 
windows 
PF3D7_0102500 erythrocyte binding antigen-181 (EBA181) 1 
PF3D7_0102800 conserved Plasmodium protein, unknown function 2 
PF3D7_0103100 vacuolar protein sorting-associated protein 51, putative (VPS51) 1 
PF3D7_0103300 conserved Plasmodium protein, unknown function 5 
PF3D7_0103500 conserved Plasmodium protein, unknown function 4 
PF3D7_0103600 ATP-dependent RNA helicase, putative 2 
PF3D7_0104100 conserved Plasmodium membrane protein, unknown function 7 
PF3D7_0106300 calcium-transporting ATPase (ATP6) 4 
PF3D7_0110200 FAD-linked sulfhydryl oxidase ERV1, putative (ERV1) 1 
PF3D7_0110600 phosphatidylinositol-4-phosphate 5-kinase (PIP5K) 1 
PF3D7_0112200 multidrug resistance-associated protein 1 (MRP1) 5 
PF3D7_0112900 Plasmodium exported protein, unknown function 3 
PF3D7_0113100 surface-associated interspersed protein 1.1 (SURFIN 1.1) (SURF1.1) 8 
PF3D7_0113600 surface-associated interspersed protein 1.2 (SURFIN 1.2), pseudogene (SURF1.2) 11 
PF3D7_0113800 DBL containing protein, unknown function 48 
PF3D7_0202100 Plasmodium exported protein (PHISTc), unknown function,liver stage associated protein 2 (LSAP2) 9 
PF3D7_0204500 aspartate aminotransferase,aspartate transaminase (AspAT) 8 
PF3D7_0207000 merozoite surface protein 4 (MSP4) 1 
PF3D7_0207300 serine repeat antigen 8 (SERA8) 3 
PF3D7_0207500 serine repeat antigen 6 (SERA6) 3 
PF3D7_0207700 serine repeat antigen 4 (SERA4) 1 
PF3D7_0208000 serine repeat antigen 1 (SERA1) 5 
PF3D7_0209000 6-cysteine protein (P230) 1 
PF3D7_0210200 conserved Plasmodium protein, unknown function 2 
PF3D7_0210800 conserved Plasmodium protein, unknown function 7 
PF3D7_0211700 tyrosine kinase-like protein, putative (TKL1) 1 
PF3D7_0212100 conserved Plasmodium protein, unknown function 4 
PF3D7_0212400 conserved Plasmodium membrane protein, unknown function 4 
PF3D7_0213800 conserved Plasmodium protein, unknown function 1 
PF3D7_0214600 serine/threonine protein kinase, putative 2 
PF3D7_0214800 conserved Plasmodium membrane protein, unknown function 1 
PF3D7_0220000 liver stage antigen 3 (LSA3) 2 
PF3D7_0220100 DnaJ protein, putative 9 
PF3D7_0220800 cytoadherence linked asexual protein 2 (CLAG2) 1 
PF3D7_0221100 Plasmodium exported protein, unknown function, pseudogene 1 
PF3D7_0221200 Plasmodium exported protein (hyp15), unknown function 2 
PF3D7_0301400 Plasmodium exported protein, unknown function 2 
PF3D7_0301800 Plasmodium exported protein, unknown function 2 
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PF3D7_0301900 conserved Plasmodium protein, unknown function 2 
PF3D7_0302100 serine/threonine protein kinase (SRPK1) 3 
PF3D7_0302600 ABC transporter, (TAP family), putative 6 
PF3D7_0303100 conserved Plasmodium protein, unknown function 1 
PF3D7_0304600 circumsporozoite (CS) protein (CSP) 3 
PF3D7_0304700 conserved Plasmodium protein, unknown function 1 
PF3D7_0305100 conserved Plasmodium protein, unknown function 1 
PF3D7_0308000 DNA polymerase epsilon subunit b, putative 1 
PF3D7_0308100 conserved Plasmodium protein, unknown function 10 
PF3D7_0309900 conserved Plasmodium protein, unknown function 5 
PF3D7_0310200 phd finger protein, putative 1 
PF3D7_0311600 dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1, putative 1 
PF3D7_0312100 E3 ubiquitin-protein ligase, putative 7 
PF3D7_0315200 circumsporozoite- and TRAP-related protein (CTRP) 5 
PF3D7_0315600 conserved Plasmodium protein, unknown function 6 
PF3D7_0316200 conserved Plasmodium protein, unknown function 8 
PF3D7_0318200 DNA-directed RNA polymerase II subunit RPB1, putative (RPB1) 7 
PF3D7_0318300 conserved Plasmodium protein, unknown function 5 
PF3D7_0319400 kinesin-8, putative 7 
PF3D7_0319800 conserved Plasmodium protein, unknown function 1 
PF3D7_0320400 oocyst capsule protein (Cap380) 12 
PF3D7_0321500 peptidase, putative 3 
PF3D7_0323400 Rh5 interacting protein (RIPR) 1 
PF3D7_0401900 acyl-CoA synthetase (ACS6) 8 
PF3D7_0402000 Plasmodium exported protein (PHISTa), unknown function 3 
PF3D7_0402200 surface-associated interspersed protein 4.1 (SURFIN 4.1), pseudogene (SURF4.1) 22 
PF3D7_0402300 reticulocyte binding protein homologue 1,normocyte binding protein 1 (RH1) 9 
PF3D7_0402400 Plasmodium exported protein, unknown function (GEXP18) 14 
PF3D7_0402800 erythrocyte membrane protein 1 (PfEMP1), pseudogene 6 
PF3D7_0404600 conserved Plasmodium membrane protein, unknown function 5 
PF3D7_0408600 sporozoite invasion-associated protein 1 (SIAP1) 23 
PF3D7_0412300 phosphopantothenoylcysteine synthetase, putative 3 
PF3D7_0413400 erythrocyte membrane protein 1 (PfEMP1), exon 1, pseudogene (VAR) 7 
PF3D7_0414000 chromosome associated protein, putative 5 
PF3D7_0414100 conserved Plasmodium membrane protein, unknown function 10 
PF3D7_0414200.1 calmodulin-like+protein 4 
PF3D7_0415200 conserved Plasmodium protein, unknown function 1 
PF3D7_0415800 RING zinc finger protein, putative 1 
PF3D7_0417200 bifunctional dihydrofolate reductase-thymidylate synthase (DHFR-TS) 2 
PF3D7_0417400 conserved Plasmodium protein, unknown function 1 
PF3D7_0418000 conserved Plasmodium protein, unknown function 12 
PF3D7_0418300 conserved Plasmodium protein, unknown function 1 
PF3D7_0418600 regulator of chromosome condensation, putative 7 
PF3D7_0419000 conserved Plasmodium protein, unknown function 3 
PF3D7_0419400 conserved Plasmodium protein, unknown function 1 
PF3D7_0419900 phosphatidylinositol 4-kinase, putative 6 
PF3D7_0420000 zinc finger protein, putative 12 
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PF3D7_0420100 serine/threonine protein kinase RIO2 (RIO2) 3 
PF3D7_0420200 holo-(acyl-carrier protein) synthase, putative 9 
PF3D7_0422200 erythrocyte+membrane-associated+antigen 8 
PF3D7_0422500 pre-mRNA-splicing helicase BRR2, putative (BRR2) 1 
PF3D7_0422800 serpentine receptor, putative (SR12) 3 
PF3D7_0424100 reticulocyte binding protein homologue 5 (RH5) 7 
PF3D7_0424300 erythrocyte binding antigen-165, pseudogene (EBA165) 5 
PF3D7_0424400 surface-associated interspersed protein 4.2 (SURFIN 4.2) (SURF4.2) 29 
PF3D7_0424600 Plasmodium exported protein (PHISTb), unknown function 7 
PF3D7_0424900 Plasmodium exported protein (PHISTa), unknown function 3 
PF3D7_0425000 Plasmodium exported protein, unknown function, pseudogene 1 
PF3D7_0500900 serine/threonine protein kinase, FIKK family (FIKK5) 5 
PF3D7_0501600 rhoptry-associated protein 2 (RAP2) 8 
PF3D7_0501800 chromosome assembly factor 1 (CAF1) 3 
PF3D7_0502400 ring-stage membrane protein 1,merozoite surface protein 8 (MSP8) 4 
PF3D7_0503200 conserved Plasmodium protein, unknown function 1 
PF3D7_0504700 conserved Plasmodium protein, unknown function 6 
PF3D7_0506500 conserved Plasmodium protein, unknown function 3 
PF3D7_0506900 rhomboid protease ROM4 (ROM4) 4 
PF3D7_0508000 6-cysteine protein (P38) 8 
PF3D7_0509600 asparagine--tRNA ligase (AsnRS) 7 
PF3D7_0511400 conserved Plasmodium protein, unknown function 1 
PF3D7_0514300 aspartate--tRNA ligase, putative 1 
PF3D7_0515500 amino acid transporter, putative 2 
PF3D7_0516100 cation-transporting ATPase 1 (ATPase1) 5 
PF3D7_0518700 mRNA-binding protein PUF1 (PUF1) 1 
PF3D7_0519300 cytochrome c oxidase assembly protein (heme A: farnesyltransferase), putative 1 
PF3D7_0519900 conserved Plasmodium protein, unknown function 1 
PF3D7_0522400 conserved Plasmodium protein, unknown function 3 
PF3D7_0523000 multidrug resistance protein (MDR1) 6 
PF3D7_0525100 acyl-CoA synthetase (ACS10) 15 
PF3D7_0525800 inner membrane complex protein 1g, putative (IMC1g) 8 
PF3D7_0526600 conserved Plasmodium protein, unknown function 2 
PF3D7_0529000 conserved Plasmodium protein, unknown function 8 
PF3D7_0529300 apicoplast TIC22 protein (TIC22) 2 
PF3D7_0529400.1 conserved Plasmodium protein, unknown function 1 
PF3D7_0529800 conserved Plasmodium protein, unknown function 1 
PF3D7_0532200 Plasmodium exported protein (PHISTc), unknown function 1 
PF3D7_0532300 Plasmodium exported protein (PHISTb), unknown function 13 
PF3D7_0532600 Plasmodium exported protein, unknown function 2 
PF3D7_0602400 elongation factor G (EF-G) 3 
PF3D7_0602800 JmjC domain containing protein (JmjC2) 2 
PF3D7_0603600 conserved Plasmodium protein, unknown function 9 
PF3D7_0604100 transcription factor with AP2 domain(s),SPE2-interacting protein (SIP2) 5 
PF3D7_0604300 conserved Plasmodium protein, unknown function 4 
PF3D7_0606000 conserved Plasmodium protein, unknown function 5 
PF3D7_0609600 probable protein, unknown function 4 
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PF3D7_0612700 6-cysteine protein (P12) 1 
PF3D7_0612900 nucleolar GTP-binding protein 1, putative 6 
PF3D7_0613300 rhoptry protein (ROP14) 6 
PF3D7_0615400 ribonuclease, putative 5 
PF3D7_0615900 conserved Plasmodium protein, unknown function 4 
PF3D7_0619500 acyl-CoA synthetase (ACS12) 6 
PF3D7_0619800 conserved Plasmodium membrane protein, unknown function 1 
PF3D7_0620400 merozoite surface protein 10 (MSP10) 6 
PF3D7_0622300 vacuolar transporter chaperone, putative 4 
PF3D7_0622800 leucine--tRNA ligase, putative 1 
PF3D7_0624800 conserved Plasmodium protein, unknown function 1 
PF3D7_0625600 poly(A) polymerase PAP, putative 5 
PF3D7_0625900 conserved Plasmodium protein, unknown function 2 
PF3D7_0628100 HECT-domain (ubiquitin-transferase), putative 2 
PF3D7_0628200 protein kinase PK4 (PK4) 1 
PF3D7_0629700 SET domain protein, putative (SET1) 12 
PF3D7_0630300 DNA polymerase epsilon, catalytic subunit a, putative 7 
PF3D7_0630600 conserved Plasmodium protein, unknown function 3 
PF3D7_0701900 Plasmodium exported protein, unknown function 7 
PF3D7_0702000 Plasmodium exported protein (hyp12), unknown function 11 
PF3D7_0702500 Plasmodium exported protein, unknown function 7 
PF3D7_0703900 conserved Plasmodium membrane protein, unknown function 3 
PF3D7_0704600 E3 ubiquitin-protein ligase (UT) 1 
PF3D7_0705200 conserved Plasmodium protein, unknown function 2 
PF3D7_0706100 conserved Plasmodium protein, unknown function 1 
PF3D7_0709300 Cg2 protein (CG2) 8 
PF3D7_0710000 conserved Plasmodium protein, unknown function 14 
PF3D7_0710200 conserved Plasmodium protein, unknown function 4 
PF3D7_0710900 50S ribosomal protein L1, mitochondrial, putative (RPL1) 3 
PF3D7_0711200 conserved Plasmodium protein, unknown function 2 
PF3D7_0713900 conserved Plasmodium protein, unknown function 2 
PF3D7_0714200 conserved Plasmodium protein, unknown function 4 
PF3D7_0716300 conserved Plasmodium protein, unknown function 5 
PF3D7_0716700 conserved Plasmodium protein, unknown function 9 
PF3D7_0716800 eukaryotic translation initiation factor 3 37.28 kDa subunit, putative 1 
PF3D7_0721700 secreted ookinete protein, putative (PSOP1) 1 
PF3D7_0723800 conserved Plasmodium protein, unknown function 1 
PF3D7_0727000 vacuolar protein sorting-associated protein 53, putative (VPS53) 1 
PF3D7_0727200 cysteine desulfurase, putative (NFS) 2 
PF3D7_0728100 conserved Plasmodium membrane protein, unknown function 9 
PF3D7_0729700 conserved Plasmodium protein, unknown function 2 
PF3D7_0731400 serine/threonine protein kinase, FIKK family, pseudogene (FIKK7.2) 2 
PF3D7_0731500 erythrocyte binding antigen-175 (EBA175) 26 
PF3D7_0801300 von Willebrand factor A domain-related protein (WARP) 6 
PF3D7_0802000 glutamate dehydrogenase, putative (GDH3) 6 
PF3D7_0802300 rRNA processing WD-repeat protein, putative 4 
PF3D7_0804500 conserved Plasmodium membrane protein, unknown function 6 
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PF3D7_0806200 conserved Plasmodium membrane protein, unknown function 2 
PF3D7_0806300 ferlin, putative 4 
PF3D7_0806500 DnaJ protein, putative 1 
PF3D7_0806700 conserved Plasmodium membrane protein, unknown function 6 
PF3D7_0808300 ubiquitin regulatory protein, putative 1 
PF3D7_0809600 peptidase family C50, putative 2 
PF3D7_0810600 RNA helicase, putative 7 
PF3D7_0810800 dihydropteroate synthetase (DHPS) 6 
PF3D7_0811300 CCR4-associated factor 1 (CAF1) 3 
PF3D7_0811600 conserved Plasmodium protein, unknown function 3 
PF3D7_0812900 probable protein, unknown function 1 
PF3D7_0814600 conserved Plasmodium protein, unknown function 1 
PF3D7_0816300 conserved Plasmodium protein, unknown function 1 
PF3D7_0818800 U3 small nucleolar ribonucleoprotein protein, putative 1 
PF3D7_0819400 perforin-like protein 4 (PLP4) 1 
PF3D7_0820700 2-oxoglutarate+dehydrogenase+E1+component 2 
PF3D7_0823800 DnaJ protein, putative 1 
PF3D7_0825800 conserved Plasmodium protein, unknown function 6 
PF3D7_0826500 ubiquitin conjugation factor E4 B, putative (UBE4B) 1 
PF3D7_0826900 conserved Plasmodium protein, unknown function 2 
PF3D7_0827100 translation initiation factor IF-2, putative 1 
PF3D7_0827600 conserved Plasmodium protein, unknown function 3 
PF3D7_0827800 SET domain protein, putative (SET3) 2 
PF3D7_0827900 protein disulfide isomerase (PDI8) 3 
PF3D7_0829000 conserved Plasmodium membrane protein, unknown function 1 
PF3D7_0829600 early transcribed membrane protein 8 (ETRAMP8) 2 
PF3D7_0829800 unspecified+product 1 
PF3D7_0830100 unspecified+product 1 
PF3D7_0830300 sporozoite invasion-associated protein 2 (SIAP2) 1 
PF3D7_0830600 Plasmodium exported protein (PHISTc), unknown function 2 
PF3D7_0830800 surface-associated interspersed protein 8.2 (SURFIN 8.2) (SURF8.2) 30 
PF3D7_0831300 Plasmodium exported protein, unknown function (GEXP13) 7 
PF3D7_0831400 Plasmodium exported protein, unknown function 6 
PF3D7_0831600 cytoadherence linked asexual protein 8 (CLAG8) 1 
PF3D7_0901700 Plasmodium exported protein (hyp5), unknown function 8 
PF3D7_0902000 serine/threonine protein kinase, FIKK family (FIKK9.1) 3 
PF3D7_0903300 conserved Plasmodium membrane protein, unknown function 1 
PF3D7_0903400 DEAD/DEAH box helicase, putative 1 
PF3D7_0903600.1 conserved Plasmodium protein, unknown function 2 
PF3D7_0904300 conserved protein, unknown function 15 
PF3D7_0905400 high molecular weight rhoptry protein 3 (RhopH3) 5 
PF3D7_0905600 conserved Plasmodium protein, unknown function 4 
PF3D7_0906400 dynein light intermediate chain 2, cytosolic 4 
PF3D7_0910800 cytosolic Fe-S cluster assembly factor NBP35, putative (NBP35) 4 
PF3D7_0911300 cysteine repeat modular protein 1 (CRMP1) 10 
PF3D7_0912200 conserved Plasmodium membrane protein, unknown function 1 
PF3D7_0912600 conserved Plasmodium protein, unknown function 2 
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PF3D7_0913900 arginine--tRNA ligase, putative 3 
PF3D7_0914000 pseudouridylate synthase, putative 2 
PF3D7_0914100 conserved Plasmodium protein, unknown function 1 
PF3D7_0915400 6-phosphofructokinase (PFK9) 8 
PF3D7_0916400 conserved Plasmodium protein, unknown function 1 
PF3D7_0920200 CS domain protein, putative 2 
PF3D7_0920700 conserved Plasmodium protein, unknown function 5 
PF3D7_0922600 glutamine synthetase, putative 6 
PF3D7_0924000 patatin-like phospholipase, putative 5 
PF3D7_0926500 conserved Plasmodium protein, unknown function 2 
PF3D7_0926600 conserved Plasmodium membrane protein, unknown function 11 
PF3D7_0927200 zinc finger protein, putative 4 
PF3D7_0929400 high molecular weight rhoptry protein 2 (RhopH2) 9 
PF3D7_0930300 merozoite surface protein 1 (MSP1) 19 
PF3D7_0935600 gametocytogenesis-implicated protein (GIG) 3 
PF3D7_0936300 ring-exported protein 3 (REX3) 2 
PF3D7_1001400 alpha/beta hydrolase, putative 3 
PF3D7_1001600 alpha/beta hydrolase, putative 4 
PF3D7_1001700 Plasmodium exported protein (PHISTc), unknown function 6 
PF3D7_1002200 tryptophan-rich antigen 3 (PArt) 9 
PF3D7_1004600 conserved Plasmodium membrane protein, unknown function 3 
PF3D7_1005000 methionine--tRNA ligase, putative 2 
PF3D7_1005300 conserved Plasmodium protein, unknown function 7 
PF3D7_1005500 regulator of nonsense transcripts, putative 4 
PF3D7_1009200 small subunit rRNA synthesis-associated protein, putative 1 
PF3D7_1010800 50S ribosomal protein L22, mitochondrial, putative 4 
PF3D7_1011500 conserved Plasmodium membrane protein, unknown function 2 
PF3D7_1011800 PRE-binding protein (PREBP) 1 
PF3D7_1013900 initiation factor 2 subunit family, putative 1 
PF3D7_1016400 serine/threonine protein kinase, FIKK family (FIKK10.1) 5 
PF3D7_1019300 zinc finger protein, putative 1 
PF3D7_1020300 cytoplasmic dynein intermediate chain, putative 1 
PF3D7_1022200 conserved Plasmodium membrane protein, unknown function 2 
PF3D7_1023700 conserved Plasmodium protein, unknown function 8 
PF3D7_1028500 conserved Plasmodium protein, unknown function 2 
PF3D7_1029000 conserved Plasmodium protein, unknown function, pseudogene 1 
PF3D7_1029100.1 conserved Plasmodium protein, unknown function 2 
PF3D7_1029400 conserved Plasmodium protein, unknown function 4 
PF3D7_1029600 adenosine deaminase (ADA) 5 
PF3D7_1031400.1 OTU-like cysteine protease, putative 6 
PF3D7_1032300 conserved Plasmodium protein, unknown function 1 
PF3D7_1033000 conserved Plasmodium protein, unknown function 4 
PF3D7_1034600 conserved Plasmodium protein, unknown function 3 
PF3D7_1035000 U2 snRNA/tRNA pseudouridine synthase, putative 4 
PF3D7_1035100 probable protein, unknown function 10 
PF3D7_1035300 glutamate-rich protein (GLURP) 18 
PF3D7_1035700 duffy binding-like merozoite surface protein (DBLMSP) 5 
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PF3D7_1036300 merozoite surface protein (DBLMSP2) 5 
PF3D7_1036400 liver stage antigen 1 (LSA1) 11 
PF3D7_1102400 flavoprotein, putative 7 
PF3D7_1102500 Plasmodium exported protein (PHISTb), unknown function (GEXP02) 6 
PF3D7_1102600 Plasmodium exported protein, unknown function (GEXP14) 2 
PF3D7_1105600 translocon component PTEX88 (PTEX88) 5 
PF3D7_1106800 protein kinase, putative 4 
PF3D7_1111700 conserved Plasmodium protein, unknown function 2 
PF3D7_1112100 conserved Plasmodium protein, unknown function 1 
PF3D7_1113000 conserved Plasmodium protein, unknown function 12 
PF3D7_1116800 heat shock protein 101,chaperone protein ClpB2 (HSP101) 2 
PF3D7_1117200 conserved Plasmodium protein, unknown function 3 
PF3D7_1118300 insulinase, putative 5 
PF3D7_1120300 metal ion channel - Mg2+, Co2+ and Ni2+ 10 
PF3D7_1120400 alpha/beta hydrolase fold domain containing protein, putative 2 
PF3D7_1121300 tyrosine kinase-like protein (TKL2) 5 
PF3D7_1121800 petidase, M16 family 5 
PF3D7_1125700 kelch protein, putative 1 
PF3D7_1125800 kelch protein, putative 1 
PF3D7_1126100 autophagy-related protein 7, putative (ATG7) 4 
PF3D7_1126600 steryl ester hydrolase, putative 7 
PF3D7_1128300 6-phosphofructokinase (PFK11) 5 
PF3D7_1128900 conserved Plasmodium protein, unknown function 6 
PF3D7_1129100 parasitophorous vacuolar protein 1 (PV1) 3 
PF3D7_1131600 conserved Plasmodium protein, unknown function 2 
PF3D7_1133400 apical membrane antigen 1 (AMA1) 29 
PF3D7_1133900 conserved Plasmodium protein, unknown function 7 
PF3D7_1135100 protein phosphatase 2C, putative 9 
PF3D7_1139100 RNA-binding protein, putative 2 
PF3D7_1140500 myosin F, putative (MyoF) 3 
PF3D7_1140900 conserved Plasmodium protein, unknown function 4 
PF3D7_1141000 conserved Plasmodium protein, unknown function 4 
PF3D7_1141300 conserved Plasmodium protein, unknown function 1 
PF3D7_1143500 conserved Plasmodium protein, unknown function 1 
PF3D7_1143800 conserved Plasmodium protein, unknown function 3 
PF3D7_1145200 serine/threonine protein kinase, putative 1 
PF3D7_1145800 conserved Plasmodium protein, unknown function 10 
PF3D7_1147500 farnesyltransferase beta subunit, putative 14 
PF3D7_1200700 acyl-CoA synthetase (ACS7) 10 
PF3D7_1201400 Plasmodium exported protein, unknown function 14 
PF3D7_1205400 conserved Plasmodium protein, unknown function 7 
PF3D7_1205900 conserved protein, unknown function 3 
PF3D7_1208200 cysteine repeat modular protein 3 (CRMP3) 4 
PF3D7_1208900 conserved Plasmodium protein, unknown function 2 
PF3D7_1215900 serpentine receptor, putative (SR10) 1 
PF3D7_1216600 cell traversal protein for ookinetes and sporozoites (CelTOS) 7 
PF3D7_1217300 GTP-binding protein, putative 3 
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PF3D7_1217700 conserved Plasmodium protein, unknown function 3 
PF3D7_1218000 thrombospondin-related apical membrane protein (TRAMP) 1 
PF3D7_1218900 conserved Plasmodium protein, unknown function 6 
PF3D7_1219000 formin+2 5 
PF3D7_1219300 erythrocyte membrane protein 1, PfEMP1 (VAR) 2 
PF3D7_1221000 histone-lysine N-methyltransferase, H3 lysine-4 specific (SET10) 1 
PF3D7_1223400 phospholipid-transporting ATPase, putative 7 
PF3D7_1226400 conserved Plasmodium protein, unknown function 3 
PF3D7_1227500 cyclin (CYC2) 3 
PF3D7_1228600 merozoite surface protein 9 (MSP9) 1 
PF3D7_1228800 conserved Plasmodium protein, unknown function 8 
PF3D7_1229500 T-complex protein 1, gamma subunit, putative 1 
PF3D7_1230000 conserved Plasmodium protein, unknown function 1 
PF3D7_1231000 conserved Plasmodium protein, unknown function 1 
PF3D7_1231400 amino acid transporter, putative 5 
PF3D7_1234200 conserved Plasmodium protein, unknown function, pseudogene 5 
PF3D7_1235200 V-type K+-independent H+-translocating inorganic pyrophosphatase (VP2) 7 
PF3D7_1235800 conserved Plasmodium protein, unknown function 2 
PF3D7_1236400 conserved Plasmodium protein, unknown function 3 
PF3D7_1237400 conserved Plasmodium protein, unknown function 2 
PF3D7_1239800 conserved Plasmodium protein, unknown function 8 
PF3D7_1239900 vacuolar protein sorting-associated protein 16, putative (VPS16) 4 
PF3D7_1240200 erythrocyte membrane protein 1 (PfEMP1), pseudogene 16 
PF3D7_1244400 conserved Plasmodium protein, unknown function 1 
PF3D7_1244500 conserved Plasmodium protein, unknown function 6 
PF3D7_1247500 serine/threonine protein kinase, putative 10 
PF3D7_1248700 conserved Plasmodium protein, unknown function 4 
PF3D7_1250100 osmiophilic body protein (G377) 2 
PF3D7_1251200 coronin 8 
PF3D7_1251700 tryptophan--tRNA ligase, putative,tryptophanyl-tRNA synthetase, putative (aTrpRS) 2 
PF3D7_1252100 rhoptry neck protein 3 (RON3) 14 
PF3D7_1252400 reticulocyte binding protein homologue 3, pseudogene (RH3) 9 
PF3D7_1301600 erythrocyte binding antigen-140 (EBA140) 7 
PF3D7_1301800 surface-associated interspersed protein 13.1 (SURFIN 13.1), pseudogene (SURF13.1) 5 
PF3D7_1302900 conserved Plasmodium protein, unknown function 13 
PF3D7_1303800 conserved Plasmodium protein, unknown function 7 
PF3D7_1305000 conserved Plasmodium protein, unknown function 5 
PF3D7_1306500 MORN repeat protein, putative 3 
PF3D7_1308400 conserved Plasmodium protein, unknown function 12 
PF3D7_1312600 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial, putative (BCKDHA) 1 
PF3D7_1312800 conserved Plasmodium protein, unknown function 3 
PF3D7_1313600 conserved Plasmodium protein, unknown function 7 
PF3D7_1318300 conserved Plasmodium protein, unknown function 6 
PF3D7_1318900 conserved Plasmodium protein, unknown function 5 
PF3D7_1320700 conserved Plasmodium protein, unknown function 15 
PF3D7_1321100 conserved Plasmodium protein, unknown function 3 
PF3D7_1321900 conserved Plasmodium protein, unknown function 3 
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PF3D7_1322300 translation+initiation+factor+EIF-2B+subunit+related 7 
PF3D7_1327300 conserved Plasmodium protein, unknown function 6 
PF3D7_1328200 conserved Plasmodium protein, unknown function 6 
PF3D7_1331000 protein kinase, putative 8 
PF3D7_1331500 conserved Plasmodium protein, unknown function 1 
PF3D7_1333400 conserved protein, unknown function 3 
PF3D7_1335100 merozoite surface protein 7 (MSP7) 18 
PF3D7_1335900 sporozoite surface protein 2 (TRAP) 37 
PF3D7_1340400 conserved Plasmodium protein, unknown function 3 
PF3D7_1342600 myosin A (MyoA) 6 
PF3D7_1342900 transcription factor with AP2 domain(s) (ApiAP2) 1 
PF3D7_1343100 conserved Plasmodium protein, unknown function 2 
PF3D7_1343400 DNA repair protein RAD5, putative (RAD5) 6 
PF3D7_1343800 conserved Plasmodium protein, unknown function 2 
PF3D7_1344000 aminomethyltransferase, putative 3 
PF3D7_1344400 conserved Plasmodium protein, unknown function 5 
PF3D7_1345600 inner+membrane+complex+protein 3 
PF3D7_1346400 conserved Plasmodium protein, unknown function 2 
PF3D7_1346700 6-cysteine protein (P48/45) 4 
PF3D7_1347200 nucleoside transporter 1 (NT1) 2 
PF3D7_1350500 conserved Plasmodium protein, unknown function 1 
PF3D7_1352700 P-loop containing nucleoside triphosphate hydrolase, putative 3 
PF3D7_1352900 Plasmodium exported protein, unknown function,fam-f protein 19 
PF3D7_1353100 Plasmodium exported protein, unknown function 9 
PF3D7_1355600 conserved Plasmodium protein, unknown function 2 
PF3D7_1358200 conserved Plasmodium protein, unknown function 4 
PF3D7_1358600 zinc finger protein, putative 2 
PF3D7_1359500 conserved Plasmodium protein, unknown function 3 
PF3D7_1359600 conserved Plasmodium protein, unknown function 3 
PF3D7_1361800 conserved Plasmodium protein, unknown function 7 
PF3D7_1362800 conserved Plasmodium protein, unknown function 1 
PF3D7_1366300 conserved Plasmodium protein, unknown function 1 
PF3D7_1366800 phosphatidylserine synthase, putative 2 
PF3D7_1368800 DNA repair endonuclease, putative (ERCC4) 1 
PF3D7_1369200 conserved Plasmodium protein, unknown function 3 
PF3D7_1401200 Plasmodium exported protein, unknown function 1 
PF3D7_1402100 conserved Plasmodium protein, unknown function 1 
PF3D7_1403200 conserved Plasmodium protein, unknown function 1 
PF3D7_1403300 conserved Plasmodium protein, unknown function 1 
PF3D7_1404300 secreted ookinete adhesive protein (SOAP) 1 
PF3D7_1406100 conserved Plasmodium protein, unknown function 4 
PF3D7_1406500 conserved Plasmodium protein, unknown function 1 
PF3D7_1406600 ATP-dependent Clp protease, putative (ClpC) 1 
PF3D7_1407700 conserved Plasmodium protein, unknown function 8 
PF3D7_1410300 conserved Plasmodium protein, unknown function 4 
PF3D7_1410400 rhoptry-associated protein 1 (RAP1) 11 
PF3D7_1412000 p1/s1 nuclease, putative 2 
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PF3D7_1414200 conserved Plasmodium protein, unknown function 3 
PF3D7_1414900 ATP-dependent protease, putative 3 
PF3D7_1415000 uracil-DNA glycosylase (UDG) 2 
PF3D7_1415400 conserved Plasmodium protein, unknown function 3 
PF3D7_1416100 root hair defective 3 GTP-binding protein (RHD3) homolog, putative 8 
PF3D7_1416200 metacaspase-like protein (MCA3) 5 
PF3D7_1417400 cyclic nucleotide-binding protein, putative, pseudogene (cNBP) 1 
PF3D7_1417600 conserved Plasmodium protein, unknown function 5 
PF3D7_1418100 liver specific protein 1, putative (LISP1) 2 
PF3D7_1420100 conserved Plasmodium protein, unknown function 5 
PF3D7_1422900 14-3-3 protein, putative 1 
PF3D7_1423500 conserved Plasmodium protein, unknown function 1 
PF3D7_1424400 60S ribosomal protein L7-3, putative 6 
PF3D7_1426700 phosphoenolpyruvate carboxylase (PEPC) 9 
PF3D7_1428500 protein kinase, putative 4 
PF3D7_1429800 coatamer beta subunit, putative 3 
PF3D7_1429900 ATP-dependent DNA helicase, putative 8 
PF3D7_1434100 queuine tRNA-ribosyltransferase, putative 3 
PF3D7_1436300 translocon component PTEX150 (PTEX150) 6 
PF3D7_1440200 stromal-processing peptidase, putative (SPP) 2 
PF3D7_1442200 GTP-binding protein, putative 3 
PF3D7_1442400 conserved Plasmodium protein, unknown function 6 
PF3D7_1442600 TRAP-like protein,sporozoite-specific transmembrane protein S6 (TREP) 4 
PF3D7_1442700 conserved Plasmodium protein, unknown function 3 
PF3D7_1443200 conserved Plasmodium protein, unknown function 4 
PF3D7_1444100 conserved Plasmodium protein, unknown function 5 
PF3D7_1445500 conserved Plasmodium protein, unknown function 1 
PF3D7_1446500 conserved Plasmodium protein, unknown function 4 
PF3D7_1447900 multidrug resistance protein 2 (heavy metal transport family) (MDR2) 6 
PF3D7_1448200 conserved Plasmodium protein, unknown function 5 
PF3D7_1448500 conserved Plasmodium protein, unknown function 7 
PF3D7_1451600 LCCL domain-containing protein (LAP5) 3 
PF3D7_1453900 conserved Plasmodium protein, unknown function 1 
PF3D7_1454200 conserved Plasmodium protein, unknown function 2 
PF3D7_1455800 LCCL domain-containing protein (CCp2) 3 
PF3D7_1457400 conserved Plasmodium protein, unknown function 1 
PF3D7_1457900 conserved Plasmodium protein, unknown function 5 
PF3D7_1458300 conserved Plasmodium protein, unknown function 8 
PF3D7_1460500 conserved Plasmodium protein, unknown function 3 
PF3D7_1461800 conserved Plasmodium protein, unknown function 5 
PF3D7_1462300 conserved Plasmodium protein, unknown function 2 
PF3D7_1462400 conserved Plasmodium protein, unknown function 2 
PF3D7_1464500 conserved Plasmodium membrane protein, unknown function 6 
PF3D7_1465800 dynein beta chain, putative 9 
PF3D7_1467600 conserved Plasmodium protein, unknown function 2 
PF3D7_1467900 rab GTPase activator, putative 7 
PF3D7_1469600 biotin carboxylase subunit of acetyl CoA carboxylase, putative (ACC) 4 
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PF3D7_1472200 histone deacetylase, putative (HDA1) 4 
PF3D7_1472400 M1-family alanyl aminopeptidase, putative 2 
PF3D7_1472700 DNA-directed RNA polymerase, alpha subunit, putative 1 
PF3D7_1474000 probable protein, unknown function 2 
PF3D7_1475100 conserved Plasmodium protein, unknown function 3 
PF3D7_1475500 LCCL domain-containing protein (CCp1) 2 
PF3D7_1475800 conserved Plasmodium protein, unknown function 12 
PF3D7_1475900 conserved Plasmodium protein, unknown function 11 
PF3D7_1476600 Plasmodium exported protein, unknown function 7 
PF3D7_1477500 Plasmodium exported protein (PHISTb), unknown function 3 
PF3D7_1477600 surface-associated interspersed protein 14.1 (SURFIN 14.1) (SURF14.1) 4 
PF3D7_1478000 Plasmodium exported protein (PHISTa), unknown function (GEXP17) 8 
PF3D7_1478600 EMP1-trafficking protein (PTP3) 5 
PF3D7_1478700 Plasmodium exported protein, unknown function, pseudogene 3 
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Table 5.2: Gene IDs for 400 bp Windows 
 
Gene ID Gene Description # of 400bp windows 
PF3D7_0113800 DBL containing protein, unknown function 13 
PF3D7_0202100 Plasmodium exported protein (PHISTc), unknown function,liver stage associated protein 2 (LSAP2) 1 
PF3D7_0402200 surface-associated interspersed protein 4.1 (SURFIN 4.1), pseudogene (SURF4.1) 1 
PF3D7_0402400 Plasmodium exported protein, unknown function (GEXP18) 3 
PF3D7_0418000 conserved Plasmodium protein, unknown function 1 
PF3D7_0420000 zinc finger protein, putative 4 
PF3D7_0422200 erythrocyte+membrane-associated+antigen 2 
PF3D7_0424400 surface-associated interspersed protein 4.2 (SURFIN 4.2) (SURF4.2) 12 
PF3D7_0525100 acyl-CoA synthetase (ACS10) 5 
PF3D7_0702000 Plasmodium exported protein (hyp12), unknown function 2 
PF3D7_0731500 erythrocyte binding antigen-175 (EBA175) 12 
PF3D7_0830800 surface-associated interspersed protein 8.2 (SURFIN 8.2) (SURF8.2) 8 
PF3D7_0930300 merozoite surface protein 1 (MSP1) 5 
PF3D7_1002200 tryptophan-rich antigen 3 (PArt) 1 
PF3D7_1035100 probable protein, unknown function 1 
PF3D7_1035300 glutamate-rich protein (GLURP) 3 
PF3D7_1133400 apical membrane antigen 1 (AMA1) 18 
PF3D7_1135100 protein phosphatase 2C, putative 4 
PF3D7_1200700 acyl-CoA synthetase (ACS7) 1 
PF3D7_1240200 erythrocyte membrane protein 1 (PfEMP1), pseudogene 3 
PF3D7_1302900 conserved Plasmodium protein, unknown function 2 
PF3D7_1320700 conserved Plasmodium protein, unknown function 1 
PF3D7_1335100 merozoite surface protein 7 (MSP7) 5 
PF3D7_1335900 sporozoite surface protein 2 (TRAP) 14 
PF3D7_1352900 Plasmodium exported protein, unknown function,fam-f protein 1 
PF3D7_1475800 conserved Plasmodium protein, unknown function 3 
PF3D7_1475900 conserved Plasmodium protein, unknown function 1 
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Table 5.3: Known Lab Strain Control Mixture Percentages 
 
sample acc 3D7* Dd2* HB3* 7G8* 
PG0389-C ERS319116 90 10 0 0 
PG0390-C ERS319119 80 20 0 0 
PG0391-C ERS319122 67 33 0 0 
PG0392-C ERS319125 33 67 0 0 
PG0393-C ERS319128 20 80 0 0 
PG0394-C ERS319130 10 90 0 0 
PG0395-C ERS319132 0 33.3 33.3 33.3 
PG0396-C ERS319134 0 25 25 50 
PG0397-C ERS319136 0 14.3 14.3 71.4 
PG0399-C ERS319140 0 0 99 1 
PG0400-C ERS319142 0 0 95 5 
PG0401-C ERS319117 0 0 90 10 
PG0402-C ERS319120 0 0 85 15 
PG0403-C ERS319123 0 0 80 20 
PG0404-C ERS319126 0 0 75 25 
PG0405-C ERS319129 0 0 70 30 
PG0406-C ERS319131 0 0 60 40 
PG0407-C ERS319133 0 0 50 50 
PG0408-C ERS319135 0 0 40 60 
PG0409-C ERS319137 0 0 30 70 
PG0410-C ERS319139 0 0 25 75 
PG0411-C ERS319141 0 0 20 80 
PG0412-C ERS319143 0 0 15 85 
PG0413-C ERS319121 0 0 5 95 
PG0414-C ERS319124 0 0 1 99 
PG0415-C ERS319127 0 0 0 100 
PG0398-C ERS319138 0 0 100 0 
* The relative abundance of each lab strain 
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Table 5.4: 200 bp Windows Results 
 
sample MOI* 
True Haplotypes 
(%) Total Haplotypes 
# Windows 
Reconstructed 
Error Free (%) 
# Windows 
Reconstructed 
3D7 1 1862 (100%) 1862 1862 (100%) 1862 
7G8 1 1862 (100%) 1862 1862 (100%) 1862 
Dd2 1 1862 (100%) 1862 1862 (100%) 1862 
GB4 1 1860 (100%) 1860 1860 (100%) 1860 
HB3 1 1860 (100%) 1860 1860 (100%) 1860 
IT 1 1769 (100%) 1769 1769 (100%) 1769 
PG0389-C 2 2266 (99.7%) 2273 1622 (99.6%) 1629 
PG0390-C 2 2796 (100%) 2796 1584 (100%) 1584 
PG0391-C 2 2834 (100%) 2834 1602 (100%) 1602 
PG0392-C 2 2828 (100%) 2828 1599 (100%) 1599 
PG0393-C 2 2800 (100%) 2801 1598 (99.9%) 1599 
PG0394-C 2 2142 (99.8%) 2146 1624 (99.8%) 1628 
PG0399-C 2 1708 (100%) 1708 1704 (100%) 1704 
PG0400-C 2 1637 (100%) 1637 1636 (100%) 1636 
PG0401-C 2 2376 (99.9%) 2379 1655 (99.8%) 1658 
PG0402-C 2 2819 (100%) 2819 1699 (100%) 1699 
PG0403-C 2 2807 (100%) 2807 1666 (100%) 1666 
PG0404-C 2 2853 (100%) 2853 1684 (100%) 1684 
PG0405-C 2 2777 (100%) 2777 1646 (100%) 1646 
PG0406-C 2 2795 (100%) 2795 1653 (100%) 1653 
PG0407-C 2 2793 (100%) 2793 1652 (100%) 1652 
PG0408-C 2 2766 (100%) 2766 1639 (100%) 1639 
PG0409-C 2 2785 (100%) 2785 1648 (100%) 1648 
PG0410-C 2 2828 (100%) 2829 1669 (99.9%) 1670 
PG0411-C 2 2843 (100%) 2844 1677 (99.9%) 1678 
PG0412-C 2 2582 (99.8%) 2586 1686 (99.8%) 1690 
PG0413-C 2 1634 (99.8%) 1638 1608 (99.8%) 1612 
PG0414-C 2 1853 (100%) 1853 1853 (100%) 1853 
PG0395-C 3 3102 (100%) 3103 1401 (99.9%) 1402 
PG0396-C 3 2989 (99.8%) 2994 1363 (99.6%) 1368 
PG0397-C 3 2975 (99.5%) 2990 1425 (99%) 1439 
 
*MOI=multiplicity of infection, number of strains in mixture 
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Table 5.5: 400 bp Windows Results 
 
sample MOI* 
True Haplotypes 
(%) Total Haplotypes 
# Windows 
Reconstructed 
Error Free (%) 
# Windows 
Reconstructed 
3D7 1 128 (100%) 128 128 (100%) 128 
7G8 1 128 (100%) 128 128 (100%) 128 
Dd2 1 128 (100%) 128 128 (100%) 128 
GB4 1 128 (100%) 128 128 (100%) 128 
HB3 1 127 (100%) 127 127 (100%) 127 
IT 1 116 (100%) 116 116 (100%) 116 
PG0389-C 2 53 (100%) 53 39 (100%) 39 
PG0390-C 2 99 (100%) 99 53 (100%) 53 
PG0391-C 2 107 (100%) 107 57 (100%) 57 
PG0392-C 2 99 (100%) 99 53 (100%) 53 
PG0393-C 2 72 (100%) 72 40 (100%) 40 
PG0394-C 2 74 (98.7%) 75 51 (98.1%) 52 
PG0399-C 2 73 (100%) 73 73 (100%) 73 
PG0400-C 2 79 (100%) 79 79 (100%) 79 
PG0401-C 2 112 (98.2%) 114 68 (97.1%) 70 
PG0402-C 2 128 (99.2%) 129 71 (98.6%) 72 
PG0403-C 2 118 (100%) 118 65 (100%) 65 
PG0404-C 2 123 (100%) 123 67 (100%) 67 
PG0405-C 2 108 (100%) 108 60 (100%) 60 
PG0406-C 2 129 (100%) 129 70 (100%) 70 
PG0407-C 2 105 (100%) 105 58 (100%) 58 
PG0408-C 2 109 (100%) 109 60 (100%) 60 
PG0409-C 2 113 (100%) 113 62 (100%) 62 
PG0410-C 2 129 (100%) 129 70 (100%) 70 
PG0411-C 2 135 (100%) 135 73 (100%) 73 
PG0412-C 2 105 (100%) 105 63 (100%) 63 
PG0413-C 2 63 (100%) 63 63 (100%) 63 
PG0414-C 2 128 (100%) 128 128 (100%) 128 
PG0395-C 3 45 (100%) 45 19 (100%) 19 
PG0396-C 3 46 (100%) 46 20 (100%) 20 
PG0397-C 3 76 (97.4%) 78 36 (94.7%) 38 
*MOI=multiplicity of infection, number of strains in mixture 
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Figures  
 
Figure 5.1: PfCSP Network 
A network of PfCSP haplotypes extracted from publicly available data was created by 
generating nodes for haplotypes colored by the region they were found in and the area of 
the node is relative to the number of times a haplotype was found. Haplotypes are 
connected if they are 2 or fewer differences from each other. Nodes were also added from a 
previous study on CSP on patients from Tanzania and Cambodia which had resulted in 45 
haplotypes and the top 5 haplotypes are labeled. The most abundant haplotype for the 
Cambodian samples can be clustered with the South East Asia haplotypes while the 
Tanzanian haplotypes are most clustered with the African samples.  
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Figure 5.2: Carmen Viewer Example 
Carmen offers an interactive HTML viewer which can be used to view the sequences ​a) ​and 
offers some lightweight functionality like translating, running muscle, etc. ​b)​ An interactive 
map can be used to view where haplotypes appeared globally, when a haplotype’s node is 
hovered over, all regions it was found in are highlighted for easy viewing.  
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Chapter VI: Discussion  
In this thesis I have presented a suite of tools designed to analyze local 
haplotype-based approaches via high-throughput sequencing especially in the cases of 
polyclonal infections.  
SeekDeep: 
Chapter II introduced the SeekDeep pipeline which can be used to analyze targeted 
amplicon approaches using sequencing technologies 454, IonTorrent, and Illumina. 
SeekDeep has undergone heavy development over the years, with a focus on being as 
adaptive as possible. SeekDeep can handle several different technologies, and has default 
settings to handle each. SeekDeep was adapted to handle multiple different barcoding 
strategies, and can also handle doing a variable number of targets at once. One of the great 
strengths of SeekDeep is its ability to be able to recover data in even low read depths; this 
aids the recovery of data in hard to amplify samples and prevents the need to over-amplify 
samples which often leads to artifacts. The work on SeekDeep accumulated in its own 
publication ​(Hathaway et al. 2017)​ but has been used for a variety of studies for both ​P. 
falciparum ​(Mideo et al. 2016; R. H. Miller et al. 2017; Verity et al. 2018)​ and ​P. vivax ​(Lin et 
al. 2015)​ but can be--and is--used on a variety of infectious sources like the microbiome and 
HIV.  
SeekDeep was used for a previous study on a region of ​P. falciparum​ CSP that 
encodes the polymorphic C-terminal region the gene. This study was with 8 patients from 
Tanzania and 8 from Cambodia and was done to detect the presence of slow clearing 
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parasites. The presence of slow clearing parasites has been linked to developing resistance 
to first line malaria treatment with Artemisinin based drug therapies ​(Noedl et al. 2008; 
Dondorp et al. 2009; Phyo et al. 2012)​. To detect the presence of slow clearing parasites, 
clearance curves are created by taking parasitemia levels following drug treatment. 
However, for complex infections with the presence of multiple different strains there could be 
a mix of drug-resistant and drug-susceptible parasites but a clearance curve based solely on 
parasitemia levels would represent an average clearance of all parasites and a slow clearing 
drug-resistance strain that was at low frequency within the infection would be masked due to 
the regular clearing of the major strains in the infections. For this reason, targeted amplicon 
sequencing was utilized to determine the relative frequencies of all strains present in the 
infection and strain specific clearance curves could be created. Up to 40% of the strains 
detected in the study differed from another strain by only a single base pair and due to 
decreasing parasitemia in the latter time points these samples often had low read depths of 
~2,000. Therefore, in order to create accurate strain specific clearance curves SeekDeep’s 
ability to detect single base difference between strains at various frequencies even at low 
read depths was essential, which is where SeekDeep has been able to outperform other 
programs ​(Hathaway et al. 2017)​.  
Another study wherein SeekDeep’s ability to detect single base differences was a 
great asset was a study conducted on ​P. vivax ​on the MSP1 gene ​(Lin et al. 2015)​. ​P. vivax 
has the ability to lay dormant in the liver of patients and disease can relapse after initial 
infection if dormant ​P. vivax ​parasite are released from the liver 3-4 weeks after drug 
treatment ​(White 2011)​. Relapse, which could be due to initial drug treatment failure, can be 
hard to distinguish from a new infection. In this study 78 adults were followed after an initial 
P. vivax​ infection and drug treatment for signs of recurrence of P. vivax in their blood. 
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Sequencing of the MSP1 gene was done for initial infection and for any follow up infections 
to determine relapse vs new infection. 70% of the parasites detected in the study were only 
a single base different from another parasite and therefore to adequately determine relapse 
vs new infection single base resolution was needed even if the parasite was at low 
frequency in order to determine the likelihood that specific parasites were in the initial 
infections, even if they were at low frequencies.  
Though SeekDeep has primarily been used with malaria samples in the literature, it 
should also be useful in the study of other microbial populations that are also haploid-like 
viruses or bacterial populations.  
kluster: Long Amplicon Clustering using k-mer Similarity Scores  
SeekDeep’s ability to analyze short amplicon sequences from technologies like Ion 
Torrent and Illumina was highlighted by Chapter II. Chapter III expands this work to longer 
amplicon approaches, primarily on PacBio sequencing which can be several kilobases in 
length. SeekDeep’s core clustering algorithm, qluster, was ill suited to handle the high error 
rate of PacBio, and was further hampered by the longer amplicon length due to its 
dependence on alignment based comparison (which can slow exponentially with sequence 
length depending on implementation of the alignment approach). For this reason Chapter III 
introduces a novel clustering algorithm based on clustering sequences based on the k-mers 
(short sequence segments) shared by the sequences. This novel algorithm, kluster, can be 
used in place of the qluster algorithm from Chapter II and is integrated into the SeekDeep 
pipeline. This means the initial extraction and final population clustering can still be taken 
advantage of while using kluster. The performance of kluster proved to be as good as that of 
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qluster and can detect single base differences even with the increased sequence length and 
error rate of PacBio to read depths as low as 500 and frequencies of 1%.  
The kluster algorithm has supported the study of ​var2csa​, a protein expressed by ​P. 
falciparum ​that causes the parasite to sequester itself to placenta of pregnant woman 
leading to poor birth outcomes ​(Rogerson et al. 2007; Salanti et al. 2003a; Tuikue Ndam et 
al. 2005)​. Due to its high diversity, ​var2csa ​is hard to study via SNP variant calling; likewise, 
primers are difficult to design due to the target diversity, and the region responsible for 
binding is approximately 1.8kb long. These factors meant that the longer read lengths 
offered by PacBio were an ideal method to analyze the region. The kluster method was used 
to analyze the sequence of ​var2csa​ from pregnant woman from Benin and Malawi and to 
correlate these sequence birth outcomes. It was found that a specific clade of ​var2csa​ was 
associated with poor birth outcomes ​(Patel et al. 2017)​.  
The kluster algorithm was then used on 15 of the women from Benin, comparing 
parasites found in the peripheral blood to parasites collected from the placenta. It was found 
that the same parasites found in the peripheral blood had the same ​var2csa​ haplotypes as 
the placental parasites for 13 out of the 15 women with the other 2 samples sharing the 
majority of the haplotypes from the two sites. This suggests that the parasites collected from 
the peripheral blood are a good approximation of what the parasites in the placenta, and the 
more invasive placental collection is not needed ​(Waltmann et al. 2018)​. As the goals of the 
study was to perfectly match up the haplotypes between the two different body sites it was 
critical that accurate sequence was called for each site to enable the matching of haplotypes 
and therefore the accuracy offered by kluster was essential for the study.  
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PathWeaver: Global Diversity of ​P. falciparum​ ​var2csa 
While Chapter II and Chapter III introduced algorithms that worked on targeted 
amplicon sequencing, another common approach is to use shotgun whole genome 
sequencing, which generates reads starting from random locations across the whole 
genome. The targeted approach analysis is simplified by the fact all the reads start and end 
at the same location and clustering/analysis can be done by using all reads; however, the 
shotgun approach requires special handling because reads are from many different regions. 
For this reason, the traditional approach to analyzing shotgun whole genome sequencing is 
to map reads to a reference genome and call SNP/INDEL variants. While this approach 
works for much of the genome, for organisms like ​P. falciparum​ which has regions that are 
so diverse due to recombination or heavy immune selection that reads can’t be mapped to 
the reference genome. These regions include key virulence factor genes in ​P. falciparum 
called ​var​ genes which encode EMP1, a protein that mediates the binding of infected 
erythrocytes to blood vessel walls often leading to the destruction of microvasculature and 
contribute to the more fatal clinical outcomes observed with ​P. falciparum​ infections like 
cerebral malaria. While several attempts have been made by utilizing genome assemblers 
like SPAdes​(Lennartz et al. 2017; Jespersen et al. 2016)​, these studies did not check for 
accuracy of these assemblies and it was observed that these programs can lead to 
erroneous assemblies especially within mix infections (Chapter IV).  
This dilemma led to the the development of the program PathWeaver which 
assembles local haplotypes for a given region of high diversity by first using the region to 
recruit initial reads to construct contigs by a graph assembly approach to then iteratively 
recruit unmapped sequences to these contigs until full local haplotypes are created. 
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PathWeaver was written with special care to not construct false haplotypes in 
multicopy/multiclonal scenarios where more than one unique sequence is present for a 
region, which can sometimes lead to variation belonging to separate copies being 
improperly stitched together, a common problem in graph assembly approaches. This was 
done by utilizing “threading” of sequences through the graph and making connections 
between variation only if supported by the underlying sequence data, an approach not 
utilized by SPAdes.  
I was able to use the PathWeaver algorithm on a specific ​var​ gene of interest, ​P. 
falciparum var2csa​, which causes poor birth outcomes in pregnant women due to its ability 
to bind to a placental protein CSA. With its high diversity, the PathWeaver algorithm was 
needed in order to properly collect genetic variation information for this gene due to only 
80% of ​var2csa​ sequence being able to be mapped to reference. PathWeaver was 
extensively tested for accuracy and precision on the ​var2csa​ region using ​in silico 
simulations and monoclonal lab strains datasets where expected sequence was known. By 
utilizing approximately 3,000 field samples, PathWeaver was then used to collect between 
1,000 and 2,000 sequences across the different domains of ​var2csa​ including the domain 
shown to be the domain most responsible for binding to CSA. Previous studies of ​var2csa 
only had approximately 30 sequences to analyze and so this number of collected sequences 
is a great improvement on fully elucidating the full global diversity of the gene. 
PCAs on the minimum CSA binding domain showed 4 major groups and 2 minor 
groups that appear to be stable in the parasite population across geographical region and 
time which is suggestive of balancing selection ​(Lipsitch and O’Hagan 2007)​ acting on this 
region. Balancing selection is a phenomenon where diversity is maintained within a genomic 
region often due to due immune pressure and is often observed for surface epitopes 
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(Weedall and Conway 2010)​. This is especially true for a parasite like ​P. falciparum​ when 
people experience multiple infections and the increase in diversity aids the parasite in 
immune evasion when infecting a person not yet exposed to the parasite harboring specific 
epitopes. This causes a parasite’s chance of survival to be inversely related to its frequency 
preventing fixation of a specific epitope. The evidence of balancing selection has 
implications for vaccine development for ​var2csa​ because, for a vaccine to protect against 
all parasites, it most likely will have to incorporate sequences from all the groups detected 
here. The two current vaccine trials only contain 1 strain each, 3D7 and FCR3, which both 
fall into different groups in the PCA and most likely will only protect against that group as 
even a single base difference has been shown to reduce the efficacy of a vaccine ​(Sedegah 
et al. 2016)​.  
I was also able to extend previous findings of copy number variation ​(Sander et al. 
2011, 2009)​ by finding multiple unique ​var2csa​ sequences across the whole gene within 
confirmed monoclonal samples. Each unique copy had the mean base genome coverage 
which supports that each copy is present in the genome. While previous studies have shown 
evidence of copy number variation, they were from only one country but here we were able 
to show that copy number variation is present in 21% of samples globally with up to 3 copies 
being observed in South East Asia and up to 5 copies in Africa though there was no 
evidence found in South America. This might be due to a sampling issue as there were only 
34 samples from South America. The study of copy number variation would not have been 
possible without the ability of PathWeaver to be able to accurately assemble closely related 
copies of the same gene.  
We have only scratched the surface for analyses that could be done here. However, 
conventional tools and metrics are not easily applied to a gene like ​var2csa​ with its complex 
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evolutionary history, high rate of recombination, high diversity preventing the ability to use 
one sequence as a reference and its multiple copies. Thanks to extremely divergent types 
there is no single good reference for sequences to be compared to which is the 
basis/requirement for many traditional measures of diversity and other population structure 
analyses. Also, a 3D structure could greatly inform the information gained from the 
sequence variation gathered here to see if variation is buried or forms pockets. There is 
currently no 3D structure available for ​var2csa​ but the amount of sequence gathered here 
could aid in the simulation of one.  
This chapter was able to prove the accuracy of the PathWeaver algorithm as well as 
demonstrate the practical use of it on highly diverse ​P. falciparum var2csa ​which suggests it 
could be useful for other highly diverse regions of ​P. falciparum​ and other species.  
Carmen: Where in the world is my haplotype?  
 As targeted approaches and other local haplotype-based analyses become more 
popular there will be a need for development for tools to view haplotype data similar to those 
created to view SNP data ​(Vauterin et al. 2017)​. For this purpose, Carmen was created. It 
utilizes the PathWeaver algorithm introduced in Chapter IV and the availability of thousands 
of publicly available shotgun whole genome sequence of field samples from around the 
world. While Carmen was written to be able to work for any input that can be aligned, it was 
primarily tested on highly diverse regions in ​P. falciparum​. These regions were chosen as 
they are commonly targeted for amplicon approaches ​(R. H. Miller et al. 2017; Mideo et al. 
2016; Bailey et al. 2012)​ and represent regions that Carmen is likely to be used on. Carmen 
was tested on monoclonal lab strains and mixtures of these lab strains for which there are 
whole genome assemblies available; this allowed checking against expected sequences. 
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Carmen was able to correctly reconstruct ~97% of the windows in all test samples and the 
majority of windows that had errors only had one or two false haplotypes from a single 
sample. Carmen had high accuracy (~99%) for windows reconstructed from samples with 
mixtures multiple strains, a scenario that may lead some assemblers to create false 
haplotypes.  
Carmen takes advantage of the metadata associated with publicly available field 
samples to create summary reports of where and when haplotypes have been found for a 
specific genomic region. Carmen was written with the output of SeekDeep specifically in 
mind. For this reason, Carmen was used on the results from a previous study on ​P. 
falciparum ​CSP gene on patients from Tanzania and Cambodia to create strain specific 
clearance curves. Carmen was able to take the population haplotypes called from this study 
and accurately determine the appropriate genomic region by wrapping LASTZ ​(Harris 2007)​. 
Approximately 3,000 sequences were collected for this region and it was found that the most 
abundant haplotypes from Tanzania and Cambodia patients in the study matched the most 
prevalent haplotypes collected from the appropriate geographical regions. These results 
help mitigate past concerns that the haplotype from Cambodia could have been 
contamination, since it was found to be the dominant infection for all the Cambodian patients 
and demonstrate the utility of the results provided by Carmen.  
Conclusion  
In this thesis I have introduced a suite of tools for analyzing local haplotypes in 
complex mixtures from high-throughput sequencing with a focus on ​Plasmodium falciparum 
polyclonal infections. Though tested primarily on ​Plasmodium​, the tools were written to take 
input general to the study of many different microbial populations and should be able to be 
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utilized for the study of populations similar to ​Plasmodium ​(e.g. viruses, other haploid 
organisms, bacterial populations, etc). This includes SeekDeep which analyzes targeted 
amplicon sequencing approaches on both short read technologies (like Ion Torrent and 
Illumina) and longer amplicon lengths with PacBio achieving one-base resolution. This 
one-base resolution enables the research of important targets for vaccine development or 
drug resistant genes, all of which can differ by only one base. I have also introduced the tool 
PathWeaver which has enabled an often ignored but very important virulence factor for 
malaria in pregnancy, ​P. falciparum​ ​var2csa​. PathWeaver’s analysis of this region has 
allowed for the further study of the global diversity and copy number variation to a much 
greater extent than previously possible which should greatly aid vaccine development. And 
lastly, Carmen uses the PathWeaver algorithm on the wealth of publicly available data to 
augment targeted amplicon analysis results by reporting on where and when haplotypes 
have been found before. These tools should hopefully prove to be useful to the field for 
years to come.  
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